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Abstract 7
2. Abstract 
 
Every second, millions of blood cells are generated and destroyed by a 
mammalian organism. At the same time, a constant pool of hematopoietic stem cells 
that are able to self renew and reconstitute the entire blood system is maintained. 
The question of how HSC can achieve self renewal and differentiation at the same 
time remains unsolved. Asymmetric cell division has been proposed as a mechanism 
of asymmetric fate choice in HSC. Employing a new imaging and single cell tracking 
technology we address the question if HSC undergo asymmetric cell division. We 
observed divisional kinetics and marker expression of HSC and closely related MPP to 
elucidate if HSC produce asymmetrically fated daughter cells. We found that HSC 
show later cell cycle entry and also longer generation time in subsequent divisions 
compared to MPP and that this is an intrinsic property of HSC. However, HSC specific 
asymmetric generation time length of daughter cells is environmentally controlled 
and not intrinsic. The use of a live marker in our movies, CD48, which identifies cells 
that have lost the ability to reconstitute the bone marrow of a mouse for its lifetime, 
allows in vitro identification of asymmetric fate decisions between self renewal and 
differentiation. Quantification of cells with asymmetrically fated daughter cells, 
according to CD48 expression onset, reveals that most HSC produce asymmetric 
daughter cells, while most MPP do not. This behaviour is independent of the 
environment. This indicates that HSC intrinsically control asymmetric fates of 
daughter cells. 
Trying to elucidate the mechanism controlling these asymmetric fate decisions 
in HSC we chose candidates that are known to play a role in asymmetric fate 
decisions in other species or tissues. We examined if these candidates are 
segregated during HSC division and found no asymmetrically segregated protein 
when overexpressing Staufen1, Staufeni and Pumilio1 as fusions to VENUS protein. 
Furthermore, we analyzed if candidates had an influence on HSC and progenitor fate 
decisions in vitro and in vivo. We found that Staufen1 isoforms did not influence 
colony potential and lineage decision in vitro, Quaking1 isoforms influenced GM 
lineage decisions of progenitors in vitro and Pumilio1 overexpression led to reduced 
colony formation as well as altered GM lineage decisions. In HSC expansion 
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conditions as assayed by reconstitution experiments, we found, that Staufen1 
isoforms, Pumilio1 as well as Quaking1 isoforms did not allow HSC maintenance in 
recipient mice for 18 weeks. In HSC homeostatic conditions, as assayed in a 
transgenic mouse line, we found that Pumilio2 when expressed under Tie2 regulatory 
elements allows HSC maintenance in adult mice. Thus, we provide evidence that 
these genes, that were not implicated in hematopoiesis so far, could play a role in 
maintenance of HSC. 
In summary we show evidence that HSC produce asymmetric fates and that 
they control asymmetric fate choices between self renewal and differentiation 
intrinsically. We could exclude involvement of several candidate molecules in 
molecular control of asymmetric cell division. In addition, we provide a method to 
screen candidate genes for their role in asymmetric protein segregation. 
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3. Introduction 
 
3.1. The Hematopoietic System 
 Blood is a very complex organ system encompassing many different cell 
types that are produced in the bone marrow, mature in tissues like the lymph nodes 
and the thymus and fill arteries and veins. Blood is needed to transport oxygen and 
to close wounds, to ward off bacteria and clear viral infections. Every second, millions 
of blood cells are produced and destroyed in the body. The precursors of all blood 
cells are the hematopoietic stem cells (HSC) which maintain a constant pool of 
themselves throughout the lifetime of the organism and at the same time proliferate 
and differentiate into all mature blood cell lineages. 
 In the case of loss of a large proportion of mature and progenitor blood cells, 
for example during irradiation to treat leukemia, HSC are needed to replenish the lost 
cells. Given to an irradiated patient through a bone marrow transplant, they expand 
their numbers and also produce progenitor and mature cells. Human bone marrow 
and peripheral blood cells have been studied closely to identify HSC and to try to 
expand these cells to be able to transplant bone marrow from one donor into several 
hosts. However, the difficulty to perform in vivo experiments, have prevented the 
isolation of cell population with a high percentage of true HSC. The use of immuno-
compromised SCID mice as recipients of human bone marrow grafts allowed the 
purification of progenitor populations with 3% HSC purity (McKenzie, Takenaka et al. 
2007). However, it is not known if cells that are able to engraft in these murine hosts 
are the same cells that can engraft in humans and replenish the human bone 
marrow. These limitations in HSC purity and of in vivo experiments have prompted us 
to conduct our experiments on murine HSC, as they can be isolated with much 
higher purity (47%) (Kiel, Yilmaz et al. 2005) than their human counterpart. In 
addition, in vivo experiments analyzing long term HSC potential have a greater 
validity than engraftment across species. Finally, there are more tools available for 
mice than for humans, including unlimited samples (e.g. mice) and transgenic mice, 
and more knowledge about differentiation along blood cell lineages and identity of 
progenitors. 
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Figure 3.1: Differentiation of hematopoietic stem cells (HSC) into the lineages of 
the blood system. HSC are able to self renew for life and give rise to all myeloid and 
lymphoid blood lineages. The different MPP stages self renew only for a short time (weeks), 
but are still multipotent. Figure adapted from Rieger and Schroeder, 2008 and Wilson, 
Laurenti et al. 2008. 
 
 A model of the hierarchy of murine blood development from the HSC down 
to mature blood cells is depicted in Figure 3.1. It is believed, that blood cell 
differentiation can only start at the HSC on the left side and irreversibly follows one 
direction towards mature blood cells. Differentiation means the decision to change 
one cell type into a different cell type with different potential (e.g. cell lineage 
potential). Typically, differentiation is accompanied by a loss in potential. For 
example, HSC are able to self renew and reconstitute all the blood cells of an 
organism for its lifetime. When they give rise to MPP, HSC differentiate and loose 
lifelong reconstitution potential and their self renewal ability decreases. Self renewal 
is the capacity to produce progeny which are identical to the mother cell thus 
allowing maintenance of a certain cell type even during proliferation. It is not known 
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until what stage in the blood cell hierarchy cells still possess self renewal capacity 
however it is generally assumed that further differentiated cells possess less self 
renewal capacity than their more immature progenitors. 
 MPP have lost their potential to reconstitute the full hematopoietic system 
life-long (Yang, Bryder et al. 2005). However, just like HSC they are still multipotent, 
that means that they can give rise to all mature blood cell types. Blood cells that 
have differentiated from MPP and are not anymore multipotent are assigned to either 
the myeloid or lymphoid lineage. Cells of the myeloid lineage include erythroid cells, 
megakaryocytic, granulocytic and monocytic cells. They are produced by bipotent 
progenitor cells, the megakaryocyte-erythrocyte progenitor (MEP) and the 
granulocyte-monocyte progenitor (GMP), which are derived from MPP. 
 MEP differentiate into erythrocytes, which make up the majority of blood 
cells found in the blood stream and are necessary for transport of oxygen, as well as 
megakaryocytes, which are large cells that when fully matured produce platelets 
necessary for blood clotting. GMP give rise to granulocytes as well as monocytic cells 
which both play an important role in the first line of defence against pathogens and 
constitute the innate part of the immune system. They impede infections by 
producing substances detrimental to pathogens, phagocytose bacteria, and alert cells 
of the adaptive immune system. 
 Cells of the lymphoid lineage include B-, T- and Nk-cells, which provide the 
adaptive immune system. The common lymphoid progenitor (CLP) gives rise to these 
three blood cell types (Kondo, Weissman et al. 1997). B-cells produce antibodies 
specific to surface proteins on pathogens and constitute the humoral immunity. T-
cells as well as Nk-cells constitute the cellular immunity. They recognize processed 
antigen presented by antigen presenting cells of the innate immune system. 
 All of these blood cell types need specific environments that sustain either 
the maintenance of a certain maturation stage or provide cues for maturation 
towards mature cells. Maturation refers to a change in morphology and/or surface 
marker expression by cells that are already committed to a certain lineage. The 
environments supporting maturation or sustaining arrest in a maturation stage are 
called niches and each cell type needs a different niche that is constituted of various 
cell types providing surface bound as well as secreted signals to the blood cells. HSC 
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self renewal niches, for example can be found in the bone marrow and it is thought 
that they are supported by stromal cells (Moore and Lemischka 2006), osteoblasts 
(Calvi, Adams et al. 2003) and endothelial cells (Kiel, Yilmaz et al. 2005). Only signals 
from this niche are able to sustain HSC potential, the ability to reconstitute the bone 
marrow for life, indefinitely. Ex vivo culture attempts to imitate this niche, but usually 
a constant decline of HSC potential per culture time illustrates the insufficient 
capacity of the artificial niche to support HSC maintenance. Other blood cell types 
require niches to complete maturation. For example, T-cells have to migrate to the 
thymus, where they learn to distinguish self from non-self to produce functional T-
cells, and B-cells need maturation steps in spleen and lymph nodes to produce 
antigen specific antibodies. 
 
 
3.2. Expression of Surface Markers by Blood Cells 
 The different blood cell types found in the murine bone marrow can be easily 
distinguished by their expression of surface markers specific to certain maturation 
stages. Starting at the bottom of the hierarchy, the commitment to the erythroid 
lineage from MEP is characterized by the upregulation of the transferrin receptor 
CD71 (Rieger, Smejkal et al. 2009). Cells of the erythroid lineage are additionally also 
negative for myeloid as well as lymphoid markers. Further maturation of these 
erythroid progenitors is accompanied by a decrease in size and increase in 
haemoglobin concentration, which can be visualized by microscopic approaches. The 
maturation stages leading to fully mature erythrocytes have been defined from these 
snapshots in differentiation. They are also accompanied by a subsequent loss of 
CD71 expression and gain of Ter119 expression (reviewed in Testa 2004). The last 
step in erythrocyte maturation includes expelling the nucleus and the progressive 
loss of all organelles and yields reticulocytes. 
 Cells committed to the megakaryocyte lineage that eventually give rise to 
platelets have lost erythroid potential of their MEP progenitors and can be identified 
by the expression of CD41 (Pronk, Rossi et al. 2007). Megakaryocyte maturation is 
accompanied by an increase in size reflecting several rounds of endomitotic divisions, 
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which encompass DNA replication and nuclear segmentation but lack nuclear and 
cytoplasmic divisions (Cramer 1999). The maturation into proplatelets involves the 
formation of pseudopodial projections by fragmentation of megakaryocyte 
membranes. These proplatelets are subsequently filled with organelles and granules 
and upon detachment from the core form platelets (Kaushansky 2008). 
 Cells of the granulocytic and monocytic lineage have to undergo several 
maturation steps to arrive at mature macrophages and granulocytes (reviewed in 
Metcalf 2005). Both mature cell types express high levels of the integrin CD11b, also 
called Mac-1 (reviewed in Mazzone and Ricevuti 1995), but only mature granulocytes 
express the Ly6G antigen (Fleming, Fleming et al. 1993). Therefore, a combinatorial 
staining with antibodies directed against these two surface proteins can distinguish 
granulocytes from macrophages in fluorescent activated cell sorting (FACS) 
approaches. 
 The progenitors of the four described mature blood cell types, MEP, GMP and 
a population known as the common myeloid progenitor (CMP), which contains both 
GM and ME progenitor cells, are all characterized by the lack of lineage marker 
specific surface markers. They further have in common a lack of stem cell antigen 
(Sca)-1 expression, but express high levels of the receptor tyrosine kinase c-kit that 
serves as the receptor for stem cell factor (SCF). The three progenitors can be 
distinguished by their expression of the sialomucin CD34 and Fcγ receptor. MEP are 
low for FcγR and are low for CD34, CMP express CD34 but lack FcγR and GMP 
express high levels of both antigens. 
 Like myeloid cells, lymphoid cells can be identified by the expression of 
specific surface receptors as well. The maturation of B-cells is accompanied by a 
change in surface marker expression (reviewed in Hardy and Hayakawa 2001). For 
example, B220, the receptor of the pan hematopoietic marker CD45, as well as CD19 
are both expressed early in B-cell maturation and are thus utilized to identify bone 
marrow cells committed to the B-cell lineage. T-lymphocytes can be distinguished by 
FACS from other bone marrow cells by the expression of CD3, which is part of the T-
cell receptor (TCR) complex (reviewed in Kuby 1997). Natural killer cells share many 
characteristics with T-cells, but their maturation is thymus independent and they do 
not express TCR and CD3, but express Fcγ receptor and CD56 (reviewed in Jobim 
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and Jobim 2008). 
 CLP, the immediate precursors of all lymphoid cells, can be distinguished 
from myeloid progenitors as well as earlier multipotent progenitors by the expression 
of the IL7R. Antibodies against its α-chain allow specific isolation of early lymphoid 
cells (Kondo, Weissman et al. 1997). In addition, CLP express low levels of both sca-
1 and c-kit. 
CLP are derived from MPP that still have the potential to give rise to blood cells of 
both the myeloid and lymphoid lineages. MPP can self renew for a limited time and 
have been recently very thoroughly classified and subdivided according to their 
expression of surface markers (Wilson, Laurenti et al. 2008). All MPP are lineage 
marker negative, express high levels of both sca-1 and c-kit (KSL phenotype) and are 
positive for CD34 but can be subdivided by their expression of CD135. In addition, 
they differentially express the SLAM family receptors CD150 and CD48, which were 
recently found to be differentially expressed on stem and progenitor populations of 
the hematopoietic system (Kiel, Yilmaz et al. 2005). Their discovery as HSC markers 
have improved and facilitated the isolation of purer HSC populations. 
 In this thesis, MPP that are positive for CD34, but negative for CD135 are 
employed in various experiments. These MPP were not analyzed for the expression of 
CD150 and CD48 and therefore encompass MPP stages 1 through 3 from Wilson 
(Figure 3.1), but for simplification will be termed MPP. In addition, in some 
experiments Flt3+ MPP are utilized which represent MPP4 from Wilson and are 
identified as such. 
 HSC are at the top of the hierarchy of the hematopoietic system. HSC are the 
only blood cells that are able to self renew and reconstitute the bone marrow of an 
organism for life. In addition, they are able to proliferate and differentiate into all the 
mature blood cell lineages and progenitors including the MPP. How HSC manage to 
self renew and to differentiate at the same time remains an enigma. In recent years 
researcher have been able to study the properties of HSC closely through the 
advancement in isolating populations with a high percentage of HSC (Uchida and 
Weissman 1992). Like their MPP progeny, HSC display the KSL phenotype. However, 
when freshly isolated and quiescent, HSC are negative for CD34, but upregulate its 
expression when they become activated upon cytokine stimulation or mobilization 
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(Brown, Greaves et al. 1991). When isolating this population as CD34
-
KSL not all of 
these cells have HSC properties. Of freshly isolated CD34-KSL, 21%-40% are able to 
reconstitute lethally irradiated mice (Osawa, Hanada et al. 1996; Ema, Takano et al. 
2000). The addition of antibodies against SLAM receptors to the isolation scheme 
allows isolation of cell population that contain HSC with reconstitution potential 
higher than 47%. Freshly isolated HSC are positive for CD150 and negative for CD48 
in addition to their CD34-KSL phenotype (Kiel, Yilmaz et al. 2005; Wilson, Laurenti et 
al. 2008). As a further advantage of the SLAM code, it is possible to purify with the 
same marker combination adult as well as fetal HSC and HSC from mice of different 
strains as well as aged and reconstituted mice as this was previously not possible 
(Kiel, Yilmaz et al. 2005; Kim, He et al. 2006; Yilmaz, Kiel et al. 2006). The 
improvement in HSC purity in recent years enables researchers to tackle long 
standing questions concerning self renewal and differentiation of HSC. 
 
 
3.3. Elucidating the Mechanism of Asymmetric Cell Division 
 It is not known how precisely the stem cell pool of an organism stays 
constant during the course of its life and how at the same time short-lived mature 
cells are generated regularly. To reach this goal, the stem cell has to either produce 
two identical fated daughter cells whose fates are subsequently altered by extrinsic 
signals like cytokines or surface molecules on surrounding cells. Another possibility 
involves intrinsically controlled generation of differently fated daughter cells. The fate 
decision is made either in the mother cell prior to mitosis or directly during the 
division. This mechanism called asymmetric cell division (ACD) is widely used in cell 
specification during invertebrate development, however it is not known if this 
mechanism is utilized by mammalian HSC (Figure 3.2). 
 Several scenarios of mechanisms controlling ACD have been reported in 
invertebrates. In the Drosophila germ line only one of the prospective daughters of 
the germ line stem cell receives maintenance signals from the surrounding niche (Xie 
and Spradling 2000). While the daughter lying adjacent to the niche remains a stem 
cell, the other daughter differentiates. In Drosophila eye development, lateral 
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inhibition causes two identical precursor daughter cells to induce different cell fates 
amongst each other (Baker, Mlodzik et al. 1990). The third example of cell 
specification during division involves the asymmetric segregation of a factor in the 
mother cell and its subsequent inheritance by only one daughter, which leads to 
asymmetric fate specification in the daughter cells (reviewed in Schroeder 2007). 
From invertebrates like Drosophila we know that asymmetric protein 
segregation is employed for cell specification during embryonic development. In the 
hematopoietic system the only example of ACD was shown in T-cells which display 
factor segregation upon stimulation by an antigen presenting cell and subsequent 
asymmetric cell fate specification in their daughters (Chang, Palanivel et al. 2007). 
However, whether ACD occurs in mammalian HSC is unclear at the moment. 
 
 
 
Figure 3.2: Asymmetric cell division (ACD) of HSC. ACD describes a hypothesis that 
links asymmetric HSC daughter cell fates to intrinsic decisions taking place during HSC 
mitosis. Fate decisions take place during division and influence asymmetric fates of daughter 
cells (A). One possibility involves segregation of self renewing or differentiation promoting 
factors during division (B). 
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3.4. Requirement for Time Lapse Microscopy and Single Cell Tracking 
 It is conceivable that HSC employ asymmetric cell division by segregating 
determinants that ensure self renewal or lead to differentiation in one daughter cell 
to meet the needs of long lived mammalian organisms with a constant need of short 
lived mature blood cells. Many studies have tried to tackle this long standing 
question. However, so far it has proven too challenging to connect events taking 
place during HSC division with fate choices of their progeny. 
 In order to study the mechanism of ACD that controls cell specification it is 
necessary to connect divisions of individual HSC to the fates of their daughters. 
Events taking place during division, like protein segregation, have to be observed and 
their effect on fate specification has to be analyzed. Asymmetric protein segregation 
during division is a process which can be captured only when monitored constantly. 
Snapshots of mitotic cells are difficult to obtain without manipulating cells to arrest 
them during mitosis. It is furthermore difficult to ensure from a still image if two 
adjacent cells are sister cells, and if a protein is segregated during division or if it is 
just silenced in one daughter. 
 To identify HSC daughter cell fates, fluorescent markers and morphological 
criteria can be employed that identify cells committed to a certain lineage. However, 
these fates of HSC become apparent only after days or weeks have passed and the 
cells have undergone several divisions. Even when starting with a single cell per well, 
after two divisions, the identity of each cell is not apparent anymore in still images. 
To overcome this problem, researchers have used micromanipulation to separate 
cells after their division and used reconstitution experiments and colony assays as a 
fate readout (Ema, Takano et al. 2000; Takano, Ema et al. 2004). With this method 
they could identify daughter and granddaughter fates of HSC. However, it was not 
possible to observe divisions directly and it is not known if manipulation of the cells 
might have altered their fates. 
 Consequently, to study protein segregation and fate choice in HSC it is 
indispensable to monitor cells constantly over several days. Thus, we have developed 
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a novel imaging and tracking system in our lab, that allows continuous observation 
using time lapse microscopy (Rieger and Schroeder 2008; Eilken, Nishikawa et al. 
2009; Rieger, Hoppe et al. 2009). In our time lapse setup we can culture cells for at 
least two weeks, while phase contrast images with a high resolution are taken in 2 
minute intervals. A motorized stage moves the culture vessels to allow monitoring of 
several positions which allows the continuous observation of large areas in a culture 
dish including migrating cells and expanding colonies. Fluorescence images are taken 
to identify fluorescent marker expression by cells that have reached certain 
maturation stages and to monitor segregation of fluorescently tagged proteins during 
division. 
 The collected time lapse videos are then analyzed frame by frame with the 
help of a self-programmed tracking software that allows manually tracking of 
individual cells and their progeny (Eilken, Nishikawa et al. 2009). Their ancestral 
relationship is recorded in pedigrees that contain information regarding cell division, 
generation time, migration, adherence, speed, cell death, morphological changes and 
marker expression of the analyzed cells. In addition, it is possible to quantify 
fluorescence intensities of labelled proteins that vary in expression strength. The 
information obtained from the individual pedigrees can then be statistically analyzed 
by the same program, yielding continuous population data with single cell resolution. 
 The combined use of high resolution time lapse imaging and single cell 
tracking allows us to elucidate longstanding hypotheses, for example if HSC undergo 
ACD, by examining protein segregation during division and evaluation of its effect on 
fate choices of HSC daughters. 
 
 
3.5. HSC Properties 
 Researchers have not been able to clarify if HSC use ACD as a mechanism of 
cell specification. However, many other properties of HSC have been elucidated in 
recent years. A hallmark of HSC is that they stay quiescent in their bone marrow 
niches during homeostasis conditions in an adult mammalian organism. When no 
expansion of HSC is needed, they divide very rarely (only every 36 to 145 days) and 
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are kept mostly in G0 and G1 phase of the cell cycle (Wilson, Laurenti et al. 2008). In 
this quiescent state, HSC have been shown to possess a more potent reconstitution 
capacity than activated HSC that are in S/G2/M phase (Nygren, Bryder et al. 2006). 
Many studies examining HSC properties however use cytotoxic drugs like 5-FU or 
BrdU to eliminate mature cells or to directly label HSC in vivo (Boswell, Wade et al. 
1984). However, these agents induce stress and so HSC leave their dormant state 
and enter the cell cycle to replace the damaged or lost cells (Wilson, Laurenti et al. 
2008). Therefore, many properties of HSC found by studies using agents that cause 
stress are properties that HSC display in artificial expansion conditions and not 
during normal homeostasis. When activated by stress or mobilizing agents, HSC 
change their surface marker expression. They for example upregulate CD34 which is 
absent in quiescent HSC (Sato, Laver et al. 1999) and activate various signalling 
cascades, like the FoxO3/Akt pathway (Yamazaki, Iwama et al. 2006). In addition, 
activated HSC divide more frequently and therefore spend an increased time in 
S/G2/M cell cycle phase (Kiel, Yilmaz et al. 2005; Nygren, Bryder et al. 2006; Wilson, 
Laurenti et al. 2008). In these characteristics, activated HSC resemble their 
immediate progeny the MPP more closely than their quiescent HSC sisters. MPP 
contain fewer cells in G0/G1 than HSC, have much shorter cell cycle transit times and 
do not contain as many long term label retaining cells within their population as true 
HSC (Nygren, Bryder et al. 2006; Wilson, Laurenti et al. 2008) 
 As the in vivo observation of HSC at the single cell level over time is 
impossible at the moment, it is indispensable to culture these cells in vitro in order to 
examine ACD of HSC. In addition, expansion of HSC is an important goal for clinical 
applications. The analysis of in vitro HSC maintenance and control of self renewal are 
important steps towards this goal. When culturing HSC in vitro, through cytokine 
stimulation they become activated, gaining therefore many properties of MPP. 
Therefore, we decided to compare the behavioural differences of HSC and MPP 
regarding their fate decisions in vitro to identify intrinsically controlled properties of 
HSC that are retained in culture. 
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3.6. Assays for HSC and Progenitor Cells 
 Examining the behaviour and fate potential of HSC and MPP, assays to 
measure these properties are needed. The only assay that identifies HSC as such 
involves the evaluation of their reconstitution potential of bone marrow cells in vivo. 
Cells are injected into the tail vein of a mouse from where they are homing via the 
blood stream to the bone marrow. In order to avoid elimination of the introduced 
stem cells by the immune system of the recipient, it is necessary to utilize immune 
compromised or irradiated wildtype mice as recipients. To analyze the reconstitution 
ability of the injected cells, donor mice with a different blood cell surface allele or a 
fluorescent marker are utilized. The peripheral blood of the recipient mice is then 
analyzed for at least 16 weeks for the presence of donor type blood cells, at which 
time only true donor HSC are still able to give rise to differentiated cells in the 
periphery. However, by definition, to prove self-renewal potential it is necessary to 
transplant bone marrow from these mice into secondary recipients. To assess exact 
numbers of HSC potential within a population of cells, they can be transplanted in 
limiting dilution. By coinjection of the cells of interest with competitor cells the exact 
number of competitive repopulation units (CRUs) present in the initial population can 
be measured (Szilvassy, Humphries et al. 1990). 
 In contrast to true stem cell potential, proliferation and multilineage potential 
can also be evaluated by in vitro assays. For example, myeloid as well as B-cell 
colony forming potential can be assayed by plating the cells in semisolid media 
containing cytokines that allow the formation of all myeloid and B-lymphoid lineages, 
respectively (Bradley and Metcalf 1966; Metcalf, Nossal et al. 1975). In this assay 
cells are seeded into semisolid media containing various growth factors and are 
allowed to proliferate and differentiate. After a certain amount of time colonies 
produced by the seeded cells are scored and identified according to colony 
morphology and blood cell types they contain. With this assay it is possible to read 
out the proliferation potential (size of colonies), colony formation potential (number 
of colonies) as well as lineage choice (types of colonies) of any blood cell progenitor 
population. 
In summary we can only identify HSC by their ability to reconstitute the bone 
marrow of a mouse and it is not possible to use any in vitro assays to identify HSC. 
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The two described assays provide us with means to evaluate stem cell and in vitro 
proliferation and multilineage potential of freshly isolated, cultured as well as 
manipulated HSC and their progenies. 
 
 
3.7. Using in vitro Markers to Label Stem Cells and Differentiated Cells 
 When examining stem cell fate choices in vitro and identifying self renewal 
as well as differentiation behaviour, it is important to be able to distinguish cultured 
cells that have retained or lost their HSC potential. As cultured HSC can only 
retrospectively be identified by transplanting single cells into lethally irradiated hosts, 
we have to rely on marker expression which correlates with reconstitution potential. 
Unfortunately HSC cannot be isolated by a single marker, but require several 
antibodies labelled by different colours for identification. In addition, several of the 
markers that distinguish freshly isolated HSC from their more differentiated progeny, 
are actually markers that recognize cell activation and mobilization rather than 
reconstitution potential. These markers, for instance CD34, are not present in 
dormant HSC, but are upregulated upon activation of HSC by cytokine stimulation in 
vitro (Sato, Laver et al. 1999). 
 In contrast, there are many markers available for labelling mature blood 
cells. Especially cells derived from transgenic mice that express a fluorescent protein 
under the control of lineage specific markers, therefore, identifying specific lineages, 
have been useful in a great number of studies. For example, cells committed to 
either the granulocyte or macrophage lineage can be identified by the expression of 
EGFP that is knocked into the Lysozyme M locus (Faust, Varas et al. 2000). Lysozyme 
M is contained in neutrophil granules (Cramer and Breton-Gorius 1987) and is 
secreted by macrophages (Gordon, Todd et al. 1974) and is utilized by these cells to 
cleave components in the cell wall of bacteria and thus serves as a pathogen defence 
mechanism. In these transgenic mice, EGFP expression identifies cells that have lost 
the bipotentiality of GMP and are committed to either the granulocytic or monocytic 
lineage (Rieger, Hoppe et al. 2009). 
 Cells committed to the megakaryocyte lineage can be identified either by 
antibody detection of CD41 surface expression or by utilizing cells from CD41 
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membraneYFP Knockin mice (Zhang, Varas et al. 2007). Cells of the erythroid lineage 
can be identified using cells of transgenic mice expressing ECFP under regulatory 
elements of the β-globin gene (Heck, Ermakova et al. 2003). Cells of the lymphoid 
lineage can be identified by utilizing cells derived from mice heterozygously 
expressing GFP knocked into the Rag1 gene identifying early lymphoid progenitors 
(Kuwata, Igarashi et al. 1999) as well as taking cells derived from mice expressing 
Pax5 controlled GFP identifying committed B-cell progenitors (Fuxa and Busslinger 
2007). In few cases phase contrast microscopy can help to identify the identity of 
cells. Developing megakaryocytes undergo endomitosis and increase in size during 
their maturation, which can be easily followed by time lapse microscopy. 
 With the described markers it is possible to identify all the mature cell types 
of the blood system in culture. Therefore, retrospectively the lineage commitment of 
progenitor cells can be concluded. However when examining fate decisions of HSC, it 
takes several days or even weeks to differentiate an HSC into a mature cell that can 
be recognized by these markers. Thus, in vitro differentiation of HSC cannot be 
monitored easily at the single cell level. In order to overcome this problem, a marker 
identifying early differentiation or loss of stemness is required. Recently, the SLAM 
code marker CD48 that is not expressed on freshly isolated HSC, but on progenitors 
that have lost stem cell potential was shown to also identify the loss of reconstitution 
potential in cultured cells (Noda, Horiguchi et al. 2008). 
 In summary although many markers are known that label maturation stages 
of mature blood cells, no single marker exists that can identify HSC in culture. CD48 
however can be used indirectly to identify HSC in culture, as it reveals loss of 
stemness events during HSC differentiation. 
 
 
3.8. Environment for Blood Cells: The Niche 
The natural environment for HSC in vivo is constituted by the stem cell niche 
which provides HSC with cues for self renewal and differentiation (Moore and 
Lemischka 2006). The identity of the niche cells is not fully elucidated yet, but it is 
speculated that a mixture of osteoblasts (Calvi, Adams et al. 2003), endothelial cells 
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(Heissig, Hattori et al. 2002), stromal cells (Dexter, Wright et al. 1977), as well as 
blood cells provide self renewal and differentiation signals to HSC. In vitro this niche 
can be recapitulated by the use of stromal cells, either derived directly from primary 
bone marrow or by using immortalized stromal cell lines. A wide variety of stromal 
cell lines have been generated for various purposes, but only few of them support 
maintenance of hematopoietic stem cells. Some of the stromal cell lines that can 
maintain at least some HSC potential in culture over a few days to several weeks are 
summarized below. 
In order to examine protein segregation and asymmetric fate decisions in HSC 
it is necessary to provide an environment that supports HSC maintenance. At the 
same time, the differentiation into and survival of progenitor cells that can be 
identified by the expression of loss of stemness or lineage restricted markers has to 
be possible. For the quantification of asymmetric fates of stem cell progeny, it is 
important to ensure that the chosen environment supports the generation of 
asymmetric fates 
 
 
3.8.1. Artificial Environment: Stromal Cell Lines 
 PA6, which are a pre-adipose stromal cell line derived from the calvaria of 
newborn mice (Kodama, Amagai et al. 1982), have been utilized to provide a stem 
cell maintaining environment for HSC. PA6 have been shown to be able to sustain at 
least some HSC potential for two to six weeks (Kodama, Nose et al. 1992; Szilvassy, 
Weller et al. 1996; Shimizu, Noda et al. 2008). The addition of cytokines, which 
induce survival signals increased the percentage of HSC maintained (Szilvassy, Weller 
et al. 1996). PA6 are also able to support the growth of MPP-like spleen colony 
forming units and their differentiation into mature myeloid lineages and can support 
long term hematopoiesis in vitro for several weeks (Kodama, Amagai et al. 1982; 
Kodama, Sudo et al. 1984). With the addition of IL-7 to PA6 cocultures, PA6 stromal 
cells are also able to support B lymphopoiesis (Sudo, Ito et al. 1989). 
 Another widely used stromal cell line, AFT024, are derived from the fetal 
liver and support the maintenance of adult bone marrow as well as fetal liver HSC for 
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up to 7 weeks (Moore, Ema et al. 1997). In addition to HSC maintenance, AFT024 
also support the generation of progenitors as well as mature blood cell types. 
A third stromal cell line, OP9 cells, are derived from newborn B6C3F1-op/op mouse 
calvaria lacking a functional M-CSF receptor (Kodama, Nose et al. 1994). OP9 are 
widely known to support hematopoiesis and are commonly used to differentiate ES-
cells into mature blood cell lineages (Nakano, Kodama et al. 1994; Nakano, Kodama 
et al. 1996) as well as for the study of lymphocyte development from bone marrow 
progenitors (Wang, Pierce et al. 2005; Wang, Pierce et al. 2006). However, OP9 have 
not been sufficiently proven to support the maintenance of HSC. 
 Other stromal cell lines with varying degrees of HSC supporting capacity 
have been described (Szilvassy, Weller et al. 1996; Wu, Kwon et al. 2007), however 
these cell lines are not widely used and therefore not useful for our purpose. 
Confronted with the challenge to choose an appropriate stromal cell line, we decided 
that OP9 are not appropriate to provide an HSC supporting environment. AFT024 do 
maintain HSC, however they are not contact inhibited and need to be irradiated for 
HSC co-culture. This results in a less uniform cell layer that makes identification of 
HSC on these stroma cells difficult which is a disadvantage for imaging purposes. 
Finally, PA6 are contact inhibited and optically clear, they support HSC over a 
timeframe interesting for imaging purposes and several researchers have used this 
cell line to study hematopoiesis. Therefore, we decided to use PA6 to provide an in 
vitro niche to study HSC fate decisions. 
 
 
3.8.2. Artificial Environment: Stroma Free Suspension Culture 
 Stromal cell lines provide supporting and differentiation signals through 
direct cell - cell contact as well as by secreting cytokines. In addition, the cultivation 
of HSC on stromal cells requires the use of serum. The variety of signals from 
cytokines, surface proteins and serum components are not well defined and 
characterized and therefore make it difficult to assess the cause of a behavioural 
change in the blood cells. In order to distinguish intrinsic properties and decisions of 
HSC from behavioural changes that are the result of extrinsic cues it is necessary to 
compare HSC behaviour in different environments. Therefore, we decided in addition 
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to an environment that closely resembles the in vivo niche, to use a clearly defined 
culture system where HSC are kept in stroma free, serum free medium with the 
addition of specified growth factors. 
 Assessing self-renewal divisions of HSC, just like on stromal cells, conditions 
are needed that maintain stem cells over several days, and allow the generation of 
progenitor as well as mature blood cell types. As we want to study ACD, that by 
definition should keep HSC numbers constant, it is important to choose culture 
conditions that maintain HSC numbers, but do not expand them, as this would point 
towards symmetric self renewal divisions rather than asymmetric maintenance 
divisions. 
 A cytokine known for its activity to support stem cell survival is SCF, which is 
the ligand for c-kit. SCF was shown to maintain stem cells in culture for at least 3 
days (Seita, Ema et al. 2007). However, SCF alone does not support proliferation or 
multi-lineage differentiation in vitro (Kato, Iwama et al. 2005) which excludes it as a 
condition to monitor asymmetric fates of HSC. 
 In contrast, single HSC suspension culture with the addition of both SCF and 
thrombopoietin (TPO) as well as SCF together with Interleukin 3 (IL3) maintained 
stem cell potential for several days, without expanding the number of stem cells 
(Ema, Takano et al. 2000). Further, these conditions allow for the differentiation of 
HSC into mature lineages and do so by generating asymmetric fates of HSC 
daughters and granddaughters (Takano, Ema et al. 2004). 
 Although asymmetric fates have been previously studied under these 
conditions we wanted to elucidate on the single cell level and under constant 
observation how asymmetric fates are generated. Therefore, we decided to use 
these two conditions that support limited stem cell maintenance of HSC to study their 
fate decisions. In addition, we decided to compare this data of HSC behaviour in 
supporting suspension conditions to non supporting conditions provided by SCF and 
Interleukin 6 (IL6) (Ema, Takano et al. 2000) and to HSC behaviour on PA6. 
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3.9. Mechanism Influencing Asymmetric Fate Decisions: Protein 
Segregation 
 Trying to elucidate the influence of protein segregation on HSC fate 
decisions, we decided to use a candidate approach and test if selected proteins play 
a role in this process. We selected candidate genes according to two criteria: Firstly, 
genes were chosen that are known to play a role in ACD in organ systems of 
invertebrates like Drosophila or C. elegans, or in other mammalian tissues. We also 
were interested in genes that regulate other genes on the RNA level, as it was 
hypothesized that this may be a mechanism important in stem cell fate specification. 
Determinants important for cell specification are often found already to be present in 
the undifferentiated stem cell as RNAs waiting to execute decisions by translation 
into proteins once a differentiation cue has been received. Finally it was of course 
important to test if the selected genes are expressed in mouse HSC. 
 
 
3.10. Candidate Genes for Protein Segregation 
3.10.1. Candidate Gene Staufen 
 As the first candidate for experiments elucidating ACD in HSC we chose 
Staufen. Staufen was first identified in a genetic screen of embryonic patterning 
determinants in Drosophila (Schupbach and Wieschaus 1986). Staufen protein 
contains dsRNA binding domains (dsRBD) with which it binds target mRNAs 
sequence independently within the 3’UTR (St Johnston, Brown et al. 1992; 
Ferrandon, Elphick et al. 1994; Li, Yang et al. 1997; Wickham, Duchaine et al. 1999). 
By employing separate domains, Staufen links target mRNAs to actin and microtubule 
filaments and transports them to the rough endoplasmatic reticulum (rER) for 
translation (Wickham, Duchaine et al. 1999; Micklem, Adams et al. 2000). By 
localizing target mRNAs, Staufen generates mRNA gradients within a mother cell that 
are subsequently segregated into only one of the daughter cells. This happens in the 
Drosophila germline (St Johnston, Beuchle et al. 1991) where Staufen plays an 
important role in determining already in the oocyte anterior-posterior axis formation 
of the developing embryo. By asymmetrically localizing homeobox mRNAs within the 
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Drosophila oocyte, Staufen sets the stage for early embryonic patterning after 
fertilization (St Johnston, Driever et al. 1989; Ephrussi, Dickinson et al. 1991; Kim-
Ha, Smith et al. 1991; Ferrandon, Elphick et al. 1994; Kim-Ha, Kerr et al. 1995). 
 Staufen also plays a role in ACD in cell specification in the developing 
nervous system of Drosophila (St Johnston, Beuchle et al. 1991). There, Staufen is 
responsible for the basal localization of the mRNA of the homeobox gene Prospero 
(Li, Yang et al. 1997; Broadus, Fuerstenberg et al. 1998). Prospero and Staufen are 
then segregated into only one daughter of a dividing neuroblast which leads to the 
specification of the ganglion mother cell. 
 In mammals, two homologues of Drosophila Staufen exist. Nothing is known 
about a role of either protein in ACD or cell specification. However Staufen1 and 
Staufen2 both play important roles in several cellular processes, like dendritic 
transport (Kiebler, Hemraj et al. 1999; Kohrmann, Luo et al. 1999; Tang, Meulemans 
et al. 2001; Duchaine, Hemraj et al. 2002) and translational initiation (Dugre-Brisson, 
Elvira et al. 2005). Mammalian Staufen also regulates nonsense mediated mRNA 
decay (Kim, Furic et al. 2005), binds to human Telomerase RNA (Le, Sternglanz et al. 
2000) and plays a role in genomic RNA encapsidation in Lentivirus assembly 
(Mouland, Mercier et al. 2000). There is no known function for Staufen1 in the blood 
system, but expression data reveals expression of human Staufen2 in hematopoietic 
progenitor as well as leukemic cells (Faubert, Lessard et al. 2004). 
 We decided to use Staufen as a candidate gene since it plays an important 
role in ACD in invertebrates. We decided to concentrate on Staufen1, rather than 
Staufen2 as a candidate gene, since its reading frame was easily accessible. Staufen1 
gene produces two alternative splice forms, Staufen1 and Staufeni. Both are 
expressed in all major tissues and we tested expression in bone marrow progenitor 
populations and HSC (see Results). Staufen1 and Staufeni localize within the rER and 
found together in the same RNA-protein complexes. Staufeni contains an amino acid 
insertion into the dsRBD3 which results in a reduced dsRNA binding affinity of 
Staufeni. It has been suggested that Staufeni regulates the amount of mRNA present 
within Staufen mRNA complexes (Wickham, Duchaine et al. 1999; Duchaine, Wang et 
al. 2000). 
 In summary, Staufen plays a role in asymmetric cell division in Drosophila 
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development, regulates cellular processes on the RNA level and is expressed in HSC. 
This renders Staufen an ideal candidate gene to examine ACD in HSC. In addition, 
the existence of a natural mutant, Staufeni provides us with an ideal functional 
control. 
 
 
3.10.2. Candidate Gene Pumilio 
 As a second candidate gene, we chose Pumilio, which was first identified in 
Drosophila and is the founding member of the PUF proteins consisting of six domains 
containing a 36 amino acid repeat (Lehmann and Nusslein-Volhard 1991; Macdonald 
1992). Pumilio plays an important role in ACD in Drosophila as well as in C. elegans 
germ line stem cells (Lin and Spradling 1997; Forbes and Lehmann 1998; Crittenden, 
Bernstein et al. 2002). Pumilio executes its function by binding sequence specifically 
to the 3’UTR of target mRNAs and represses their translation (Murata and Wharton 
1995). In Drosophila for example, Pumilio represses translation of the mRNA of the 
anterior determinant Hunchback at the posterior end of the embryo, leading to 
formation of the abdominal segments (Barker, Wang et al. 1992). 
 In mammals two separate Pumilio genes exist, that play an important role in 
mammalian stem cells and in differentiation processes and act on the RNA as well as 
protein level. As in Drosophila, mammalian Pumilio2 is expressed in female and male 
germ cells as well where it interacts with proteins and mRNAs with a function in 
fertility and maintenance of germ cells (Moore, Jaruzelska et al. 2003; Spik, 
Oczkowski et al. 2006). In addition to its function in germ cells, Pumilio also plays a 
role in further differentiated cells of the nervous system. It regulates neuronal 
excitability through controlling Na+ channel mRNAs (Schweers, Walters et al. 2002; 
Mee, Pym et al. 2004; Muraro, Weston et al. 2008) and modulates synaptic function 
and morphology in developing neurons (Menon, Sanyal et al. 2004; Ye, Petritsch et 
al. 2004; Vessey, Vaccani et al. 2006). 
 Pumilio expression in germ cells and the early embryo points towards a 
general role in stem cell regulation. Also, C.elegans Pumilio proteins have been 
shown to regulate mRNAs encoding MAP kinase proteins, which are implicated in 
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stem cell maintenance and tumor progression (Lee, Hook et al. 2007). Pumilio’s 
putative role in stem cell regulation is further corroborated by the fact that Pumilio1 
and 2 are expressed in stem cell enriched populations of mouse fetal liver and adult 
bone marrow (Spassov and Jurecic 2003). 
 The described expression of Pumilio1 and 2 in early bone marrow 
progenitors as well as their function as translational repressors and their role in 
asymmetric cell division in invertebrates have led us to choose these genes as further 
candidates for asymmetric cell division in mouse hematopoietic stem cells. 
 
 
3.10.3. Candidate Gene Quaking1 
 As a third candidate gene we chose a member of the signal transduction and 
activator of RNA (STAR) family of proteins. The STAR domain is composed of a KH 
homology  (hnRNP K homology) domain, responsible for RNA binding, flanked by two 
QUA domains that manage signal transduction (Vernet and Artzt 1997). The 
C.elegans gene Gld1 (Jones and Schedl 1995) as well as the closely related mouse 
gene Quaking1, are both members of this family. This protein family was interesting 
to us, because in C.elegans Gld1 is a target of the Pumilio homologue Fbf. Fbf 
represses the translation of Gld1 mRNA to prevent germ line stem cells to enter 
meiosis (Crittenden, Bernstein et al. 2002; Suh, Jedamzik et al. 2006). Gld-1 protein 
itself acts as a translational repressor and controls mitosis promoting genes such as 
the Notch receptor Glp1, thereby favouring entry of germ line stem cells into the 
meiotic pathway (Francis, Barton et al. 1995; Marin and Evans 2003). 
 The mammalian homologue of Gld1, Quaking1, is the gene found partially to 
be responsible for the quaking mutant phenotype, described in mice that display a 
myelination defect and shaking behaviour (Sidman, Dickie et al. 1964). Quaking1, 
like its homologue, is regulated at the RNA level and itself regulates, for instance, 
myelin basic protein, by binding to its RNA. This interaction is necessary for correct 
myelination of Schwann cells in the developing brain (Ebersole, Chen et al. 1996; 
Hardy, Loushin et al. 1996; Li, Zhang et al. 2000). 
 Quaking1 produces 3 major transcripts, which apart from their expression in 
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the brain, are also expressed in a variety of other tissues. Quaking1 isoforms are 
expressed in the visceral endoderm of the yolk sac in mouse and control endothelial 
cell proliferation as well as vascular remodelling during development (Noveroske, Lai 
et al. 2002; Bohnsack, Lai et al. 2006) Also in Xenopus embryogenesis a Quaking1 
homologue is found in the organizer region and the notochord during gastrulation 
(Zorn and Krieg 1997). In chicken the transcripts of an orthologue of Quaking1 show 
differential expression in spermatogenesis (Mezquita, Pau et al. 1998). 
 The control of a STAR protein by a PUF family member in C.elegans makes 
mouse Quaking1 an interesting protein to study together with Pumilio in HSC. So far, 
nothing is known about a connection of Quaking1 and Pumilio in the mouse, 
however, we found both genes to be expressed in HSC. Therefore, Quaking1 is an 
interesting candidate gene to try to study fate decisions in these cells. Also 
Quaking1, like Pumilio, regulates its targets on the RNA level and is found in various 
stem cell types. As Quaking1 produces three known natural splice variants, we 
decided to incorporate all of them to study HSC fate choice. 
 
 
3.10.4. Candidate Gene Prominin1 
 Our last candidate gene, Prominin1, is a five transmembrane glycoprotein 
that localizes to cholesterol binding lipid rafts present in plasma membrane 
protrusions. (Weigmann, Corbeil et al. 1997; Roper, Corbeil et al. 2000). Prominin1 is 
the first gene that has been implicated to play a role in ACD in mammals. In dividing 
neuroepithelial cells, Prominin1 concentrates at the midbody apical surface. Upon 
division, the midbody is released and, if the cells are undergoing asymmetric 
divisions, the apical surface containing Prominin1 is retained by one of the 
daughters. In symmetric divisions, the released midbodies are called prominosomes 
and include apical membrane containing Prominin1. They can be found in the lumen 
of the neural tube as well as in all bodily fluids (Marzesco, Janich et al. 2005; 
Dubreuil, Marzesco et al. 2007). 
 A similar mechanism has been suggested but not been proven to occur in 
human hematopoietic progenitor cells (Bauer, Fonseca et al. 2008). In these cells, 
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Prominin1 shows a polarized distribution during migration and can be asymmetrically 
distributed during mitosis (Giebel, Corbeil et al. 2004; Fargeas, Fonseca et al. 2006; 
Bauer, Fonseca et al. 2008). It is not known however, if this asymmetric localization 
influences fate decisions in the daughter cells, as these studies were done in fixed 
cells. 
 Human Prominin1, also known as CD133, has led to the isolation of purer 
stem and progenitor cells from various tissues, including neuronal and hematopoietic 
stem cells and is now regarded as a pan adult stem cell marker (Yin, Miraglia et al. 
1997; Richardson, Robson et al. 2004; Lee, Kessler et al. 2005). However, nothing is 
known so far about the expression of Prominin1 in mouse HSC and progenitor cells 
and there is no information about the function of Prominin1 in any cell type. 
Nevertheless, found Prominin1 an interesting candidate for protein segregation and 
influence on HSC fate decisions and decided to analyze its expression in mouse HSC. 
 All of the discussed genes are involved in ACD or fate decisions of stem cells 
of various cell types and species. Because such basic and ancient mechanisms such 
as protein segregation and ACD are often conserved across species and cell types, it 
is possible that these genes also play a role in HSC asymmetric fate decisions of 
mammals. Three of the candidates also influence their target genes on the RNA 
level. It is known, that in stem cells of all tissues, many of the genes necessary for 
the differentiation into mature cells are already present as RNAs but not as proteins 
in the stem cell compartment. Translational repressors, like Pumilio, are needed to 
prevent translation of these RNAs into proteins and therefore could provide a 
checkpoint control for differentiation into progenitors and loss of stemness. 
Therefore, RNA regulation could be a common characteristic of genes regulating 
stem cell fate decisions. 
 
 
3.11. Experimental Approach 
 There are several possibilities to screen for candidate genes that play a role 
in ACD in HSC. The most physiological method would be to knock in a fluorescent 
reporter protein fused to the reading frame of the candidate gene into the natural 
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locus of the gene. With this system, the kinetics of unmanipulated wildtype gene 
expression can be observed in all cell types and during every developmental stage. A 
disadvantage to this approach is that it is not useful for screening candidates 
because of the great effort and time that is needed to generate Knock-in lines. 
 Another commonly employed approach to examine physiological protein 
segregation in vitro uses antibody detection of endogenous candidate proteins in 
fixed cells. Although it is possible to observe wildtype expression and distribution of 
candidate proteins with this method, it has severe disadvantages. In order to capture 
a large number of cells during mitosis, agents to arrest cells during division have to 
be employed and can influence protein segregation. More importantly, observing the 
segregation of proteins in fixed cells does not allow following the fates of the two 
daughter cells, which cannot be read out until several days after the division took 
place. Without a fate-readout of the daughter cells, it is impossible to make a 
statement about the influence of a candidate protein that is segregated during 
division on fate choices of HSC daughters. 
 The third avenue to elucidate the mechanism of ACD is to exogenously 
introduce a fusion of the candidate gene with a fluorescent protein into the cell and 
to visualize the segregation of this protein chimera during division, proliferation and 
differentiation towards various cell fates. The disadvantage to this approach is that it 
introduces non-physiological levels of the transgene since its expression is controlled 
not by its endogenous, but by an exogenous promoter. This could lead to overloading 
of the protein segregation machinery and proteins that are segregated 
asymmetrically when expressed endogenously could be missed using this approach. 
This method however, allows following the fate of both daughters by using our movie 
system combined with single cell tracking and provides a fast approach to screen 
several candidate genes. 
In addition to examining the role of candidate genes in protein segregation, 
the effect of candidate overexpression on HSC maintenance and lineage choice can 
be evaluated with this method as well. For this purpose the candidate gene and the 
fluorescent protein are separated by an internal ribosome entry site (IRES). In 
contrast to the fusion gene approach, this ensures that the wild type candidate 
protein is not altered by the fusion with a fluorescent protein and therefore, the 
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effect of the non-manipulated protein on stem cell function can be assessed. We 
chose to employ this method as it allows for fast screening of several candidate 
genes for their ability to segregate during stem cell divisions and to elucidate their 
role in fate determination. 
 
 
3.11.1. Overexpression of Candidates with a Lentivirus 
 For overexpression of the candidate genes in HSC a transfection system is 
needed. Since plasmid transfection using lipofectamine or similar reagents does not 
work well in primary cells, we chose to use a viral vector for gene transfer. γ-
retroviral vectors are widely used for gene transfer into hematopoietic cells, however, 
they are able to infect only dividing cells since they lack nuclear localization signals 
and the polypurine tract that are needed to cross an intact nuclear membrane 
(Uchida, Sutton et al. 1998; Chang and Sadelain 2007). 
 When introducing candidate genes by overexpression into HSC, it is 
important to consider that only 30-50% of starting cells will be true HSC (Osawa, 
Hanada et al. 1996; Ema, Takano et al. 2000; Kiel, Yilmaz et al. 2005). In addition, 
as HSC in maintenance conditions will undergo ACD as well as symmetric 
differentiation divisions, an even lower percentage of HSC within the total population 
will be present after the first division. The lower the number of true HSC within an 
evaluated population, the more difficult it will be to identify cells that show protein 
segregation and asymmetric fate choice in daughters as this is thought to be a 
mechanism highly specific to HSC. Therefore, it is important to introduce the 
candidate gene into cells that have not yet divided and monitor transgene 
segregation during the first division. As γ-retroviral vectors cannot infect quiescent 
cells, they are not useful for our purposes. 
 Lentiviral vectors, derived from the human immunodeficiency virus (HIV) can 
infect non dividing cells and are therefore the vector of choice to monitor protein 
segregation during first divisions (Naldini, Blomer et al. 1996). Lentiviral vectors of 
the 4th generation have been used widely to transduce bone marrow and specifically 
hematopoietic stem cells (Dull, Zufferey et al. 1998; Schambach, Galla et al. 2006). 
These lentiviral vectors are replication incompetent and lack virulence genes not 
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necessary for viral packaging and DNA integration. For added security, viral 
components are divided between four separate plasmids, ensuring that virus 
recombination cannot occur. 
 Lentiviral vectors can be made specific for various species as well as cell 
types by using different envelop proteins. Ecotropic pseudotyped lentiviral vectors 
can only infect rodents but not humans or other primates (Schambach, Galla et al. 
2006). Therefore, these viruses do not pose a risk to the researcher. In contrast, 
lentiviral vectors using an envelop protein from the Vesicular Stomatitis virus, the 
VSVG protein, can bind to all cells expressing the receptor for this protein, including 
rodent as well as human cells (Chang, Urlacher et al. 1999). Handling of these 
lentiviruses does pose a potential risk to the researcher. However, it is known that 
VSVG protein renders the Lentivirus more stable in ultracentrifugation and we found 
infection efficiencies of HSC to be higher with this virus. In experiments contributing 
to this thesis both virus types were used. 
 
 
3.12. Conclusion 
 In summary, the work presented in this thesis, explores the mechanism of 
asymmetric cell division as a means to control HSC self renewal. Towards this goal it 
was first examined if HSC produce daughters with asymmetric fates. The behaviour 
of cultured HSC regarding divisional kinetics and marker expression indicating loss of 
reconstitution potential was quantified using time lapse microscopy and single cell 
tracking and compared to the behaviour of closely related cells. It was further 
investigated if HSC specific behaviour is caused by certain environmental cues or if 
this behaviour is intrinsically controlled by HSC themselves. To this end behaviour or 
HSC and MPP was analyzed using several different culture conditions. 
 To gain insight into the molecular mechanism controlling potential ACD in 
HSC, candidate proteins were screened for their ability to segregate asymmetrically 
during HSC divisions. In addition, it was analyzed if the overexpression of candidates 
in HSC causes a change in fate choice and self renewal capacity. 
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4. Goals of the Thesis 
 
Asymmetric cell division has been shown to be a mechanism of cell 
specification in invertebrate as well as few mammalian cell types. For the 
hematopoietic stem cell (HSC) this mechanism has been long postulated, but could 
not be proven so far. 
The aim of my thesis is to employ time lapse imaging and single cell analysis 
to clarify if HSC undergo asymmetric cell division. First it has to be established if HSC 
produce asymmetric fates and whether they are controlled intrinsically by the HSC or 
extrinsically by the environment. Therefore, HSC behaviour on different environments 
needs to be compared. In addition, it is important to compare obtained data about 
marker expression as well as divisional kinetics and number of apoptotic events from 
HSC to closely related cells that have lost reconstitution potential, MPP, to be able to 
identify HSC specific characteristics. To identify asymmetric fates in daughter cells, a 
marker identifying either HSC or loss of HSC potential needs to be identified. With 
this marker, asymmetric fates of HSC and MPP daughters cultivated on different 
environments need to be quantified and compared to draw conclusions about the 
existence, the specificity to HSC, and the intrinsic or extrinsic control of asymmetric 
fates. 
Furthermore, the mechanism controlling asymmetric cell division needs to be 
explored. Several candidate genes have to be evaluated for their role in fate 
specification of HSC. First, lentiviral infection of HSC with viral vectors containing 
candidate genes has to be optimized to yield a high infection efficiency of HSC. 
Second, it has to be examined if candidate genes are segregated asymmetrically into 
HSC daughter cells when overexpressed as a reporter gene fusion. And third, it has 
to be established if candidate overexpression in HSC influences fate decisions in vitro 
and in vivo. 
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5. Results 
 
5.1. Asymmetric Fates of HSC Daughters 
5.1.1. Experimental Setup for Analysis of Asymmetric Fates 
In order to determine if HSC undergo ACD, it was first analyzed if HSC 
produce asymmetric fates. This requires following individual cells during the course 
of their proliferation and differentiation and quantifying their daughter cell fates. 
Fates of HSC and their progeny were observed on PA6 stroma as well as in stroma 
free suspension culture by time lapse microscopy. To elucidate HSC specific behavior, 
we compared them to closely related cells, MPP, which share the multi-lineage 
potency of HSC but have lost their long term self renewal potential. This enables us 
to identify behavior that is specifically connected to self renewal of HSC. 
To this end we isolated the bone marrow of 12 week old male C57Bl6/6J mice 
by crushing femur and tibia to dislodge bone marrow cells from the bone. Cells were 
stained with antibodies for the isolation of HSC populations. HSC and MPP were 
isolated by using CD48-CD34-Flt3-KSL and CD34+Flt3-KSL marker combinations 
respectively (Figure 5.1). In detail, cells with small size and low granularity 
containing immature cells were gated in the FSC/SSC plot. These cells were further 
purified by their lack of lineage marker expression and high expression of Sca-1 and 
c-kit. From this KSL population we then took on the one hand the CD34+Flt3- cells 
constituting the MPP population (Yang, Bryder et al. 2005)and on the other hand the 
CD48-CD34-Flt3- cells as the HSC population (Osawa, Hanada et al. 1996; Noda, 
Horiguchi et al. 2008). To validate the accuracy of our sorting gates for HSC and MPP 
we showed that 500 sorted HSC are sufficient to reconstitute W41/W41 Gpi1a Ly5.1 
mice for 16 weeks but not MPP (experiment performed by Angelika Roth, data not 
shown). In addition, we verified in colony assays that our freshly sorted HSC as well 
as MPP contained a high number of multipotent cells (data not shown). After sorting, 
cells were immediately plated either onto confluent layers of PA6 stromal cells or in 
stroma free suspension culture. As depicted in Figure 5.1, we then observed co-
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cultured cells in time lapse movies for up to seven days, taking images in two minute 
intervals.  
 
Figure 5.1: Sorting scheme and imaging setup for time lapse movies 
recording HSC and MPP asymmetric fate. For the HSC population CD34-Flt3-
CD48 c-kit+sca-1+lineage- (KSL) cells were sorted. For the MPP population CD34+Flt3-
KSL cells were sorted. Cells are imaged in time lapse movies with 2 minute intervals 
for up to 7 days. 
 
 
 
 
5.1.2. Divisional Kinetics of HSC and MPP 
We chose PA6 stroma as a niche for HSC and MPP, since PA6 provide an 
environment that allows self renewal of HSC. PA6 support HSC potential for at least 2 
weeks with 14% reconstitution potential left at this time (Szilvassy, Weller et al. 
1996). Our own data showed that HSC that were cultured for 4 days on PA6 still are 
able to contribute to the peripheral blood of recipient mice after 17 weeks, 
supporting the maintenance of HSC potential by PA6 stroma (Figure 13F). We 
conducted time lapse movies of HSC and MPP that were cultured on PA6 and 
analyzed them by tracking individual cells and recording their behavior in pedigrees. 
Supplemental Movie 5.1B shows an individual HSC that migrates underneath the PA6 
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stromal cells and divides to give rise to several generations of progeny. Supplemental 
Movie 5.1A shows in detail the second division of the HSC progeny. In Figure 5.2A 
this proliferation is depicted as a pedigree, displaying time of division, lifetime of the 
cells and hierarchical relationships graphically. The state of adherence of a cell over 
time (see also figure legend) is indicated by the color of the lines connecting one 
generation with the next. Cells migrating underneath stroma are called adherent 
whereas cells migrating above the stroma are in suspension. Initially we evaluated 
the first three divisions of individual HSC and MPP to determine if they differ in their 
divisional behavior. Figure 5.2B, C, and D show progeny after the first, second, and 
third division respectively that are migrating underneath the stroma. 
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Figure 5.2: Proliferation of HSC on PA6 stroma. Pedigree shows 
the proliferation of a single HSC over the course of 3d. Arrows mark 
corresponding frames. Numbers next to cells 1 through 7 indicate 
generation time length (A). Panels show corresponding frames from 
movie1. Red circles show position of cells (B, C, and D). HSC daughter 
cells are shown shortly after their first (B), second (C), and third 
division (D). Scale bar: 10µm, time scale: days – hours:minutes 
 
 
 
 
 
 
 
 This data, together with data of the first 3 divisions from 120 HSC and 97 MPP 
trees from 4 separate movies is summarized in Figure 5.3A. Here the percentage of 
trees that have undergone their first, second and third division, respectively, is 
depicted for HSC and MPP over time. It is shown that after isolation, MPP go into 
cycle earlier than HSC. Also for the subsequent two divisions HSC on average have a 
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significantly longer generation time than MPP. This is depicted in Figure 5.3B, which 
shows the time point when 50% of cells have divided in HSC and MPP populations. 
 
 
 
 
 
 
Figure 5.2: Proliferation of HSC on PA6 stroma. Pedigree shows the proliferation 
of a single HSC over the course of 3d. Arrows mark corresponding frames. Numbers 
next to cells 1 through 7 indicate generation time length (A). Panels show 
corresponding frames from movie1. Red circles show position of cells (B, C, and D). HSC 
daughter cells are shown shortly after their first (B), second (C), and third division (D).
Scale bar: 10µm, time scale: days – hours:minutes 
 
 
We asked if this difference in divisional kinetics was dependent on the PA6 
environment itself or unknown effectors in the serum-containing media, or if the 
observed delay in cell cycle entry and longer generation time was an intrinsic 
property of HSC. Therefore, we also conducted experiments in stroma free and 
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serum free suspension culture, adding cytokines that allow for HSC self renewal. The 
addition of SCF and TPO allows maintenance of HSC for at least six days with 66% of 
initial HSC number left at this time (Ema, Takano et al. 2000). When comparing HSC 
and MPP divisional behavior in these self renewal conditions we found that the 
behavior of these two populations was similar as on PA6 and when containing serum. 
Initial cycle entry and subsequent generation times were significantly later and 
longer for HSC than for MPP (Figure 5.3C and D). To assess whether this behavior 
was specific to HSC self-renewing conditions we also analyzed cell behavior in 
differentiating conditions. We cultured HSC in SCF and IL3, which reduce self 
renewing capacity to 26.5 % after 3d compared to 66.7 % after 3d and 25.5 % after 
6d in SCF, or in TPO and SCF and IL6 which do not maintain any self renewal 
capacity for three days (Ema, Takano et al. 2000). In both differentiation conditions 
we found similar kinetics of HSC divisional kinetics within their first three generations 
as in self renewal conditions (Figure 5.4A, B, and C). This indicates that later entry 
into cycle and longer generation time is an intrinsic property of HSC that is 
independent of culture conditions and that is lost in closely related cells such as MPP.  
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Figure 5.4: Cell cycle entry and 
generation time length does not 
differ significantly between HSC 
cultured in stroma free self 
renewal and differentiation 
conditions. First three divisions of 
HSC are shown as a percentage of 
divided cells over time in stroma free 
culture containing SCF and IL3. The 
data shown is the average of 2 
independent experiments with a total 
of 43 pedigrees analyzed (A). First 
three divisions of HSC are shown as a 
percentage of divided cells over time 
in stroma free culture containing SCF 
and IL6. Data is the average of 2 
independent experiments with a total 
of 45 HSC pedigrees analyzed (B). 
Time it takes for 50% of HSC to 
divide in stroma free culture 
containing differentiation cytokines. 
Data summarizes data from A and B 
as well as Figure 5.3D (C). Error bars 
show standard deviation. 
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5.1.3. Searching for Markers of Intrinsic Control of HSC Asymmetric 
Daughter Cell Fates 
5.1.3.1. Quantification of Daughter Generation Time Reveals 
Environmentally Controlled Asymmetric Fates 
We were interested in asymmetric fates of HSC daughters and therefore, we 
had to find a marker that allowed us to read out asymmetric fate decisions of HSC. 
As we had already found a difference in cell cycle entry and divisional kinetics 
between HSC and MPP, we wondered whether we can use the generation time of 
HSC and MPP daughter cells to indicate asymmetric fates. Previous studies examining 
the daughter cell fates of human hematopoietic progenitors have used asymmetric 
generation time as an indicator for asymmetric fate potential as well (Brummendorf, 
Dragowska et al. 1998; Punzel, Zhang et al. 2002; Punzel, Liu et al. 2003). 
Therefore, we looked for differences of sister cell generation time (GT) lengths. This 
difference was calculated as the percentage difference between the longer lifetime 
and the shorter lifetime of sister cells in generation 1 (direct progeny from colony 
initiating cell) divided by the longer lifetime. An example of a pedigree with 
asymmetric GT in the HSC daughter cells is depicted in Figure 5.5A. This pedigree 
and corresponding Supplemental Movie 5.2 show a difference of 64% in the GT of 
daughter cells. It is shown that while cell 2 divides at 2d 3min 19sec after the start of 
the movie (Figure 5.5C), cell 3 almost takes another 2d until it divides at 4d 59sec 
after the movie had started (Figure 5.5D). Shortly thereafter, at 4 d 1 h 36 min, the 
daughter of cell 2, cell 5 divides again and produces granddaughter cells to cell 2. In 
summary, this pedigree shows asymmetric GT of the immediate daughter cells of the 
starting cell. 
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We then quantified the number of trees with asymmetric GT that started from 
HSC and MPP and were cultured on PA6 stroma. We found that most of the analyzed 
trees showed a difference of generation time up to 30%. Therefore, we compared 
the number of trees from HSC and MPP with a generation time difference of at least 
10%, 20% and 30% to evaluate which percentage of generation time difference of 
daughter cells indicated HSC specific behavior. We found that 58.3% (±21.0) of a 
Figure 5.5: Pedigree with asymmetric generation time of 
daughter cells. Pedigree originates from an HSC that produces daughters 
with a different length of generation time (more than 20% difference). 
Arrows indicate corresponding cells in frames B, C, and D (A). Frames (B, 
C, D, and E) correspond to Movie 2. Cells after first division (B). Cells 4 
and 5 shortly after second division while cell 3 has not divided yet (C). 
Two days later cell 3 has divided and produced cells 6 and 7 (D). Time 
scale: days – hours:minutes 
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total of 125 analyzed HSC trees but only 21.1% (±10.6, p=0.04) of a total of 87 MPP 
trees showed more than 10% generation time difference of daughter cells (Figure 
5.6A). When 20% difference in generation time was used as a criteria of asymmetry, 
21.4% (±6.8) of HSC and only 4.4% (±5.9) of MPP trees were asymmetric regarding 
their daughter cell generation time (p=0.001), and a 30% difference in daughter 
generation time resulted in 11.6% (±12.9) and 2.3% (±4.1) of asymmetric HSC and 
MPP trees respectively (p=0.17). These results show that significantly more HSC 
than MPP produce daughters with asymmetric generation time length suggesting that 
asymmetric daughter cell generation times are predetermined specifically in HSC. 
To assess whether this asymmetric behavior was intrinsically controlled, we analyzed 
pedigrees of HSC and MPP that were cultured in stroma free HSC maintenance 
conditions conditions containing SCF and TPO. However, we found that only 2.8% 
(±3.9) of 33 HSC showed asymmetric daughter cells GT, while 5.9% (±8.3) of 37 
MPP were asymmetric regarding their daughter generation time, when quantifying 
trees with at least 20% GT length difference (p=0.7, Figure 5.6B). Also the number 
of trees with a difference of 10% or 30% in daughter cell GT length did not differ 
significantly between HSC and MPP (data not shown). This indicates that HSC, when 
cultured in stroma free self renewal conditions, do not produce daughters with 
asymmetric GT. Also, when we analyzed pedigrees of HSC cultured in differentiation 
conditions, we found a much lower number of asymmetric daughter generation times 
than when cultured on PA6. Only 2.5% (±3.5) of HSC cultured in SCF and IL3 
(n=43) and 9% (±5.7) of HSC cultured on SCF and IL6 produced daughters that 
differed in their generation time by at least 20% (Figure 5.6B). These results show 
that environment, such as PA6 stroma, can induce HSC to produce daughters with 
asymmetric GT. This induction can only be found for HSC, but not for MPP. However, 
the results also indicate that while cell cycle entry and average GT length of HSC 
daughters is intrinsically controlled, this does not hold true for asymmetric HSC 
daughter GT. 
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Figure 5.6: PA6 dependent HSC specific asymmetric generation time of 
daughter cells. Percentage of HSC and MPP that produce daughters with a 
difference in generation time of at least 20% when cultured on PA6 stroma. 
Data is the average of 5 independent experiments with a total of 185 HSC and 
87 MPP pedigrees analyzed (A). Percentage of HSC and MPP that produce 
daughters with a difference in generation time of at least 20% when cultured in 
stroma free culture containing self renewing and differentiation cytokines. Data 
is the average of 2 independent experiments for each condition with 33 HSC 
and 37 MPP pedigrees analyzed for stroma free conditions containing SCF and 
TPO, and 40 and 48 HSC pedigrees analyzed for stroma free conditions 
containing SCF and IL3, and SCF and IL6, respectively (B). Error bars show 
standard deviation, ** = p<0.01 
 
 
 
 
 
 
 
 
 
 
5.1.3.2. Quantification of Apoptotic Cells Reveals no Conclusion about 
Asymmetric Fates 
Since we could only observe asymmetric GT of HSC daughters on PA6 stroma, 
but not in stromal free cultures also allowing HSC self renewal, asymmetric GT 
cannot serve as readout of asymmetric HSC self renewal. Therefore, we decided to 
look for other indicators of such decisions. It is known that apoptosis occurs in 
cultured cells. However, only snapshots of endpoint stainings have been evaluated 
for apoptotic cells so far. From these snapshots it cannot be assessed how many 
cells have died during the culture period and from which starting cell apoptotic cells 
have originated. By continuous observation and single cell tracking we can identify 
every apoptosis, know when it occurred, and know how the apoptotic cell is related 
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to the starting cell. Apoptosis on one hand indicates how well cultures are 
maintained and if cells for example were damaged during isolation. On the other 
hand, apoptosis can serve as a measure of fate decision. If cells have differentiated 
into a cell fate that requires certain survival signals and these signals are not 
provided by the environment, the cell will undergo apoptosis. In this respect, discrete 
apoptotic events can serve as an indicator of differentiation and lineage commitment. 
However, it is difficult to distinguish between these two possibilities as a mixture of 
both is likely to occur.   
We quantified the number of apoptotic events in cells cultured on PA6 and in 
stroma free suspension culture. When cells were cultured on PA6, we found that 
15.3% (±8.2) and 21.6% (±9.4) of HSC and MPP starting cells respectively had died 
before they could divide (Figure 5.7A). We found a similar number of apoptotic cells 
when HSC and MPP were cultured in stroma free culture. Of all analyzed starting 
cells we found 25.8% (±3.9), 28.8% (±5.2) and 19.6 % (±7.6) of HSC cultured in 
SCF and TPO, SCF and IL3, and SCF and IL6 respectively to undergo apoptosis. For 
MPP cultured in conditions with SCF and TPO however this number was slightly 
smaller as we found only 6.6% (±3.5) of cells to die before their first division 
(p=0.02, Figure 5.7B). These initial apoptosis are likely due to stress caused by the 
isolation procedure. Overall, the number of apoptosis of HSC and MPP in suspension 
conditions decreased as the generation number increased for all the conditions used. 
In contrast, the percentage of apoptotic events for HSC and MPP cultured on PA6 
remained the same or slightly increased. This seems to indicate that when cultured 
on PA6, a constant proportion of HSC and MPP are differentiating towards a lineage 
that is not supported by PA6. For example, PA6 do not support the formation of 
lymphoid cells without the addition of lymphoid cytokines. Therefore, it is possible 
that the observed apoptoses indicate differentiation of cells into the lymphoid 
lineage. To test this hypothesis we added cytokines necessary for lymphoid 
differentiation on PA6 (Flt3L and IL7) and asked if this would decrease the number of 
observed apoptosis. However, we could not observe any change in frequency or time 
of apoptotic events (data not shown) and therefore concluded that the observed 
apoptosis are not due to non supported lymphoid differentiation. Since PA6 cultures 
contain many different uncharacterized cell types and the utilized serum contains 
many unknown factors, a variety of explanations could account for the observed 
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apoptotic events. Moreover, as we did not observe similar kinetics for apoptosis of 
cells cultured with and without stroma, we decided that there might be a number of 
mechanisms contributing to the observed apoptotic events and that it was too 
difficult to attribute any to asymmetric fate decisions. Therefore, we could not utilize 
apoptotic events as an indicator of asymmetric fate decisions.  
 
 
 Figure 5.7: Percentage of apoptotic cells in 
pedigrees of HSC and MPP. Percentage of apoptotic 
cells per generation of all cells contained in that 
generation. Data of HSC and MPP cultured on PA6 is the 
average of 3 independent experiments with 69 HSC and 
61 MPP trees analyzed (A). Data of HSC and MPP 
cultured in stroma free suspension culture is the average 
of 2 independent experiments for each condition. For 
data of cells cultured in SCF and TPO, 54 HSC and 46 
MPP pedigrees were analyzed. For data of cells cultured 
in SCF and IL3, and SCF and IL6, 61 and 52 pedigrees 
were analyzed respectively (B). Error bars show standard 
deviation, ** = p<0.01 
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5.1.3.3. Quantification of Megakaryocyte Fates Reveals no Conclusion 
about Asymmetric Fates 
Since general characteristics of cells such as generation time and apoptosis 
were not useful as indicators of intrinsically controlled fate decisions, we wanted to 
quantify cell behavior indicating commitment towards a certain lineage and loss of 
HSC potential. When analyzing fates of HSC, it is necessary to identify lineage 
decisions using markers that indicate lineage commitment. However, most 
progenitors that have committed to a lineage do not upregulate markers of that 
lineage until a certain maturation stage is reached. Starting with an HSC, this can 
take several days or weeks in culture (personal communication with Dr. Michael 
Rieger). This makes identification of cell fates in short movies where cells are 
followed over few generations difficult. Running movies for several weeks is 
technically possible, but the more generations of a colony have to be tracked, the 
higher the chance of losing individual cells of the pedigree due to high cell density. 
We found however, that megakaryocytes can be easily identified by their size in time 
lapse movies and arise from HSC or MPP within days. These cells belong to the 
myeloid lineage and are the precursors of platelets which are necessary for blood 
clotting. Megakaryocytes undergo endomitoses, which involve DNA replication and 
nuclear segmentation without division of the nucleus and the cytoplasm. This process 
can be visualized as shown in Supplemental Movie 5.3 and in the pedigree in Figure 
5.8A, where cells generated by an MPP develop into mature megakaryocytes. The 
movie shows cell 7 depicted in the pedigree and still images of Figure 5.8 dividing 
into two cells with normal size (Figure 5.8C). These cells then slowly increase in size 
by performing several rounds of endomitosis and are then identified as 
megakaryocytes (Figure 5.8D and E).   
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We quantified the number of pedigrees producing megakaryocytes from HSC 
and MPP when cultured on PA6 (Figure 5.9A). We found similar numbers of 
pedigrees producing megakaryocytes from HSC (9.9% ± 7.2, n=159) and MPP 
(6.1% ± 5.8, p=0.38, n=128)). In contrast, in stroma free cultures, hardly any cells 
developed into megakaryocytes in the tracked time. We did not find any trees 
containing megakaryocytes in SCF and TPO (n=40) and SCF and IL3 (n=43) 
conditions and only 3 trees containing megakaryocytes in stroma free conditions with 
Figure 5.8: Pedigree of a colony generating megakaryocytes. 
Pedigree of an MPP differentiating into megakaryocytes and other cells. 
Some of the progeny cells of cell two were lost when they left the field of 
view. Arrows indicate corresponding movie panels (A). Frames 
corresponding to Movie 3. Cell 7 is marked by a blue arrow and is above 
the stroma and has not increased in size yet (B). Cell 14 and 15 are 
marked by red arrows. They will mature into megakaryocytes, but still are 
small in size (C). Cell 15 is marked by a red arrow and enlarged and now 
identified as a mature megakaryocyte (D). Cell 15 is marked by a red arrow 
and even larger and surrounded by progenitor cells that are from a 
different colony and underneath the stroma (E). Scale bars are 10µm, time 
scale: days – hours:minutes 
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SCF and IL6 (n=45; data not shown). It appears that the first two cytokine 
conditions do not support either commitment to megakaryocyte fate or are not 
sufficient for maturation of megakaryocytes to stages that can be identified in time 
lapse microscopy.  
We then analyzed the trees for asymmetries in megakaryocyte production. 
Trees where not all branches of the tree produce megakaryocytes at the same time 
could be indicators of lineage choice between self renewal and differentiation during 
division. An example is given in Figure 5.8A, where one of the daughters (cell 3) of 
the seeded MPP is committed to the megakaryocyte lineage since all its progeny 
produce megakaryocytes. At least one progeny of the other daughter (cell 2) 
however does not produce megakaryocytes within the same generation but 
continues to divide. The other progeny of cell 2 were lost in the tracking process and 
therefore, their fate cannot be determined.  
We found that the number of asymmetric megakaryocyte trees was small and 
varied a lot between movies and so we could not see a difference in the frequency of 
asymmetric megakaryocyte trees between HSC and MPP (Figure 5.9B, 59.5% ± 4.7 
and 62.5% ± 41.5 respectively). Since the percentage of pedigrees containing 
megakaryocytes as well as asymmetric onset of megakaryocytes was similar in 
pedigrees starting with HSC and MPP, we conclude that a population of cells that has 
already lost its HSC potential and that is present within both the sorted HSC and MPP 
population gives rise to megakaryocyte trees. Therefore, megakaryocytes cannot 
serve as an indicator of self renewal versus differentiation decisions in HSC.  
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Figure 5.9: Type and number of megakaryocyte containing 
pedigrees does not differ between HSC and MPP. Percentage of 
megakaryocyte trees of all pedigrees derived from HSC and MPP cultured 
on PA6 stroma. Data is the average of 7 independent experiments with 
159 HSC and 128 MPP analyzed trees (A). Number of trees with 
asymmetric onset of megakaryocytes as a percentage of all 
megakaryocyte containing trees derived from HSC and MPP cultured on 
PA6. Data shows the average of 7 independent experiments with 14 HSC 
and 6 MPP analyzed trees (B). Error bars show standard deviation. 
 
 
 
 
 
 
 
5.1.4. Evaluation of HSC Daughter Fates by ‘Loss of Stemness Marker’ 
CD48  
Megakaryocyte differentiation did not prove to be a useful marker for 
asymmetric cell fate decisions, and therefore, a different marker indicating either 
true HSC themselves or marking cells that have lost their self renewal potential was 
needed. As mentioned in the introduction, markers reliably identifying cultured HSC 
are not available. Also, HSC that differentiate into progenitor cells and lose their self 
renewal capacity do not undergo morphological changes that can be visualized by 
phase contrast images. We therefore, needed a molecular marker that is expressed 
as soon as HSC have lost their repopulation capacity.  
Recently, the SLAM markers CD150 and CD48 have been introduced for 
improved HSC sorting purities (Kiel, Yilmaz et al. 2005). Freshly sorted HSC, are 
positive for CD150 but negative for CD48. In addition, it was recently shown that 
HSC also stay negative for CD48 during in vitro culture. When reconstituting mice 
with cells from cultured HSC, only cells lacking CD48 expression were still able to 
reconstitute a lethally irradiated recipient, while large numbers of CD48+ cells did not 
contain any cells with HSC potential (Noda, Horiguchi et al. 2008). Therefore, we 
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chose to employ CD48 in our time lapse movies to identify cells that have lost 
reconstitution potential. 
 It is possible to fix cultures after a movie is recorded, stain these fixed cultures 
with a labeled antibody and then deduct from this endpoint staining and the tracked 
pedigree which of the cells in the tree have switched on CD48. However, much more 
information can be drawn from a live staining where onset of CD48 expression can 
be visualized in real time. Therefore, we directly added a fluorochrome labeled 
antibody against CD48 in living cultures and observed its staining of cells by time 
lapse imaging. Eilken et al. have previously shown that this approach is applicable for 
several antibodies. Live staining however does not work with every antibody, which 
could be isotype or species specific. We chose Alexa647 as a direct label for CD48 
antibody as this fluorochrome is detectable both in FACS as well as with our 
microscope filters (Figure 5.10) and can be spectrally combined with other typically 
used fluorochromes emitting green and red light. 
 
 
Figure 5.10: Spectral properties of Alexa647 
fluorochrome. Alexa647 can be detected with Zeiss 
microscope filter 50 as well as with the FACS Aria 
using the 633nm laser and 660/30 emission filter.  
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5.1.4.1. Establishing CD48 as a Live Marker of Loss of Stemness 
5.1.4.1.1. CD48 Antibody Titration in FACS and Expression in Freshly 
Isolated Cells 
To evaluate the amount of self labeled antibody needed in a FACS stain, we 
utilized 106 lineage+ cells per antibody concentration and stained them with 0.2, 0.5, 
1 and 2 µg of concentrated CD48 Alexa647 antibody in 50µl total staining volume 
(open squares Figure 5.11A). We compared this self labeled antibody with 
commercially available antibodies labeled with APC and with FITC. Cells stained with 
0.2 µg CD48 Alexa647 showed higher mean percentage of positive cells (46.9%) 
compared to cells stained with the same amount of FITC antibody (33.1%) and APC 
antibody (28.3%). An increase of CD48 Alexa647 concentration in the FACS staining 
solution did not yield a noticeable increase in positive cells. Therefore, we chose this 
concentration for all subsequent FACS stainings with CD48 Alexa647.  
Using CD48 antibody as a real time marker in our movies, we wanted to 
determine what percentage of our sorted populations do express CD48 at the time of 
isolation. In CD34-Flt3-KSL cells we found 4% of CD48+ cells. For all our analysis we 
have excluded this CD48+ population by including CD48 in the sorting paradigm. For 
the Flt3-CD34+KSL MPP population we found 51% of cells to express CD48, whereas 
the Flt3+CD34+KSL population that identifies the MPP4 included 80% of cells with 
detectable CD48 expression (Figure 5.11B). These results are in accordance with 
published data and confirm that HSC do not express CD48, and that this marker is 
upregulated early during differentiation.  
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 Figure 5.11: FACS titration of Alexa647 labeled CD48 
antibody and application in bone marrow staining. Mean 
fluorescence of lineage+ cells stained with CD48 antibody labeled 
with Alexa647, FITC and APC. 106 cells were labeled in 50µl 
staining solution (A). Percentage of CD48+ cells in KSL 
populations stained with CD48 Alexa647 (B). 
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5.1.4.1.2. CD48 Expression in Cultured Cells 
To titrate our CD48 antibody in living cultures, we asked what concentration of 
antibody was sufficient to cover all CD48 epitopes on the cells and at what 
concentrations some of these epitopes would remain free for staining in a FACS stain 
with a differently conjugated antibody of the same clone. For this purpose we sorted 
KSL cells, which contain both HSC and MPP and cultured them with different 
concentrations of CD48 Alexa647 antibody for four days in stroma free culture in the 
presence of differentiation promoting cytokines (SCF, IL3, and IL6). We expected 
CD48 expression in at least some of the initial KSL cells, but in a larger proportion in 
the more differentiated cells that arise in culture after four days. After the four days 
of culture we washed the cells and stained them in a normal FACS stain with CD48 
FITC antibody and analyzed them by FACS (Figure 5.12A). When using 2 µg/ml and 
1 µg/ml concentrations of CD48 Alexa647 antibody in living cultures, all stained cells 
are only positive in the Alexa647 channel, but not the FITC channel when analyzed 
by FACS. However in these concentrations background fluorescence can be observed 
(not shown). No background fluorescence was visible when using antibody dilutions 
of 0.2 µg/ml and 0.1 µg/ml. When analyzing 0.2 µg/ml dilution, 38 % of cells positive 
for CD48 Alexa647 were also positive for FACS staining with the FITC conjugated 
CD48 antibody (Figure 5.12B). This trend continued when a concentration of 0.1 
µg/ml of CD48 Alexa647 was utilized in culture staining. At this concentration, FACS 
staining with CD48 FITC rendered 75% of Alexa647 positive cells also positive for 
FITC signal. In none of these dilutions did the percentage of cells positive for in 
culture CD48 Alexa647 decrease, indicating that competitive binding of the two 
antibodies did not result in fewer cells being stained, but that only the percentage of 
epitopes per cell bound by in culture CD48 Alexa647 antibody was reduced. Indeed, 
the intensity of Alexa647 staining is slightly reduced with reduced amounts of CD48 
Alexa647 antibody present in culture (Figure 5.12A). We decided to utilize 0.2 µg/ml 
dilution of antibody in our cultures. Using this antibody dilution ensures that most of 
the epitopes recognized by CD48 antibody are covered in all cells expressing the 
antigen and additionally keeps background fluorescence to a minimum. The 
possibility of toxicity of antibody is also lower at lower concentrations. 
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Figure 5.12: In culture staining of progenitor cells with CD48 Alexa647.
CD48 Alexa647 titration in live cell culture. Decreasing concentrations of CD48 
Alexa647 in culture staining compete for same epitopes on KSL cells with CD48 
FITC FACS staining. CD48 Alexa647 in culture concentration shows final antibody 
concentration in culture medium. CD48 FITC is used in a FACS stain at 0.2µg/ml 
antibody in 50µl staining volume (A). Kinetics of CD48 expression onset in cells 
derived from MPP and HSC cultured on PA6 (B). Error bars show standard deviation
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After showing that the self labeled CD48 antibody works in culture, we used it 
in movies as a live marker for loss of HSC potential of cultured cells. When we 
analyzed all trees starting from HSC and MPP cultured on PA6 and determined the 
percentage of cells that expressed CD48 over the course of the movie, we found that 
when analyzing HSC as a starting population, we observed less than 20% of all cells 
expressed CD48 by 60h from the start of the movie (Figure 5.12B). This percentage 
increased to 50% by 84h after movie start. In contrast, in cells arising from MPP, 
already 30% of cells were positive at 12h after movie start. The percentage of CD48+ 
cells in trees with MPP as starting population increased over the next few days so 
that by 60h after movie start, 80% of cells were positive for CD48. This percentage 
increased to almost 100% by day 4. Therefore, the utilization of anti-CD48 in movies 
reveals increased differentiation of cells over time. As expected, in HSC, which 
remain in an undifferentiated state for longer, the percentage of CD48 expressing 
cells increases slower compared to MPP cells which show a sharp increase in the 
percentage of CD48+ cells. MPP are already more differentiated from the start and 
reach CD48+ maturation stages faster than HSC. It is established that MPP do not 
anymore possess long term reconstitution potential (Yang, Bryder et al. 2005). 
However, not all MPP are positive for CD48 when isolated. This indicates that anti-
CD48 does not identify all cells immediately after loosing their self renewal capacity, 
but at a slightly later stage. Nevertheless, the above data indicates that CD48 can be 
used as a marker to indicate asymmetric fate decisions. A difference in time of onset 
of CD48 expression between sibling cells can identify asymmetric fate decisions 
between self renewal and differentiation. In addition, CD48 expression started in 
many cells during the first four days, a time frame during which we can easily follow 
our cells by single cell tracking.  
 
 
5.1.4.1.3. Confirmation that CD48- but not CD48+ Cells Possess 
Reconstitution Potential 
 Our data concerning the difference in onset of CD48 expression in cultured 
HSC and MPP indicates that CD48 is a useful marker when analyzing loss of self 
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renewal potential in HSC. However, we wanted to confirm that CD48 expression in 
culture identifies cells that have lost their reconstitution potential. To analyze this, we 
sorted HSC (Figure 5.13A) and cultured them under the same conditions that we 
used for our PA6 co-culture movies. We cultured HSC for 90h, a time frame during 
which nearly 50% of the cells starting from HSC express CD48 (Figure 5.12B), but 
when CD48 has been expressed only for a short period of time in most positive cells. 
After culture on PA6 we purified hematopoietic cells according to their CD48 
expression. Cells were also stained for CD45 to distinguish blood cells from PA6 cells 
(Figure 5.13B). In addition, we stained the cultured cells with KSL markers to assess 
their immaturity in relation to CD48 expression (Figure 5.13C, D and E). When 
analyzing CD45+CD48+ cells for the presence of KSL markers, we found that of the 
CD48high cells only 7% were KSL cells after 90h (Figure 5.13E. In contrast, of the 
CD45+CD48- cells 61% were still KSL cells (Figure 5.13D). This indicated that CD48- 
cells contain a larger portion of immature cells than CD48+ cells. We sorted CD48+ 
and CD48- cells (Figure 5.13C) and transplanted them into recipient mice. For 
recipient mice we chose W41/W41 Gpi1a Ly5.1 mice (kindly provided by Dr.  Norman 
Iscove), that have a point mutation within the c-kit receptor. These mice contain a 
normal blood system and do have HSC however the mutation renders their HSC less 
competitive. Any congenic wild type HSC population that is transplanted into these 
mice can therefore expand in their bone marrow and slowly replace the host bone 
marrow without the need for irradiation of the recipients. W41/W41 Gpi1a Ly5.1 mice 
are congenic to bl6 which were used for donor cells however donor type and 
recipient type cells can be distinguished by the expression of two different alleles of 
the pan hematopoietic marker CD45. Donor type cells from bl6 mice express CD45.2, 
whereas recipient type blood cells from the utilized W41/W41 Gpi1a Ly5.1 mouse line 
express CD45.1.  The presence of donor bone marrow cells is read out by analyzing 
the peripheral blood (PB) of the recipient. Donor derived bone marrow cells that 
produce lymphoid as well as myeloid PB cells for 16 weeks after transplantation are 
likely to be HSC, which should also have the ability to reconstitute secondary 
recipients. By analyzing the PB of recipient mice we can assess if the transplanted 
population contained any HSC. Analysis of peripheral blood of transplanted mice 17 
weeks after transplantation of CD48+ and CD48- cells indicated that indeed CD48+ 
cells did not lead to any donor cell contribution within the peripheral blood (Figure 
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5.13F), whereas mice transplanted with low numbers of transplanted CD48- cells 
showed some contribution (2.9% ± 3.39) to the PB that was increased when higher 
numbers (equivalent of 500 CD48-KSL cells) of CD48- cells were transplanted into 
recipients (41.2%). This indicates that in cultured cells all HSC are contained within 
the CD48- fraction, while the CD48+ fraction has completely lost all reconstitution 
potential. Transplantations of cells cultured on PA6 as well as FACS analysis of 
peripheral blood were performed by Angelika Roth.  
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Figure 5.13: Transplantation of HSC derived cultured cells with CD48- and 
CD48+ phenotype into W41/W41 Gpi1a Ly5.1 confirms retention of 
reconstitution potential in CD48- fraction. CD48- HSC (A) were cultured on PA6 
stroma for 3.75 days and CD45+ cells (B) that are either CD48- or CD48+ were 
transplanted (C). KSL marker expression of CD48- cells (D) and CD48+ cells (E) after 
culture. (F) Percentage of donor contribution to peripheral blood of recipient mice 17 
weeks after transplantation of CD48- and CD48+ cells. Numbers of CD48-KSL and 
CD48+KSL cells are the equivalents of transplanted total CD48- and CD48+ cells. 
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5.1.4.2. Type of CD48 Expression Onset in HSC and MPP Pedigrees 
As we now have shown that CD48 can be used as a live marker of loss of HSC 
potential, we set out to use this marker in movies to compare the differentiation 
behavior of HSC and MPP. As we used CD48 as a marker of loss of HSC potential, we 
defined every cell that had switched on CD48 as a differentiated cell that had lost 
HSC potential and would not regain that potential even upon loss of CD48 
expression. We tracked pedigrees until the third division. In pedigrees that did not 
express CD48 by that time we decided to track cells and their progeny for at least 
4d, after which cells are easily lost in the tracking process due to high cell density.   
We observed different types of trees according to their expression of CD48. 
We saw CD48 negative trees that during a 4d time frame never switched on CD48 
(Figure 5.5). We cannot say anything about the differentiation status of those cells, 
as the lack of CD48 expression does not necessary tell us if these cells still have HSC 
potential. Of the CD48 expressing pedigrees, some trees expressed CD48 in the 
starting cells. These cells were either already CD48+ at the start of the movie or 
started to express CD48 before the first division. This indicates that these cells had 
probably already lost their HSC potential at the start of the movie (Figure 5.14A). All 
the cells of the pedigree express CD48 as indicated by the blue lines. As can be seen 
in the corresponding Supplementary Movie 5.4, CD48 expression is visible both on 
the cell surface and within the cytoplasm of the cells, where endocytosed antibody 
accumulates (Figure 5.14B).  
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We also observed pedigrees that did not show CD48 expression in the starting 
cell, however showed start of CD48 expression in one or more progeny cells (Figure 
5.15A and B). This pedigree stays CD48- until CD48 is switched on in all 4 cells of 
generation 3 at the same time (Figure 5.15A and C). At the time point when CD48 is 
first switched on, the expression of CD48 is very weak (Figure 5.15C and 
Supplemental Movie 5.5) and increases over time, until 8h 36min later a very strong 
CD48 signal can be observed (Figure 5.15D). When analyzing CD48 expression we 
noticed cells with stronger and weaker CD48 expression levels, however we did not 
quantify this and recognized all of these cells as CD48+. 
Figure 5.14: Pedigree of a colony with CD48 expression 
onset in the mother cell. The pedigree originates from an MPP 
and expresses CD48 (blue lines) from the starting cell and in all 
progeny. Orange arrow indicates cells shown in panel B (A). Frame 
from corresponding Movie 4 shows cells in phase contrast and 
fluorescence positive for CD48 expression (B). Scale bars are 
10µm, time scale: days – hours:minutes
Results 65
 
 
 
 
 
 
 
 
When we quantified pedigrees according to the mentioned categories, we 
found for HSC cultured on PA6 44.5% (±20.3) of trees remaining negative for CD48 
for 4 days, whereas only 5.2% (±4.7) of trees starting with an MPP remained CD48- 
(Figure 5.16A). Only 2.5% (±4.3) of HSC expressed CD48 in the mother cell but 
42.2% (±13.0) of MPP starting cells turned on CD48 expression. The number of 
Figure 5.15: Pedigree of a colony with CD48 expression onset 
in progeny: Symmetric onset. Pedigree originates from an HSC and 
shows onset of CD48 expression in all cells of generation 3 indicated 
by blue arrows that correspond with frame in panel C (A). Frames 
corresponding to Movie 5 (B, C, and D). The starting cell is negative 
for CD48 (B). Weak expression of CD48 in cells marked by blue arrows 
(C). Stronger expression of CD48 in cells marked by track marks (D). 
Scale bars are 10µm, time scale: days – hours:minutes 
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trees with a later onset of CD48 was the same in HSC and MPP when cultured on 
PA6 (53.0% ± 24.6 and 52.6% ± 8.5). The differences between HSC and MPP 
regarding the number of negative trees and trees with CD48 mother cell onset were 
significant (p=0.04 and p=0.03 respectively) meaning that a large number of HSC 
contain cells with HSC potential that is not lost within the first 4d according to CD48 
expression. In contrast, MPP contain a large number of cells that have lost their HSC 
potential at the start of the movie or shortly thereafter.  
We could observe a similar result for cells cultured in stroma free suspension 
culture containing self renewal cytokines (Figure 5.16B). Under these conditions, 
again a higher number of trees remained negative when started with a HSC (50.0% 
± 7.1) compared to an MPP (2.2% ± 3.1, p=0.018). As on PA6 stroma, we again 
found less HSC trees (10.0% ± 7.1) than MPP trees (65.4% ± 6.5; p=0.007) with 
mother cell onset in stroma free self renewal conditions. For trees that showed CD48 
onset in a progeny, the percentage of HSC (40% ± 14.1) and MPP (32.4% ± 3.4) 
derived pedigrees did not differ (p=0.3). In summary, HSC cultured in stroma free 
self renewal conditions also produced a high percentage of pedigrees that did not 
express CD48 during a 4d culture period, indicating that these cells still possessed 
HSC potential. Only very few HSC lost their reconstitution ability within the mother 
cell as indicated by CD48 expression and less than half of initial HSC lost their 
potential during the 4d tracking period in one or all of their daughter cells. For MPP, 
we found almost no cells that remained CD48- during 4d of culture but found a high 
percentage of cells that had differentiated very early on as indicated by CD48 mother 
cell onset. In addition, a third of initial MPP differentiated and expressed CD48 during 
the course of the movie.  
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When cells were cultured in differentiation promoting cytokines we expected 
the distribution of trees in the CD48 onset types to closer resemble that of MPP than 
that of HSC. When we looked at HSC cultured in SCF and IL3, this was partly true, as 
we found 4.8% (±6.7) CD48 negative trees (Figure 5.17A). The number of cells that 
showed CD48 onset of expression in the mother cell however was lower than in MPP 
Figure 5.16: Type of CD48 onset in self renewal 
conditions. Percentage of CD48 onset types in trees 
originating from MPP and HSC cultured on PA6. Data 
shows the average of 5 independent experiments with 90 
HSC and 87 MPP pedigrees analyzed (A). Percentage of 
CD48 onset types in trees originating from MPP and HSC 
cultured in stroma free culture containing SCF and TPO. 
Data shows the average of 2 independent experiments 
with 40 HSC and 42 MPP pedigrees analyzed (B). CD48 
expression onset was followed for 4 days. Error bars show 
standard deviation, * = p<0.05 ** = p<0.01 
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but higher than in HSC cultured in self renewal conditions (19.5% ± 0.7). The 
amount of trees that showed CD48 onset in progeny cells when HSC were cultured in 
SCF and IL3 was higher than that of both HSC and MPP in self renewal conditions 
(75.7% (±6.1). These results confirm that the rapid loss of HSC potential in 
differentiation promoting conditions is also reflected by an earlier CD48 onset in the 
cultured cells.  
When we examined trees that started with HSC cultured in SCF and IL6, we 
expected this trend to continue and CD48 onset properties to resemble MPP cultured 
under self renewal conditions even closer. IL6 is known to promote a complete loss 
of HSC potential within three days (Ema, Takano et al. 2000). However, our results 
do not agree with the published data, instead we saw similar behavior of HSC 
cultured in SCF and IL6 as in self renewal conditions (Figure 5.17B). We detected 
64.0% (± 10.5) of trees being negative for CD48, 2.2% (±3.1) of trees that turned 
on CD48 in the starting cell and 33.9% (±7.5) of the examined trees starting to 
express CD48 in progeny cells. These results indicate that either IL6 in our hands 
allows maintenance of HSC potential or that IL6 differentiates cells into a lineage that 
remains CD48- or actively suppresses CD48. It is also possible that these conditions 
promote maintenance of a cell type that has lost self renewal potential but that are 
still CD48- like the MPP1 described in the introduction (Wilson, Laurenti et al. 2008). 
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Figure 5.17: Type of CD48 onset in 
differentiation conditions. Percentage 
of CD48 onset types in trees originating 
from HSC cultured in stroma free culture 
containing SCF and IL3. Data shows the 
average of 2 independent experiments 
with 43 pedigrees analyzed (A). 
Percentage of CD48 onset types in trees 
originating from HSC cultured in stroma 
free culture containing SCF and IL6. Data 
shows the average of 2 independent 
experiments with 44 pedigrees analyzed 
(B). CD48 expression onset was followed 
for 4 days. Error bars show standard 
deviation. 
 
5.1.4.3. Time of CD48 Expression Onset in HSC and MPP Pedigrees 
After determining the types of CD48 onset in pedigrees, we also were 
interested in when CD48 is first expressed in pedigrees of cells cultured in the 
different conditions. When HSC were cultured in PA6, we saw 2.8% (±4.9) of trees 
at 12h after movie start to express CD48 (Figure 5.18A). The percentage of trees 
expressing CD48 did not increase significantly until 60h when 21.3% (±4.0) of trees 
expressed CD48. This increase in CD48 expressing trees leveled off at 72h (39.4% ± 
9.2) and did not increase much until 96h (54.9% ± 17.5). MPP in contrast showed an 
initial 31.1±19.7% of CD48 expressing trees, recapitulating that already a large 
proportion of MPP were CD48+ when isolated. The proportion of CD48+ MPP trees 
continued to increase until it reached 94.5% (±5.5) at 96h. HSC and MPP were 
significantly different at all time points except at 12h. 
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Figure 5.18: CD48 onset kinetics 
in pedigrees of cells cultured in 
self renewal and differentiation 
conditions. Percentage of trees 
containing at least one CD48 
expressing cell starting with an MPP or 
HSC cultured on PA6 (A). Percentage 
of trees containing at least one CD48 
expressing cell starting with an MPP or 
HSC cultured in stroma free culture 
containing SCF and TPO (B). 
Percentage of trees containing at least 
one CD48 expressing cell starting with 
an HSC cultured in stroma free culture 
(C). CD48 expression onset was 
followed for 4 days. Error bars show 
standard deviation. 
 
 
When we examined CD48 onset kinetics in stroma free self renewal 
conditions, we found a similar trend. In HSC the initial percentage of CD48 was low 
(2.6% ± 3.7) at 12h and did not rise significantly until 60h when 36.8% (±7.4) of 
trees expressed CD48 (Figure 5.18B). The percentage of CD48+ trees increased 
slightly from thereon until at 96h 50% (± 3.7) of the trees were positive for CD48. In 
MPP, similar to when cultured on PA6, we found 21.2 (±5.4) of CD48+ trees at 12h. 
After an initial sharp increase in the number of CD48+ trees to 61.1% (±12.6) the 
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increase in CD48+ trees leveled off until at 96h when 97.8% (±3.1) of trees were 
positive for CD48. HSC and MPP were significantly different at all time points except 
at 36h, showing that HSC when cultured in self renewal conditions, remained CD48 
negative for a longer time than MPP, which adopted CD48 expression much faster.  
We then compared the behavior of HSC cultured in stroma free culture of self 
renewal and differentiation promoting cytokine conditions. CD48 expressing trees 
from cells cultured in SCF and IL3 increased with a steep incline linearly to 93.2% 
(±9.6) at 96h, while trees from culture in SCF and IL6 increased also linearly, but 
less quickly to only 37.5% (±11.8) (Figure 5.18C). CD48 onset kinetics between 
these two cytokine conditions differed significantly at 24h (p=0.03), 60h (p=0.03), 
72h (p=0.02), and 96h (p=0.04). The CD48 onset kinetics in cells cultured with SCF 
and TPO overall showed less CD48+ trees (not significant, 2 tailed t-test) than when 
cultured in SCF and IL3. SCF and TPO did not induce a significantly higher number of 
CD48+ trees than SCF and IL6. The data concerning the CD48 onset kinetics of cells 
cultured in stroma free culture recapitulates data from the CD48 onset types in 
Figures 5.16 and 5.17. IL3 clearly promotes differentiation as shown by an increasing 
number of CD48+ trees over time, while IL6 allows almost two-thirds of trees to 
remain CD48 negative after 4d in culture.  
 
5.1.4.4. Asymmetric CD48 Expression Onset Reveals Intrinsic Control of 
Asymmetric Fates of HSC Daughters 
Having established CD48 detection as a means of detecting loss of HSC 
potential, we used this marker to identify asymmetric fate decisions of HSC. We were 
interested in trees that showed an asymmetric onset of CD48 expression in progeny 
cells. In Figure 5.19A the pedigree corresponding to Supplemental Movie 5.6 is 
shown, where the daughters of the starting cell display CD48 onset at different time 
points. While cell 2 starts to express CD48, marked by a blue arrow and shown in B, 
cell 3 remains negative (Figure 5.19B). The progeny of cell 2 continue to express 
CD48, but the daughters of cell 3 first do not express CD48, as shown in Figure 
5.19C, until shortly before division, cell 6 starts to express CD48 (Figure 5.19D). At 
the same time cell 7 still remains negative, until just after division, when its 
daughters start to express CD48.   
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Figure 5.19: Pedigree of colony with CD48 expression onset in 
progeny: Asymmetric onset. Pedigree starting with an HSC shows 
asymmetric onset (more than 12h) of CD48 expression. Blue arrows 
indicate CD48 expressing cells in corresponding frames while white 
arrows indicate CD48 negative cells in corresponding frames (A). 
Frames corresponding to movie 6 (B, C, and D). Cell 2 indicated by a 
blue arrow expresses CD48, while cell 3 indicated by a white arrow at 
the same time does not express CD48 (B). Cells 4 and 5 indicated by 
blue arrows express CD48, while cells 6 and 7 indicated by white arrows 
are still negative for CD48 (C). Cell 6 indicated by a blue arrow is now 
CD48+ while cell 7 indicated by a white arrow remains CD48- (D). Scale 
bars are 10µm, time scale: days – hours:minutes 
Another example of asymmetric onset of CD48 expression is shown in Figure 5.20. 
The pedigree corresponding to Supplemental Movie 5.7 shows daughters 2 and 3 
initially negative for CD48 (Figure 5.20B). Shortly before division, cell 2 starts to 
express CD48, as shown in Figure 5.20C, and all further progeny of cell 2 also remain 
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CD48+. In contrast, cell 3 remains negative and also its progeny do not upregulate 
CD48 (Figure 5.20C and Figure 5.20D). 
   
 
 
 
 
 
 
 
 
Figure 5.20: Another example: Pedigree of colony with CD48 
expression onset in progeny: Asymmetric onset. Pedigree starting with 
an HSC shows asymmetric onset of CD48 expression. Arrows indicate 
corresponding frames. The left branch of the tree turns on CD48 in cell 2 and 
remains CD48+, while the right branch of the tree remains CD48- (A). Frames 
correspond to Movie 7. Cell 2 and 3 indicated by white arrows are negative for 
CD48 expression (B). Cell 2 indicated by a blue arrow is CD48+ while cells 6 and 
7 indicated by white arrows remain CD48- (C). Progeny of cell 2 express CD48 
(blue arrows) while daughters of cell 3 remain CD48- (white arrows) (D). Scale 
bars are 10µm, time scale: days – hours:minutes 
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To define trees with asymmetric onset of CD48 expression, we chose a 
minimal time difference of 12 hours. This eliminates differences in onset of CD48 
expression of two or three hours which could be attributed to technical detection 
delays, and is the approximate length of one generation. 
   Of HSC cultured on PA6 stroma that showed onset of CD48 expression in their 
progeny, we found 69.5% (±13.0) of pedigrees with asymmetric onset (Figure 
5.21A). In contrast, only 10.5% (±10.6) of MPP progeny were asymmetric in the 
onset of CD48 expression (p=0.03). A similar trend could be observed when cells 
were cultured in stroma free self renewal culture containing SCF and TPO. Here 53.3 
(±8.9) of HSC trees showed asymmetric CD48 onset, whereas only 20.8% (±5.9) of 
MPP trees were asymmetric regarding the onset of CD48 expression (p=0.1, Figure 
5.21B). HSC cultured in differentiation conditions also showed similar percentages of 
asymmetric CD48 onset as when cultured in the presence of self renewal cytokines. 
When cultured in SCF and IL3 54.6% (±11.2) of HSC progeny showed asymmetric 
onset of CD48 expression, while 50.0% (±23.6) of pedigrees with onset of CD48 
expression in their progeny were asymmetric when cultured in SCF and IL6 (Figure 
5.21B). These results show, that asymmetric onset of CD48 expression is specific to 
HSC and not MPP and that it is independent of the environment that cells are 
cultured in. This leads to the conclusion that asymmetric CD48 onset in HSC 
pedigrees is intrinsically controlled. Therefore, the onset of CD48 expression serves 
as a live marker of loss of self renewal that helps to identify asymmetric fate 
decisions in HSC. 
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Figure 5.21: More HSC than MPP produce pedigrees 
with asymmetric CD48 onset. Percentage of pedigrees 
with asymmetric onset of CD48 expression in progeny cells 
derived from HSC and MPP and cultured on PA6 stroma. Data 
shows the average of 5 independent experiments with 49 HSC 
and 44 MPP pedigrees analyzed (A). Percentage of pedigrees 
with asymmetric onset of CD48 expression in progeny cells 
derived from cells cultured in stroma free conditions. Data 
shows the average of 2 independent experiments for each 
condition. For cells cultured in SCF and TPO, 16 HSC and 14 
MPP pedigrees were analyzed. For HSC cultured in SCF and 
IL3 and SCF and IL6, 31 and 15 pedigrees were analyzed 
respectively (B). Error bars show standard deviation, * = 
p<0.05 
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5.2. Examining Candidate Protein Segregation as a Potential Mechanism 
Controlling Asymmetric Fate Decisions of HSC 
5.2.1. Expression of Candidate Genes in Bone Marrow Populations 
To evaluate whether the candidate genes mentioned in the introduction might 
play a role in ACD, we first set out to examine their presence in mouse HSC, MPP 
and other major myeloid progenitor population. For this, we isolated these 
populations by FACS sorting and measured candidate expression at the mRNA level. 
In detail, KSL cells were subdivided to yield HSC, MPP and MPP4. HSC and MPP were 
isolated like shown above as CD48-CD34-Flt3-KSL and as CD34+Flt3-KSL respectively. 
MPP4 were isolated as CD34+Flt3+KSL (Figure 5.22A), (Wilson, Laurenti et al. 2008). 
Myeloid progenitors are lineage marker negative, lack expression of Sca-1 and 
express high levels of c-kit. This KLS- population can be subdivided according to the 
expression of Fcγ receptor (FcγR) and CD34 (Figure 5.22B). GMP, which can give rise 
to cells of the monocytic and the granulocytic lineage, express FcγR as well as CD34. 
MEP, which can give rise to megakaryocytes and erythrocytes, are negative for both 
markers. In addition, MEP do also not express CD71, as CD71 expressing cells have 
already committed to the erythroid lineage. CMP, which can give rise to GMP and 
MEP do not express FcγR, but do express CD34.  
In order to avoid detection of genomic rather than cDNA with our primers, we 
chose exon-spanning primers to detect all selected genes (Table1). We could not 
detect Prominin1 expression in HSC or other immature progenitors (Figure 5.22C), 
however we found that GMP are the only population tested that expressed Prominin1 
mRNA. Since we could detect as low as one copy of Prominin1 in plasmid dilutions 
(data not shown) we could exclude that the lack of Prominin1 expression in HSC is 
due to insensitivity of the primers to low copy numbers of the mRNA. These results 
were confirmed by Affymetrix chip analysis (Dr. M. Rieger). In contrast, Pumilio1 and 
Pumilio2 were both expressed in HSC as well as MPP and all myeloid progenitors, but 
not in MPP4 (Figure 5.22C). Quaking1 expression was analyzed using primers 
recognizing all three splice isoforms. We were able to detect Quaking1 expression in 
HSC as well as MPP populations and all myeloid progenitors (Figure 5.22C). To 
assess Staufen1 expression we used primers recognizing both Staufen1 and Staufeni. 
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Like Quaking1, we detected Staufen1 expression within the HSC population and in all 
other analyzed progenitor populations except for MPP4 (Figure 5.22C). 
 
 
 
 
 
In summary, all candidate genes except for Prominin1 were expressed in HSC 
and in most of the other analyzed progenitor populations. Since Staufen1 and both 
Pumilio1 and 2 genes are expressed in HSC we decided to continue our studies 
concerning protein segregation with these candidates. We also were interested in 
their effect on HSC lineage choice. Prominin1 was not expressed in HSC so we did 
not pursue this candidate any further. Despite the fact that we found Quaking1 to be 
expressed in HSC, since so far it has not been directly implicated in protein 
segregation, we decided to not employ Quaking1 in protein segregation experiments. 
Rather, Quaking1 seems to be an effector gene, executing decisions of upstream 
genes that are segregated asymmetrically. Therefore, we decided to evaluate the 
effect of Quaking1 on fate choices of HSC only.  
Table 5.1: RT-PCR primers for candidate genes. Sequence and 
binding location of primers to detect candidate RNA expression in 
hematopoietic progenitors. 
 
Results 78 
 
 
 
 
 
 
Figure 5.22: RT-PCR of candidate genes in bone 
marrow progenitor populations. Sorting scheme of 
HSC and myeloid bone marrow progenitors (A). mRNA 
expression of candidate gene specific sequences (see 
Table 1) in 50 cell equivalents of bone marrow 
progenitors (B). 
 
5.2.2. Cloning of Candidate Expression Constructs 
For each of the candidates, two different lentiviral expression constructs were 
generated. The first, used to analyze protein segregation of candidate proteins, 
consists of a direct fusion of the candidate protein to the VENUS fluorescent protein. 
For analysis of the influence of candidate genes on fate decisions, we had to exclude 
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that the fusion to a fluorescent protein alters the function of the wild type candidate 
protein. Therefore, constructs were generated whereby the expression of the 
candidate gene was separated from VENUS expression by an internal ribosome entry 
site (IRES). This results in the production of one mRNA containing two separate 
translation initiation sites for the candidate and VENUS and ensures that every cell 
expressing the introduced candidate gene also expresses VENUS under the control of 
the same promoter. In addition, VENUS expression was targeted to the nuclear 
membrane by the addition of an importin sequence (Imamoto, Shimamoto et al. 
1995). 
 
 
5.2.3. Optimization of Lentivirus Infection 
Viruses expressing candidates either as fusions to VENUS or as IRES 
constructs were produced using an optimized protocol from Dr. Christopher Baum’s 
laboratory (Schambach, Galla et al. 2006). We used an ecotropic envelope protein to 
produce virus that can only infect rodents, but not humans. We tested the virus on 
HSC isolated from mouse bone marrow using a multiplicity of infection (MOI) of 600. 
Infection of these cells with vector control virus expressing only VENUS resulted in 
infection efficiencies of 7% (±11.9, black bar, Figure 5.23A), while virus containing 
either Staufen1, Staufeni or Quaking1 resulted in infection efficiencies of 2% (±0.7), 
2% (+1.3) and 1% (±2.0) respectively. Infection efficiencies in this range are 
challenging to work with, as HSC are a rare population (maximum 1000 cells per 
mouse) and a large number of positive cells are needed to yield significant results. 
We tried to increase infection efficiency by centrifuging virus, cells and protamine 
sulfate, which should facilitate virus infection by bringing virus and cells in close 
contact. However, the percentage of VENUS positive cells did not increase using this 
spin infection method (white bars, Figure 5.23A). Also, variation of temperature and 
MOI during spin infection as well as precoating of plates with retronectin did not 
increase infection efficiency (Figure 5.23A and B and data not shown), as these 
methods yielded efficiencies of not more than 6%. 
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Figure 5.23: Optimization of lentiviral infection: 
Infection conditions. Comparison of infection 
efficiencies of 4 different lentiviruses with two 
infection methods. Data shows average of two 
independent experiments (A). Comparison of 
lentivirus infection efficiency using various MOIs and 
spin infection at three different temperatures. Data 
shows results of one experiment (B). Error bars show 
standard deviation. 
 
 
 
 
 
 
 
Finally, we decided to test vesicular stomatitis virus G protein (VSVG) 
pseudotyped lentivirus to infect HSC. VSVG protein can recognize and bind to 
receptors present on rodent as well as human cells and renders the virus more stable 
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during ultracentrifugation. Using VSVG pseudotyped virus poses a potential risk for 
the researcher, especially when working with suspected oncogenes, and hence work 
needs to be performed under strict S2 conditions. Using GFP containing VSVG 
lentivirus (kindly provided by Dr. Christopher Baum) to infect HSC, resulted in more 
than 80% of infected cells when directly adding the lentivirus. Using this same 
condition for infection of HSC with several of our ecotropic lentiviral vectors resulted 
in infection efficiencies below 10% irrespective of construct or method (Figure 
5.24A). Therefore, we decided to produce VSVG pseudotyped lentivirus and compare 
it to the obtained GFP VSVG virus resulting in similar infection efficiencies at two 
different MOI (Figure 5.24B). At an MOI of 10 VSVG GFP virus showed 43% and 
VENUSnucmem virus showed 33% of infected cells. At an MOI of 100 VSVG GFP 
virus showed 73% and our self produced virus showed 79% of VENUS positive cells. 
Therefore, we decided to produce all our viruses as VSVG pseudotype and use them 
at an MOI of 100. 
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Figure 5.24: Higher infection efficiency of VSVG 
compared to ecotropic pseudotyped virus. 
Comparison of infection efficiency of VSVG and 
ecotropic pseudotyped lentivirus using different 
infection methods. Virus was directly applied to the 
cell suspension. Data shows results of one 
experiment with three replicates (A). Comparison of 
infection efficiency between obtained and self 
produced VSVG pseudotyped lentivirus (B). Data 
shows results of one experiment. Error bars show 
standard deviation.
 
 
 
 
 
 
 
 
5.2.4. Segregation of Candidate Proteins during HSC Divisions 
5.2.4.1. Experimental Setup for Analysis of Protein Segregation 
ACD is assumed to be a mechanism used by HSC to generate asymmetric self 
renewal fates of daughter cells. Thus, cells that have lost their HSC capacity could be 
no longer able to segregate fate determining proteins asymmetrically to generate 
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asymmetric daughter cell fates. To analyze a potential role of ACD in HSC self 
renewal control, it is crucial to analyze cells that have not lost their HSC potential yet. 
HSC, when cultured under self renewal maintanence (not expansion) conditions, will 
divide either symmetrically to give rise to two differentiated cells that have both lost 
their HSC capacity or they will asymmetrically divide to yield an HSC and a 
differentiated cell. Therefore, it is important to analyze protein segregation during 
the first division, since the identity of the cell can only then be assured. 
Examining the role of candidate proteins in ACD of HSC, we decided to isolate 
a cell population that contains the highest possible percentage of cells with 
reconstitution potential. Using CD150+CD48- within the CD34-KSL cell population 
yields HSC with a purity of over 47% (Kiel, Yilmaz et al. 2005; Wilson, Laurenti et al. 
2008) (Figure 5.25A). We isolated this cell population and infected them in stroma 
free culture in the presence of only SCF for 44h, washed them and initially replated 
them onto PA6 stroma to analyze protein segregation (Figure 5.25B). However, as 
we discovered that the PA6 cells were also infected by the virus, thus complicating 
the analysis of protein segregation in the blood cells, we switched to stroma free 
culture containing SCF and TPO.  
After the infection period, we observed the infected cells and tracked and 
quantified only presumed first divisions, which we found occurred mostly within the 
first two days of the time lapse movie (Figure 5.25C). We compared the fluorescence 
intensity of sister cells normalized to background immediately after division and 
recorded the difference as a ratio. We assumed ratios above 2 as a potential 
asymmetric segregation of protein between the two sister cells. In addition, any 
sister cells producing a ratio higher than 1.5 were again closely examined to 
determine the reason for the higher ratio. In most cases, a ratio above 1.5 was due 
to uneven background illumination or imprecise area definition before quantification 
and after adjustment of area yielded a lower ratio. 
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Figure 5.25: Experimental setup to examine 
protein segregation in HSC. HSC sorting scheme, 
isolation of CD34-CD48-CD150+ KSL cells for protein 
segregation experiments (A). Experimental setup of 
lentiviral infection (B). Time lapse movie, single cell 
tracking and quantification of fluorescence in sister 
cells (C). 
 
 
 
 
 
 
5.2.4.2. Staufen1 and Staufeni Are Not Segregated during HSC Divisions 
We analyzed a total of 650 divisions of VENUS positive cells for Staufen1 and 
Staufeni segregation, but we did not find any sister cells that significantly differed in 
their fluorescent intensity, i.e. a ratio of more than 2 (Figure 5.26A and B). We still 
took a closer look at the data and noticed background intensity variations across the 
field of vision in a range from 0 to 14000 fluorescence units (FU) for Staufen1VENUS 
movies and a range of 500 to 10000 FU for StaufeniVENUS movies (data not shown). 
Differences in background ranges between Staufen1 and Staufeni movies are due to 
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differences in histogram adjustment at acquisition and do not have an effect on real 
signal intensities and cell ratios. We also noticed that the fluorescence intensity over 
background (FOB) varied widely within a movie (Figure 5.26A and B). This is 
probably due to different numbers of lentiviral integrations into the genome of the 
cells, some cells containing multiple and other cells containing single copies of fusion 
genes. To evaluate the influence of FOB on sister cell ratio we plotted cell ratios 
against FOB and found that cells with the lowest FOB also had the highest ratios 
(Figure 5.26A and B). Presumably, the lower the absolute fluorescence intensity of a 
cell, the higher the error rate coming from imprecise area definition around the cell 
and limitation in recognizing pixel intensity differences. However, also in cells with a 
very low FOB, we did not find sister cell ratios above 2, indicating that our 
measurement tools were actually quite sensitive. We decided to take a closer look at 
sister cell pairs that displayed cell ratios above an arbitrary line that would exclude 
cells with very low signals, as we assume a higher error rate in these cells, as well as 
cells with a high intensity but very low cell ratio, as those cells are unlikely to contain 
sister pairs that display asymmetric protein segregation. Examples of protein 
segregation during division of HSC can be observed for Staufen1 expressing cells 
(Supplemental Movies 5.8A, 5.8B, 5.8C, and 5.8D) and for Staufeni expressing cells 
(Supplemental Movies 5.9A, 5.9B, 5.9C, and 5.9D).  
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Figure 5.26: Quantification of Staufen protein 
segregation. Circled data points correspond to Movies 5.8A-
D and 5.9A-D. Ratio of sister cell fluorescence over average 
fluorescence signal of sister cells of Staufen1 expressing cells 
(A). Ratio of sister cell fluorescence over average 
fluorescence signal of sister cells of Staufeni expressing cells 
(B). Results show data points from 2 independent 
experiments. 
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 Supplemental Movie 5.8A shows dividing Staufen1 expressing cells that differ 
in their focal plane shortly after division, which may account for a high cell ratio. In 
Supplemental Movie 5.8B the dividing cells are located at the edge of the cell culture 
dish which causes uneven background fluorescence and therefore also a high 
fluorescence ratio. Supplemental Movie 5.8C shows dividing cells with equally strong 
signal in both sister cells. No obvious difference can be observed that would account 
for the high fluorescence ratio. In Supplemental Movie 5.8D sister cells both express 
equally high levels of VENUS protein which is reflected in the low cell ratio, but high 
FOB. 
 Supplemental Movie 5.9A shows a Staufeni expressing cell that appears to 
contain clumps of fluorescent protein. Upon division these clumps are segregated 
unevenly and it seems that the upper cell receives more protein. This uneven 
segregation of clumpy protein is reflected by a cell ratio of 1.98. Also in 
Supplemental Movie 5.9B Staufeni overexpression causes the formation of clumps 
which appear to be segregated unevenly during division resulting in a high cell ratio. 
In Supplemental Movie 5.9C cells express a low level of Staufeni and seem not to 
differ in their expression strength. In contrast, Supplemental Movie 5.9D shows cells 
that express a high level of Staufeni in clumps that seem to get segregated slightly 
unevenly during division.  
It is evident from the plots denoting Staufen1 and Staufeni cell ratios, that in 
Staufeni overexpressing cells, the number of cells with potential asymmetric 
segregations is higher than in Staufen1 overexpressing cells. When analyzing these 
events closely, however, we found that Staufeni overexpressing cells often contain 
clumps that make correct quantification difficult. According to published data 
(Duchaine, Wang et al. 2000), these clumps are an overexpression artifact and are 
not an indicator of asymmetric protein segregation. In concordance with the 
literature we could only see these clumps in cells with high Staufeni signal.  
In summary, we did not find asymmetrically segregated Staufen1 or Staufeni 
fusion proteins in HSC. Sister cell fluorescence intensity ratios stayed below the 
cutoff of 2 and cells that displayed ratios between 1.5 and 2 were due to uneven 
background or in the case of Staufeni due to overexpression artifacts and do not 
reflect asymmetrically segregated protein. 
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5.2.4.3. Evaluating the Number of Analyzed Divisions 
We have monitored 650 divisions for each of the Staufen1 isoforms. This 
seems like a large number of divisions; however a number of factors have to be 
taken into consideration. First, it is important to know if the monitored divisions were 
really first in vitro HSC divisions. Second, not all cells in the isolated starting 
population possess HSC capacity. And third, not every HSC may undergo asymmetric 
division.  
To address the first point it is necessary to elucidate the number of cells that 
had divided before the start of the movie monitoring protein segregations. As 
mentioned above, our movies were started only after a non visualized 44h infection 
period. This time frame for infection was chosen, since by this time the infection of 
HSC was completed and a fluorescent signal could be detected by microscopy (data 
not shown). We did not know however if during this infection period the plated cells 
had divided already. Therefore, we decided to elucidate the divisional behavior of 
cells during the infection period. To this end we visualized cell behavior of freshly 
isolated HSC cultured under the same conditions as the cells during infection. When 
we analyzed the behavior of cells cultured under infection conditions during the first 
70h, we found that 46% of cells divided at least once, 48% of cells died and only 6% 
of cells survived without division until the end of the movie (Figure 5.27A).  
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Figure 5.27: Evaluation of cell behavior during non video monitored 
infection period. Cell fates of HSC after 70h in SCF. Fate of starting cell is 
shown: Division, Apoptosis and Nothing (does not divide or apoptose). Data 
shows average of two independent experiments with 207 colonies analyzed 
(A). Kinetics of first division and apoptosis over time during first 70h. Data 
 
 
The high percentage of divisions and apoptoses was a surprise, as we had 
assumed SCF without the addition of any proliferative signal to be neutral, providing 
survival and quiescence signals to the cells. We wanted to know if within the dividing 
cells the first division already took place during the 44h infection period or if they 
divided at a later time during which we had already started our movie and could then 
visualize and quantify divisions.  
We found that after 44h 73% of surviving cells had undergone their first 
division (Figure 5.27B). Therefore, we could deduct from this that only 27% of the 
divisions monitored in our segregation movies were really first divisions. Having 
quantified 650 divisions each for Staufen1 and Staufeni, we can conclude from the 
divisional behavior in SCF within the first 44h, that only 27%, that is 175 divisions, 
were really first divisions. Combining HSC isolation protocols (Osawa, Hanada et al. 
1996; Kiel, Yilmaz et al. 2005; Wilson, Laurenti et al. 2008) we know that within the 
monitored cells more than 47% are true HSC. That leaves us with at least 82 first 
HSC divisions out of the initial 650. And if we assume that asymmetric cell division 
only occurs in e.g. a third of total divisions (a much lower probability of ACD would 
render this process not important for cell specification) we have 27 divisions in which 
we would expect to see asymmetrically segregated protein. From this we can 
conclude that it should be sufficient to monitor 650 divisions in this matter, and that 
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neither Staufen1 nor Staufeni segregate asymmetrically in HSC when overexpressed 
as fusion genes as we would have recorded these asymmetric segregations within 
the number of divisions quantified. 
As we recorded apoptosis in 48% of cells during the first 70h when cultured 
under infection conditions, we were curious to know if these cells that died during 
this time, did so after or before the end of the 44h culture period. When we looked 
at the kinetics of apoptosis of these cells, we found that more than 90% of apoptotic 
cells had died before the cells were switched to SCF and TPO at 44h (Figure 5.27C). 
Therefore, those cells would be dead already at the start of the movie examining 
segregations. The early time of apoptosis of such a high number of cells can be 
caused by negative influence of the sorting process on the cells, but when culturing 
cells in SCF and TPO, apoptosis of starting cells was not higher than 25% (Figure 
5.7B), indicating that the high number of apoptoses cannot be due to damage from 
the sorting process alone. It is possible that a subtype of cells with HSC surface 
phenotype is not responsive to SCF and therefore, does not receive survival signals. 
HSC are sorted for cells that express high levels of c-kit, the receptor of SCF. 
Therefore, a lack of SCF responsiveness cannot be due to a complete lack of c-kit, 
but to either rapid downregulation of c-kit or blocked signaling pathways 
downstream of c-kit (Wandzioch, Edling et al. 2004) inducing apoptosis in a subset of 
cells. However, our results for division and survival of SCF cultured cells are similar to 
data from Selta et al., who found a slightly higher division rate (55% compared to 
our 46%) but a lower apoptosis rate (30% compared to our 48%) when culturing 
HSC in SCF for 72h (Seita, Ema et al. 2007). 
 
 
5.2.4.4. Pumilio1 Is Not Segregated during HSC Divisions 
When planning segregation movies for Pumilio1, we decided that we would be 
able to observe a higher percentage of first divisions when our infection period would 
be shorter than the 44h. In addition, infection of HSC with Pumilio1VENUS fusion 
virus showed in initial experiments, that VENUS signal could be detected as soon as 
30h after start of infection (data not shown). Therefore, we decided to reduce the 
infection period for Pumilio1 to 30h during which time less than 20% of HSC had 
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divided in infection condition time lapse movie, another 51% of cells had divided 
between 30h and 44h (Figure 5.27B).  
For Pumilio1 we initially monitored 266 divisions in a two day time-lapse 
movie. Of these 266 divisions, 212 divisions were first divisions and out of these, 99 
divisions were generated from cells with true HSC potential. If a third of these cells 
divide asymmetrically and use the segregation of Pumilio1 as a means to accomplish 
an asymmetric fate choice, we would expect to observe 33 divisions with a 
fluorescence sister cell ratio above 2. However, we did not find sister cell pairs that 
differed in their fluorescent intensity as much (Figure 5.28).  
Like in time-lapse movies monitoring Staufen1 and Staufeni protein 
segregations, we found variations in background intensity ranging from 463 to 7589 
fluorescence units (FU) when examining Pumilio1 segregation (data not shown). FOB 
also varied widely in Pumilio1 expressing cells from only 78 to 5350 (Figure 5.28A), 
which is probably due to cells containing different copy numbers of the fusion gene. 
Even though there were no sister cell pairs with a ratio of fluorescence of 
above 2, we still took a closer look at divisions that had a FOB of above 3000 or a 
fluorescence ratio above 1.4. Supplemental Movie 5.10A shows a Pumilio1 expressing 
cell that is dividing. No obvious difference in intensity of fluorescence can be 
observed between the two sister cells. The cell pair depicted in Supplemental Movie 
5.10B also displays cell ratio and FOB slightly above the arbitrary threshold. 
Observing the corresponding Supplemental Movie 5.10B the two sister cells seem to 
have different sizes in addition to laying on top of fluorescent debris. This may 
account for the high cell ratio, however as we did not find any cell pairs with similar 
size difference it might be an overexpression artifact. In Supplemental Movie 5.10C 
the two Pumilio1 expressing sister cells seem to be slightly out of focus at the time of 
division. Shortly thereafter though, they express relatively high amounts of Pumilio1 
in their cytoplasm. In Supplemental Movie 5.10D the sister cells expressing Pumilio1 
both have low levels of fluorescence (average FOB 1189) as can be also seen in 
Figure 5.28. A bit of fluorescent debris is present underneath the cells and in addition 
with higher measuring error in low expressing cells can account for the cell ratio of 
1.42. 
Overall these results indicate that Pumilio1 when overexpressed in HSC as a 
fusion protein does not segregate asymmetrically in daughter cells. Fluorescence 
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ratios of sister cell pairs shortly after division only rise above an arbitrary threshold 
when fluorescent debris is present, the background fluorescence is uneven, or the 
area definition for the fluorescence measurement was imprecise.  
When we analyzed Pumilio2 segregation during HSC divisions, we found that 
the fluorescence signal from the fusion gene was barely detectable over the 
background. We found maximum signal strength of 11.5% of background 
fluorescence in Pumilio2 expressing cells (data not shown), whereas we had found 
maximum signal strength of 267.7% of background fluorescence in Pumilio1 
expressing divisions. In addition, we found only very few sister cell pairs positive for 
Pumilio2 signal. This was probably due to the low titer of the virus which we used to 
infect HSC. Virus titer for Pumilio2 fusion gene was never higher than 2x106 per ml, 
whereas titers of other fusion genes ranged from 1x107 to 1x108 per ml. We think 
that the long ORF of Pumilio2 (3.2kb) or structural problems influence proper VENUS 
signal and that thereby titers and infection efficiency stay low because single 
integrations might give a too low signal and cannot be detected. In any case, we 
decided that our fusion gene overexpression approach cannot be used for the 
Pumilio2VENUS fusion and therefore did not monitor any further divisions of Pumilio2 
expressing HSC. We cannot conclude if Pumilio2 is segregated during HSC divisions 
as not enough divisions of Pumilio2 expressing cells could be monitored due to 
inefficiency of Pumilio2 lentivirus. 
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Figure 5.28: Quantification of Pumilio1 protein 
segregation. Circled data points correspond to Movies 
5.10A-D. Ratio of sister cell fluorescence over average 
fluorescence signal of sister cells of Pumilio1 expressing 
cells. Results show data points from 2 independent 
experiments. 
 
 
 
 
 
 
5.2.5. Influence of Candidate Genes on Fate Decisions 
In addition to the role of our candidate genes in protein segregation during 
HSC division, we wanted to know if these genes play a role in fate decisions of HSC. 
Therefore, we overexpressed candidate genes in HSC by using a lentiviral vector and 
observed the influence of candidate genes on colony potential, lineage choice and 
proliferation ability. For this purpose we used our viral vectors containing IRES 
expression cassettes to allow for wildtype overexpression of candidates in HSC. 
 As for experiments examining protein segregation, we again sorted 
CD150+CD48-CD34-KSL as HSC population (Figure 5.29A). HSC were infected with 
lentivirus during a 72h infection period in stroma free culture containing SCF and 
TPO (Figure 5.29B). During this time frame virus was allowed to integrate into the 
genome and cells to proliferate. The longer infection period also allowed time for 
accumulation of VENUS protein in these cells to yield a stronger fluorescence signal. 
We know that after 3d of culture in SCF and TPO only 61-72% of initial HSC potential 
is left (Ema, Takano et al. 2000). However, a colony formation assay does not read 
out HSC potential but rather multipotency of cells and therefore, these infection 
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conditions are good enough for this in vitro analysis of fate potential. After the 
infection period, cells positive for VENUS expression, reflecting successful infection 
and overexpression of candidate genes, were resorted, counted and plated into 
methylcellulose containing cytokines allowing formation of all myeloid lineages 
(M3434) (Figure 5.29C). We had found it to be very difficult and time consuming to 
judge if a colony is positive for VENUS expression in dense colonies in 
methylcellulose. Therefore, by plating only VENUS positive colonies, we ensured that 
all colonies within the dish were positive and did not have to be analyzed for VENUS 
expression when determining colony type at the end of the experiment. 
 
 
 Figure 5.29: Experimental setup examining the in 
vitro effects of candidate genes on progenitors. Sorting 
scheme, isolation of CD34-CD48-CD150+ KSL cells for 
experiments examining in vitro effects (A). Experimental 
setup of lentiviral infection (B). Resort of VENUS+ cells and 
plating into colony assay (C). 
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 As infection efficiency as well as signal strength varied widely between fusion 
gene lentiviral vectors, we decided to first analyze these two parameters using the 
IRES construct lentiviral vectors before examining the effect of candidate genes on 
HSC lineage potential in vitro. As described above, for the vector control virus we 
saw an infection efficiency of 92.8% (±5.0) (Figure 5.30A), whereas lentiviral 
infection with viruses containing various candidate genes resulted in lower 
efficiencies. Staufen1 expression resulted in 18.5% (±10.7) of positive cells, while 
infection with Staufeni containing virus yielded 42.6% (±20.5) of cells positive for 
VENUS expression. Infection efficiencies for the two Quaking1 isoforms were similar: 
overexpression of Quaking1-6B and 5A resulted in 35.5% (±9.6) and 36.1% (±11.1) 
of cells respectively being positive for VENUS expression. When we examined 
lentiviral vectors containing Pumilio1 and Pumilio2 we found only 3.9% and 4.6% of 
cells respectively to express VENUS.  
The mean fluorescence of VENUS+ cells denotes the signal strength and gives 
information as of how well positive and negative populations can be separated by 
FACS. When cells were infected with control virus we detected a mean fluorescence 
of 27852.2 FU (±11090.6) in VENUS+ cells (Figure 5.30B). Mean fluorescence of cells 
infected with candidate gene vectors was much lower. Staufen1 and Staufeni 
overexpression led to similar values of mean fluorescence of positive cells (5726.2 FU 
± 3027.1 and 7044.6 FU ± 4040.4 respectively). Quaking1 6B and 5A showed a mean 
fluorescence of 15054.7 FU (±999.0) and 14452.7 FU (±446.4) respectively. 
Overexpression of Pumilio1 and Pumilio2 however resulted in only 1619 FU and 2768 
FU respectively of mean fluorescence in VENUS+ cells. 
In summary, infection efficiencies for IRES containing lentiviral vectors co 
expressing either Staufen1, Staufeni, Quaking1-5A and 6B were not as good as for 
vector control virus, but still high enough to answer questions regarding fate 
decisions in HSC progeny. Similarly, mean fluorescence levels of VENUS positive cells 
in candidate infected cells were lower than in vector control infected cells, but still 
high enough such that the VENUS+ population could be easily separated in FACS 
from the VENUS- population. In contrast, infection efficiencies for Pumilio1 and 2 
were extremely low and also mean fluorescence levels of those few positive cells did 
not allow clean separation of VENUS+ from VENUS- cells. We therefore decided to 
use Pumilio1 fusion virus instead of the IRES virus to examine the effect of Pumilio1 
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on lineage decision, even if the fusion protein could have altered function compared 
to the wild type. Pumilio1 fusion virus showed high infection efficiencies of 31.5% 
(±2.4) and high mean fluorescence of positive cells of 13740.5 FU (±598.8). 
Unfortunately, for Pumilio2 we could not use the fusion virus since this also resulted 
in a low number of infected cells with barely detectable mean fluorescence, as shown 
above.  
 
Figure 5.30: Properties of IRES 
construct lentivirus vectors. 
Efficiency of lentiviral vector infection 
from different candidate genes as 
measured by FACS, all are IRES 
constructs (A). Mean fluorescence of 
VENUS positive cells of candidate 
lentivirus infected cells as measured 
by FACS (B). Results show average of 
three independent experiments. 
Error bars show standard deviation. 
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5.2.5.1. No Influence of Staufen1 and Staufeni on Proliferation and 
Lineage Choice of Progenitor Cells In Vitro 
We analyzed the influence of Staufen1 and its splice isoform Staufeni on HSC 
lineage decision. We found that both isoforms allowed formation of all mature 
myeloid lineages. Colony formation potential and proliferation was also not affected 
by either Staufen1 or Staufeni overexpression. In addition, we found that the 
proportions of different colony types were similar to those produced by vector control 
overexpressing HSC (Figure 5.31A). However, since a role for Staufen in leukemia 
was suggested previously (Faubert, Lessard et al. 2004), we decided to look at 
colony potential during serial replatings. Leukemic cells should be able to be replated 
indefinitely, retaining a constant colony potential efficiency. When we replated 
colonies for five times we saw varying percentages of colony potential, however 
overall colony potential decreased in vector control as well as Staufen1 and Staufeni 
infected cells, until almost no more cells grew in culture after the fifth replating 
(Figure 5.31B and 5.32A). In addition to similar colony potential, the absolute 
number of colonies was also similar in Staufen1, Staufeni and vector control infected 
cells (Figure 5.32B). Therefore, Staufen1 and Staufeni are unlikely to cause aberrant 
cell proliferation seen in leukemia.  
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Figure 5.31: No influence of 
Staufen1 on in vitro fate decisions. 
Influence of Staufen1 isoforms on 
lineage choice and colony formation of 
HSC, count1 (A). Colony formation and 
lineage choice of Staufen1 and Staufeni
expressing cells after first replating, 
count2 (B). Data shows the average of 
three independent experiments with 
three replicates each. Error bars show 
standard deviation 
 
 
When we analyzed the multipotency of colonies we found that it decreased 
already after the first replating. In the first count we could observe 20% (±5.2) of G 
colonies and 13.4% (±3.1) of multipotent GEMM colonies in vector controls (Figure 
5.31A). In the second count after the first replating however, we counted 77.3% 
(±1.9) G colonies, but no multipotent GEMM colonies (Figure 5.31B). In the third 
count we could observe almost 100% G colonies with only very few Megakaryocytes 
present (data not shown). Similar results were obtained for cells overexpressing 
Staufen1 or Staufeni (Figure 5.31A and B).  
In summary we found that although at least one of the Staufen1 splice 
isoforms is expressed at the mRNA level in HSC and bone marrow progenitor 
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populations, overexpression of neither form influences lineage decisions and 
proliferation ability of progenitor cells in vitro. 
 
 
 
 
 
 
 
 
 
Figure 5.32: Staufen does not cause aberrant 
proliferation in vitro. After analysis of colonies in 
methylcellulose, colonies were dissociated and resulting 
cells replated in fresh methylcellulose. Colony potential is 
the number of seeded cells divided by the number of 
resulting colonies. Colony potential of infected cells over 
five replatings (A). Total colony number in each replating 
(B). Data shows the average of two independent 
experiments with three replicates each. Error bars show 
standard deviation 
 
5.2.5.2. Negative Influence of Pumilio1 on In Vitro Progenitor Potential 
As shown above, when trying to overexpress Pumilio1 using an IRES 
construct, we found that virus titers and efficiencies of expression in HSC were very 
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low (6x105 and 4% respectively). As discussed earlier we therefore decided to use 
the Pumilio1VENUS fusion constructs instead, which we had successfully used in 
segregation studies, to analyze Pumilio1 function on HSC fate decisions. When we 
infected HSC with Pumilio1 VENUS containing lentiviral vector we found 31.5% 
(±2.4) of cells to be infected with the virus. A colony assay of VENUS+ replated cells 
resulted in normal proliferation and the formation of colonies of all myeloid lineages. 
We saw however decreased colony formation potential from 25.1% in vector control 
expressing cells to 10.3% in Pumilio1 expressing cells. Moreover, we saw an increase 
in the percentage of GM colonies from 31.9% (±6.0) to 66.3% (±6.4, p=0.007) and 
a decrease of G colonies from 38.6% (±1.9) to 9.6% (±1.1, p=0.03) when cells 
expressed Pumilio1 compared to vector control. Therefore, Pumilio1 seems to have 
an influence on GM fate decisions. In addition, when we reanalyzed VENUS 
expression by FACS after counting of colonies, we found only 3% (±0.3) VENUS+ 
cells, while 64.2% (±11.6) of vector infected cells were still VENUS+. We do not know 
if only individual cells of Pumilio1 expressing colonies were negative or if whole 
colonies did not express Pumilio1. This indicates that cells Pumilio1 expression was 
detrimental to either cell survival or proliferation leaving only cells without exogenous 
Pumilio1 expression. As control infected cells also displayed a reduced percentage of 
VENUS+ cells, it is likely that some cells silenced both VENUS and candidate gene 
expression (Figure 5.33).  
For Pumilio2 we encountered the same problem as for Pumilio1. Although viral 
titers for Pumilio2 IRES viral vectors reached 1x107, infection efficiencies of HSC did 
not exceed 5%. Unlike Pumilio1, where we could increase infection efficiency using 
virus expressing a fusion gene, using Pumilio2VENUS fusion constructs did not 
increase the efficiency of viral infection. Therefore, we decided not to analyze the 
effect of Pumilio2 on fate decisions in HSC by this method. In summary we think that 
Pumilio1 and 2 could have a toxic effect on HSC or their progeny resulting in a low 
number of Pumilio2 overexpressing cells and loss of Pumilio1 positive cells after 
differentiation. 
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Figure 5.33: Pumilio1 alters lineage choice in 
vitro. Influence of Pumilio1 on lineage choice and 
colony formation of HSC. GM colonies are 
increased (p=**) and G colonies reduced (p=*) in 
Pumilio1 expressing colonies. Data shows the 
average of two independent experiments with 
three replicates each. Error bars show standard 
deviation, * = p<0.05 ** = p<0.01 
 
 
5.2.5.3. Quaking1 Influences GM Lineage Decisions 
We chose to evaluate the influence of Quaking1 on fate decisions of HSC 
because of indications that it could be a downstream target of Pumilio. In C.elegans 
the Quaking1 homolog Gld1 is regulated by Fbf, a Pumilio homolog, and acts as 
Pumilio’s effector to carry out fate decisions (Crittenden, Bernstein et al. 2002; Suh, 
Jedamzik et al. 2006). In addition, Quaking also plays a role in germ cell fate 
decisions and regulates targets at the RNA level (Francis, Maine et al. 1995; 
Ebersole, Chen et al. 1996). 
 Quaking1 gene produces three different known isoforms that provided us with 
natural mutants and would make any observed effects caused by one isoform but 
not the others more significant. Quaking1-7B ORF is identical to Quaking1-6B ORF. 
These two splice isoforms only differ within their 3’UTR but not within their ORF. The 
third Quaking1 isoform, Quaking1-5A differs within the 3’ portion of its ORF from the 
other two isoforms. Therefore, we generated two constructs containing the two 
different ORF which we will subsequently refer to as Quaking1-5A and Quaking1-6B. 
Introducing these two splice variants into HSC by lentiviral overexpression allowed 
formation of all myeloid lineages, including megakaryocytes, erythrocytes, 
granulocytes and macrophages. The colony formation and proliferation capacity of 
HSC was also not affected by overexpression of either transgene as can be seen in 
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Figure 5.34A. Moreover, all types of colonies including multipotent GEMM colonies 
could be produced by Quaking1 overexpression. However, we saw an increase of 
macrophage (M) colonies in Quaking1-6B expressing colonies (14.0% ± 1.8, p=0.07) 
compared to empty vector control (1.5% ± 0). Therefore, we decided to focus on the 
role of Quaking1 in GM progenitors.  
To analyze Quaking1 effects in GM progenitors, it was important to choose the 
right starting population that would after a 72h proliferation period still contain 
bipotent cells that can produce GM colonies as well as unipotent cells with either G or 
M potential. Using CMP as a starting population, we found that after 72h in SCF and 
TPO, these cells could give rise to only very small and few unipotent colonies (data 
not shown). Therefore, we decided to use cells that had lost their self renewal 
capacity, but that were still multipotent. We chose MPP4 (Wilson, Laurenti et al. 
2008) and isolated them as CD34+Flt3+CD48+KSL cells. When we infected these cells 
and cultured them for three days in SCF and TPO, we found that mainly colonies of 
the GM, G and M type were produced, but very few colonies with ME type (Figure 
5.34B). Therefore, this population was useful to examine the effect of Quaking1 
isoforms on GM lineage decisions. 
 Introducing Quaking1-6B and -5A into these MPP4, we found a higher number 
of M colonies (50% ± 4.5, p=0.04, and 36% ± 10.8, p=0.09, respectively) compared 
to control (15.8% ± 9.0). The number of G colonies was reduced in Quaking1-6B and 
5A (11.2% ± 2.3, p=0.006 and 20.4% ± 2.7, p=0.008, respectively) compared to 
empty vector control infected MPP4 (46.8% ± 3.5, Figure 5.34B). We then checked 
absolute colony numbers produced by Quaking1-5A and -6B infected MPP4 and 
normalized them to absolute colony numbers of vector control infected cells. We 
found that in Quaking1-6B expressing cells the number of M colonies was higher at 
the expense of G colonies and constant GM colonies compared to vector controls, 
indicating that Quaking1-6B influenced lineage choice between G and M in bipotent 
progenitors. In Quaking1-5A expressing cells the number of GM colonies was higher 
at the expense of G colonies compared to vector controls. This indicates that 
bipotent GM progenitors preferentially produced GM colonies than G colonies. In 
summary, Quaking1 isoforms when overexpressed in HSC and progenitor cells allow 
differentiation and maturation into all myeloid lineages. However, Quaking1 isoforms 
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seem to influence lineage decisions within the GM lineage and slightly interfere with 
formation of G colonies. 
 
Figure 5.34: Influence of Quaking1 on in 
vitro fate decisions. In HSC, Quaking1-6B 
affects G versus M lineage decisions (A). In 
MPP4, both Quaking1 isoforms affect G versus 
M lineage decisions. Quaking1-6B and -5A 
increase G (p=**), Quaking1-6 decreases M 
(p=**) (B). Data shows the average of two 
independent experiments with three replicates 
each. Error bars show standard deviation, * = 
p<0.05 ** = p<0.01 
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5.2.6. Influence of Candidate Genes on In Vivo HSC Potential  
5.2.6.1. Reconstitution Potential of Candidate Transduced HSC Reveals 
Influence of Candidates during Expansion Conditions 
5.2.6.1.1. Contribution to Peripheral Blood of Recipient Mice 
Except for Pumilio1, our other candidate genes had little or no effects on 
lineage decisions of hematopoietic progenitors and none of the candidates seemed to 
be segregated during HSC division. However, as in vitro assays can not adequately 
assess HSC function, we decided to analyze effects of candidate genes on HSC 
themselves in vivo. To this end we transduced HSC with virus containing 
overexpression constructs of Staufen1, Staufeni, Pumilio1, Quaking1-5A and 
Quaking1-6B for two days in medium containing SCF only. Following assessment of 
the infection efficiencies by counting positive and negative cells in a snapshot image, 
all the cells (both transduced and non-transduced) were transplanted into recipient 
mice (Figure 5.35A, transplants performed by Angelika Roth). For recipient mice we 
again chose the W41/W41 Gpi1a Ly5.1 strain that does not require irradiation before 
receiving a bone marrow transplant. We examined the peripheral blood (PB) of these 
mice at 4, 8, 12 and 16 weeks after transplant for the presence of VENUS positive 
cells and CD45.2 donor type cells within the CD45+ white blood cells (Figure 5.35B). 
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Figure 5.35: Transplantation of candidate gene 
expressing HSC into W41/W41 Gpi1a Ly5.1 mice. 
Experimental setup of HSC infection and transplantation 
(A). Analysis of peripheral blood for percentage of donor 
contribution (CD45.2) and VENUS+ cells (B).
 
 All mice that had been transplanted showed donor type blood cells in their PB. 
The percentage of CD45.2 expressing blood cells increased from 0.5% to 1.5% at 
4weeks to 12.7% to 18% at 16 weeks in all mice irrespective of transgene 
expression (Figure 5.36A). 
The transplanted cells had initially been transfected by viral vectors containing 
candidate genes separated by IRES from VENUS or in the case of Pumilio1 by vectors 
containing the VENUS fusion gene. Therefore, the percentage of VENUS expressing 
cells first reflects infection efficiency after the two day infection period and later, 
when isolating cells from the mouse, indicates survival of cells with overexpressed 
candidate genes. After the infection period, control cells showed an infection 
efficiency of 94%, whereas cells transduced with the various candidate genes 
showed infection efficiencies ranging from 13% to 45%. To account for the different 
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initial percentages of VENUS positive cells we normalized percentages of VENUS 
expressing cells isolated from the PB of the transplanted mice to the initial 
efficiencies (Figure 5.36B). However, we still observed a high difference in the 
percentage of VENUS + cells which we derived from mice transplanted with vector 
control infected cells compared to mice transplanted with candidate infected cells 
(Figure 5.36B).  
The presence of donor type blood cells in the PB of the recipients 16 weeks 
after transplant is a good indicator for the presence of true HSC in the initial donor 
population as only HSC are able to continuously produce mature cells over the course 
of 16 weeks. If after 16 weeks the percentage of VENUS+ cells within the donor type 
blood remains the same as in the starting population, this would indicate that 
infected cells and non infected cells possess the same amount of HSC potential and 
that there is no negative effect of overexpression on HSC behavior as read out by 
contribution to PB. 
For control cells we found 72.9% (±13.8) VENUS+ cells within the donor type 
population of the PB after 16 weeks (Figure 5.36B) compared to an initial 94% of 
VENUS+ cells after infection. This could indicate that the virus per se has a slightly 
negative effect on HSC survival or behavior. In mice transplanted with Pumilio1 
transduced cells we could barely detect any VENUS positive cells (highest: 2.7% ± 
2.0 at 12 weeks), compared to 25% of initially infected cells, indicating a negative 
effect of Pumilio1 on HSC function. In mice transplanted with Staufen1 infected cells 
the percentage of VENUS+ cells increased up to 14.6% (±15.4) at 8 weeks after 
which the percentages of VENUS+ cells dropped to 8.7% (±10.2) at 16 weeks. In 
mice transplanted with Staufeni transduced cells the percentage of VENUS+ cells rose 
continuously until 7.6% (±0.4) of cells were positive at 16 weeks. This indicates that 
Staufen1 and Staufeni overexpression in HSC allowed some HSC potential to be 
maintained as read out by the percentage of VENUS+ cells in PB after 16 weeks 
however, it is likely that HSC function is influenced somehow. When analyzing PB of 
mice transplanted with isoforms of Quaking1 a decrease over time in PB contribution 
of VENUS positive cells was observed for both Quaking1-6B (from 9.7% ± 3.1 to 
0.6% ± 0) and for Quaking1-5A (from 14.5% ± 0.7 to 2.3% ± 2.0).  
In summary, the overexpression of Pumilio1, both Staufen1 isoforms as well 
as both Quaking1 isoforms in HSC proved to be detrimental to normal HSC function 
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as read out by contribution to PB. This result however does not explain how HSC 
function is affected by transgene overexpression. Therefore, we decided to analyze 
the bone marrow of the transplanted mice and examine the percentages of VENUS+ 
cells in progenitor and HSC populations directly.  
 
 
Figure 5.36: Result of peripheral blood analysis of 
candidate transplanted mice. Donor contribution in PB over 
16 weeks (A). Percentage of VENUS+ cells of PB donor type 
cells over 16 weeks. Percentages in parenthesis show initial 
infection efficiency before transplantation (B). Data shows the 
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5.2.6.1.2. Contribution to Bone Marrow Populations of Recipient Mice 
Bone marrow populations of transplanted mice were analyzed at 18 weeks 
after transplant to elucidate the type of effect of candidate gene overexpression on 
HSC. We decided to first analyze one mouse each from the mice transplanted with 
cells transduced with the different viral constructs to be able to decide if and how 
secondary transplants should be performed with the bone marrow from the 
remaining mice. We assessed the percentage of CD45.2 cells within the CD45 
expressing bone marrow cells. As was seen in the peripheral blood, donor type blood 
cells were equally contributing to the total bone marrow in all analyzed mice 
irrespective of transgene expression (a range of 32 - 48% of CD45.2 cells within total 
CD45 expressing cells). When we analyzed VENUS expression in the bone marrow, 
we assessed the percentage of VENUS+ cells within each population. For example, 
30.4% of all KSL cells in control mice are positive for VENUS expression (Figure 
5.37A and B). We further found 85.1% of donor type cells positive for VENUS 
expression (Figure 5.37B). This percentage is very close to the initial infection 
efficiency of 94%. When examining HSC populations in the bone marrow of 
transplanted mice, we found however a lower percentage of cells to be VENUS 
positive. Only 39.4% of CD150+CD48-CD34-KSL cells expressed VENUS. This 
indicates that the viral vector alone has a slightly negative effect on stem cell 
maintenance; however, it allows normal production of progenitors and mature blood 
cells as we found the expected number of VENUS expressing donor blood cells.  
 Examining the bone marrow of mice transplanted with cells transduced with 
the various candidate genes, the results are quite different. Overexpression of 
Pumilio1 in transplanted HSC allowed only 1.2% of total donor type blood cells to 
survive in the bone marrow until 18 weeks and to still express VENUS (Figure 5.37C). 
No HSC maintenance was allowed by Pumilio1 overexpression as read out by the 
percentage of VENUS+ cells within the CD150+CD48-CD34-KSL population. Staufen1 
as well as Staufeni allowed only 3.1% and 1.6% respectively of total donor type 
blood cells to survive as measured by the percentage of VENUS positive cells. Neither 
isoform allowed the maintenance of HSC, however, in Staufeni transplanted mice we 
found 1.1% of VENUS+ cells within the KSL population, a population which 
encompasses true HSC but has otherwise lost self-renewal capacity.  
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Figure 5.37: Bone marrow population 
analysis of transplanted mice: HSC. Example 
of FACS analysis: Percentage of VENUS+ cells 
within the KSL population are analyzed (A) 
Percentage of VENUS+ cells within CD45.2, KSL 
and HSC of vector control transplanted mice (B). 
Percentage of VENUS+ cells within CD45.2, KSL 
and HSC of candidate gene transplanted mice (C). 
Results show data of one mouse.  
 
For Quaking1-5A and Quaking1-6B we found only 0.4 % and 0.9% 
respectively of donor type blood cells to be positive for VENUS. Within the KSL 
population, only 0.2% of cells expressed Quaking1-6B, whereas 1.9% expressed 
Quaking1-5A. Concordantly, for Quaking1-6B no positive cells were found in the HSC 
compartment, whereas 2.5% of the cells within the HSC compartment expressed 
Quaking1-5A (Figure 5.37C). This indicates that Quaking1-5A overexpression allows 
at least a small number of cells with an HSC surface marker phenotype to survive for 
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18 weeks in the bone marrow of recipient mice, whereas overexpression of all the 
other candidate genes cause such severe defects in HSC when overexpressed that no 
HSC expressing these candidates could be detected after this time. 
 Examining progenitor populations in the mouse transplanted with vector 
control transduced cells we again determined the percentage of VENUS expressing 
cells within the various progenitor populations (Figure 5.38A). We found VENUS 
expression in 92.5% of CMP and 90.4% of GMP (Figure 5.38B). However, when 
examining lymphoid cells and common lymphoid progenitors (CLP), we found 66.0% 
and 39.9% of VENUS+ cells respectively. This indicates that vector control 
transduction per se does not negatively affect generation and maintenance of 
myeloid progenitors. However, it may have an inhibiting effect on the lymphoid 
progenitors.  
 In mice transplanted with Pumilio1 infected cells, we did not find any VENUS+ 
cells within CMP or GMP (Figure 5.38C). However, we found 3.6% of early lymphoid 
cells but not CLP to express VENUS. In Staufen1 transplanted mice we saw VENUS 
expression in 2.3% of MEP but no VENUS positive cells in CMP and GMP. Staufen1 
expression as detected by VENUS signal could be found to a high extent in CLP and 
other early lymphoid cells where we found 26.9% and 28.5% of cells respectively 
expressing VENUS. Mice transplanted with Staufeni transduced cells showed VENUS+ 
cells in 2.1% of the CMP, 1.1% of the GMP and 2.6% of the MEP and 10.5% of the 
early lymphoid cells, but no VENUS+ cells in CLP (Figure 5.38C). This indicates that 
overexpression of the two Staufen1 isoforms has differential effects on myeloid and 
lymphoid cell populations. When we analyzed mice transplanted with cells transduced 
with Quaking1-6B, we found no VENUS+ cells within CMP, GMP, MEP and CLP and 
only 3.1% VENUS expressing cells in early lymphoid cells. For mice transplanted with 
Quaking1-5A transduced cells, we found 0.3% CMP, 0% GMP, 0.3% MEP, no CLP 
and 0.9% of lymphoid cells (Figure 5.38C).  
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  Figure 5.38: Bone marrow population analysis of transplanted 
mice: Progenitors. Example of FACS analysis: Percentage of VENUS+ 
cells within progenitor populations are analyzed (A). Percentage of 
VENUS+ cells of vector control transplanted mice in myeloid and 
lymphoid progenitors (B). Percentage of VENUS+ cells of candidate 
gene transplanted mice in myeloid and lymphoid progenitors (C). 
Results show data of one mouse. 
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We wanted to take a closer look at more mature cells residing within the bone 
marrow. We analyzed the GM lineage which is negative for Ter119 expression. We 
distinguished cells of the granulocytic and monocytic lineage by their expression of 
granulocyte specific Ly6G, a subtype of Gr-1, and Mac-1, a marker that can be found 
on both granulocytes and monocytes. Therefore, granulocytes were identified by 
being Ly6G+Mac-1+ (M2) and distinguished from monocytes that are Ly6G-Mac-1+ 
(M1, Figure 5.39A). When we analyzed cells from control transplanted mice we found 
72.3% and 86.2% of VENUS+ cells in monocytic and granulocytic cells respectively 
(Figure 5.39B). For mice transplanted with Pumilio1 overexpressing cells we found 
0.4% VENUS+ cells in immature cells that were not committed to either myeloid 
lineage, but no VENUS+ cells in mature monocytic or granulocytic cells (Figure 
5.39C). Staufen1 allowed the formation of few (0.8%) granulocytic cells but no 
monocytic cells, whereas Staufeni allowed the generation of both monocytes and 
granulocytes at low percentages (0.5% and 1.6%, respectively). In Quaking1-6BA 
transplanted mice we did not see any VENUS+ cells in either myeloid lineage, but we 
found a low number (0.6%) of VENUS+ cells in both myeloid lineages in Quaking1-5A 
transplanted mice. These data indicate that candidate gene overexpression in HSC 
allowed for little or no mature myeloid VENUS+ cell formation 18 weeks after 
transplants.  
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Figure 5.39: Bone marrow population analysis of 
transplanted mice: Myeloid lineage. Expression of 
Ly6G and Mac-1 in Ter119- bone marrow cells (A). 
Percentage of VENUS+ cells of vector control transplanted 
mice within myeloid lineage cells (B). Percentage of 
VENUS+ cells of candidate gene transplanted mice within 
myeloid lineage cells (C). Results show data of one mouse. 
 
We also looked in detail at cells of the erythroid lineage, which were negative 
for myeloid markers Gr-1 and Mac-1 and lymphoid markers CD19 and B220. We 
distinguished three maturation stages within the erythroid lineage and analyzed only 
stages that still express CD45 since this marker is used to determine donor or 
recipient blood type (Figure 5.40A). More mature stages that lack CD45 expression 
were not analyzed. The Ter119 and CD71 double negative population encompasses 
all immature cells and no cells that are committed to the erythroid lineage (S0). 
Stage1 characterized by CD71+Ter119- expression identifies cells committed to the 
erythroid lineage (S1). Stage2 encompasses CD71+Ter119mid cells that are defined as 
proerythroblasts (S2) and stage3 contain double positive cells that are basophilic 
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erythroid cells (S3). All subsequent stages of erythroid maturation contain only very 
low numbers of CD45 expressing cells and were therefore not analyzed for VENUS 
expression.  
Analyzing cells from vector control transplanted mice we found 94.7% VENUS+ 
cells in S1 and 88.6% in S3 cells, but only 54.8% in the S2 population (Figure 
5.40B). Since we are excluding CD45- cells from our analysis, this lower percentage 
might not indicate a negative effect of viral vector expression on this compartment. 
However, also in mice transplanted with cells overexpressing the various candidate 
genes, we always found the lowest percentage of VENUS+ cells in S2 cells, indicating 
that this population might be less represented in virus transduced cells (Figure 
5.40C). We found that Staufen1 as well as Staufeni expression allowed generation of 
2.3%, 0.8% and 5.4% of VENUS+ cells in stages 1 through 3 of the erythroid 
lineage, whereas Pumilio1 positive cells could only generate 0.8% of VENUS+ cells up 
to S1. Percentages below 1% of Quaking1-6B and -5A expressing cells could be 
found in all erythroid stages. In summary it seems that Staufen1 as well as Quaking1 
allow the generation of few erythroid cells, whereas Pumilio1 seems to block at least 
part of this lineage.  
From all these analyses of bone marrow populations of transplanted mice we 
can conclude that HSC that were initially transduced with vector control virus and 
transplanted into recipients can be maintained for at least 18 weeks in vivo as 
identified by surface marker expression. Overexpression of our candidate genes in 
HSC did not allow HSC maintenance over this time period in vivo. Only Quaking1-6B 
overexpression allowed survival of a few cells with HSC phenotype.  
As for the other bone marrow populations, we found that Staufen1 as well as 
its splice isoform Staufeni allowed the survival of a few mature myeloid and erythroid 
cells as well as MEP. Only Staufeni allowed the survival of a few myeloid progenitors 
(CMP and GMP) and maintenance of some early lymphoid cells that were more 
mature than CLP. It is interesting to note, that overexpression of Staufen1 led to the 
survival of quite large numbers of CLP, but no Staufen1+ cells could be found in the 
KSL compartment.  
Confirming our in vitro assays, Pumilio1 does not allow survival of cells over 
longer periods of time. We could only find very few Pumilio1+ cells in lymphoid and 
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early erythroid cells, but since the number of observed VENUS+ events was so low, 
this could have also been an artifact.  
In mice transplanted with Quaking1 expressing cells, we found that neither 
isoform allowed the survival of any myeloid or lymphoid progenitors, apart from very 
few early lymphoid cells. Both isoforms seem to allow survival of a few myeloid and 
erythroid committed cells though. Quaking1-6B was the only candidate that allowed 
survival of cells within the KSL compartment and specifically of HSC. We were not 
able to confirm that these cells truly had self renewal capacity by transplanting them 
into secondary recipients because the other Quaking1-6B transplanted mouse died of 
unknown reason before we could conduct the experiment. 
 
 
 Figure 5.40: Bone marrow population analysis of 
transplanted mice: Erythroid lineage. Expression of CD71 and 
Ter119 in lineage- bone marrow cells (A). Percentage of VENUS+ 
cells of vector control transplanted mice within the erythroid 
lineage (B). Percentage of VENUS+ cells of candidate gene 
transplanted mice within the erythroid lineage (C). Results show 
data of one mouse. 
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5.2.6.2. Candidate Transgenic Mice Allow Analysis of Candidate 
Influence on Hematopoiesis during Homeostasis Conditions 
5.2.6.2.1. Testing Functionality of Transgenes: Expression in the Skin 
Transplanting HSC into compromised mice results in HSC expansion and 
differentiation, that does not occur in normal homeostasis conditions. In order to 
analyze effects of candidate genes on hematopoiesis under homeostasis conditions 
transgenic mice carrying inducible expression constructs of candidate genes were 
generated by Dr. Timm Schroeder in Japan. Expression of a candidate gene either as 
a fusion gene or from an IRES construct was driven by a chicken beta actin promoter 
(pCAG). Insertion of a loxP site flanked STOP cassette in front of the promoter 
rendered the expression cassette inactive. CRE expression in these cells results in 
recombination of the two loxP sites thereby excising the STOP cassette and 
initializing gene expression by the pCAG promoter. By crossing transgenic mice 
containing this expression cassette to mouse lines expressing CRE under cell and 
stage specific promoters the effects of transgene expression can be analyzed in a cell 
type and developmental stage specific manner during homeostasis. 
 The F1 offspring of the initial six transgenic founders were transferred to the 
Helmholtz center mouse facility. Mice were genotyped for VENUS presence in the 
genomic DNA and positive mice backcrossed to the C57/Bl6 background (Table 3). 
Genotype positive mice were further tested for functional VENUS expression upon 
CRE recombination. We decided to first use fibroblasts grown out of tail clips from 
transgenic mice to analyze for VENUS functionality. To this end, fibroblasts were 
isolated from the tails of transgenic mice and infected with a lentivirus expressing 
CRE and TOMATO fluorescent protein localized to the mitochondria. Using fibroblasts 
from our inducible mouse lines, successfully infected cells express TOMATO as well 
as CRE which then recombines the two loxP sites and excises the STOP cassette in 
front of the transgene, thus inducing expression of both the candidate gene and 
VENUS. Seven days after infection of the fibroblasts with the CRE virus cells were 
analyzed by FACS analysis to check for TOMATO and VENUS expression. 
Analysis of infected and CRE recombined fibroblasts showed a large proportion 
of negative cells, that show high auto fluorescence in both TOMATO and VENUS 
channels (Figure 5.41A). Cells above the negative cells indicate TOMATO positive 
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infected cells, whereas cells below the negative cells indicate VENUS positive cells. 
We did not see any VENUS positive cells in non-infected fibroblasts, therefore, we 
were sure that the latter cells were in fact double positive for TOMATO and VENUS, 
but appeared to be singly VENUS positive due to compensation artifacts.  
In mice containing a Staufen1VENUS expression cassette we found mice from 
all three founders to be functional for VENUS expression in the skin (Table 2). Not all 
the mice of each line were found to be positive. This is probably due to the fact that 
from some mice only very few fibroblasts grew out of tail clips and therefore, we 
could have missed the low number of double positive cells. In mice containing the 
Staufeni IRES VENUSnucmem expression cassette we did not find fibroblasts from 
any mouse with functional VENUS expression. This means that Staufeni 
overexpression does not work in skin fibroblasts in these mice. In Pumilio2 IRES 
VENUSnucmem containing mice we found all four mice tested (1 Founder) to be 
positive for VENUS expression indicating functional Pumilio2 overexpression in these 
cells.  
 
 
Table 5.2: Functionality of expression 
cassette in the skin of inducible 
transgenic mice. Functionality of 
expression cassette was analyzed by FACS 
coexpression of VENUS and TOMATO in 
tailclip derived fibroblasts infected with 
CRE-IRES-mitoTOMATO. 
 
 
 
 
 
Results 118 
 
 
 
 
Table 5.3: Inducible candidate gene expressing mice: 
breeding scheme and functionality of expression cassettes in 
bone marrow. Transgenic mice were bred to C57/Bl6 mice for 
several generations as indicated. Functionality of expression cassette 
in transgenic mice was determined by coexpression of VENUS and 
TOMATO in CRE-IRES-mitoTOMATO lentivirus infected c-kit+lin- 
derived cells. 
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5.2.6.2.2. Testing Functionality of Transgenes: Expression in Bone 
Marrow Cells 
As we were interested in the overexpression of candidate genes in the bone 
marrow, the presence of VENUS expression in skin fibroblasts is a good indicator for 
functionality in other tissues, but cannot substitute for a functional characterization 
of bone marrow cells themselves. We decided to analyze the bone marrow of all 
previously tested mice, including the ones that did not show expression in the skin. 
Therefore, we sorted c-kit+ lin- bone marrow cells from the transgenic mice and 
infected them with the same CRE expressing lentivirus we had used for the 
fibroblasts (Figure 5.41B). A functional inducible N-CadherinVENUS mouse and a 
C57/Bl6 mouse were used as positive and negative controls, respectively.  
Re-analysis of cells was done after 6 days, when enough time had passed for 
infection, CRE expression and recombination and subsequent VENUS expression to 
have been completed. As shown in Figure 5.42C, cells were analyzed for TOMATO 
and VENUS expression. Gates were set using uninfected C57/Bl6 cells. Negative as 
well as positive control cells infected with mock control (IRES-mitoTOMATO) showed 
22% TOMATO positive cells but no VENUS positive or double positive cells. This 
result shows that the infection per se worked and that the inducible system is not 
active without CRE recombination. C57/Bl6 cells infected with the CRE lentivirus 
showed again 22% of TOMATO positive cells but 0% of VENUS or double positive 
cells as these mice do not contain VENUS coding sequences in their genome. 
However, CRE lentivirus infection of cells from N-Cadherin VENUS mice resulted in 
22% TOMATO positive cells as well as 3% VENUS and TOMATO double positive cells. 
With this system we could now test functionality of the transgenic mice in bone 
marrow cells. 
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Figure 5.41: Experimental setup testing VENUS functionality of transgenic 
mice. FACS analysis of infected tailclip derived fibroblasts of C57/Bl6 and candidate 
inducible transgenic mouse. Red triangle: infected cells. Green ellipse: VENUS and 
TOMATO double positive cells (A). Sorting scheme of c-kit+lin- bone marrow cells (B). 
FACS analysis of infected c-kit+lin- from negative and positive control mice (C).  
 
Two to six mice from each of the six different founders were tested in the 
described manner from the following mouse lines: Staufen1VENUS, Staufeni-IRES-
VENUSnucmem, and Pumilio2-IRES-VENUSnucmem. Unfortunately we found that no 
progeny from the founders of either Staufen1VENUS or Staufeni-IRES-
VENUSnucmem mouse lines expressed VENUS after CRE-mediated recombination in 
bone marrow cells (Figure 5.42 and Table 3). However, bone marrow cells from 
Pumilio2-IRES-VENUSnucmem mice showed 0.2-1.1% VENUS positive cells upon CRE 
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recombination (Figure 5.42), and it was therefore possible that these mice contained 
functional expression cassettes in bone marrow cells. 
 
 
Figure 5.42: Functionality of expression cassette in the bone marrow 
of inducible transgenic mice. Functionality of expression cassette was 
confirmed by coexpression of VENUS and TOMATO in c-kit+lin- derived cells 
infected with a lentivirus containing CRE-IRES-mitoTOMATO. FACS analysis of 
VENUS and TOMATO expression in c-kit+lin- derived cells. The shown graphs are 
 
 
 
 
 
5.2.6.3. Tie2 Controlled Homeostatic Pumilio2 Overexpression Allows 
Maintenance of Cells with HSC Phenotype 
To prove functionality of Pumilio2-IRES-VENUSnucmem mice, we crossed 
them to Tie2-CRE mice to induce candidate gene overexpression in blood and 
endothelial cells directly in the mouse (Table 3). Crossing of heterozygous Pumilio2-
IRES-VENUSnucmem with heterozygous Tie2-CRE mice resulted only in one 
genotype double positive mouse. At 12 weeks of age, this mouse was analyzed for 
VENUS expression in the peripheral blood and bone marrow progenitor populations. 
In addition, bone marrow cells from this mouse were compared to wild type C57/Bl6 
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cells to check for effects of Pumilio2 overexpression on lineage decision and 
distribution of cells within the progenitor populations. 
Within the lineage negative population of the Pumilio2+/-CRE+/- mouse, we 
found 0.75% (±1.06) of cells were VENUS positive (Figure 5.43B) and also the 
myeloid progenitors did not show a higher percentage of VENUS+ cells (0.2% ± 0 for 
KLS- cells, Figure 5.43B). However, analysis of populations enriched for stem cells 
revealed that VENUS+ cells were present in the KSL population (1.85% ± 0.49), and 
were further enriched in the HSC population defined by CD150+CD48-CD34-KSL 
markers (5.75% ± 4.03, Figure 5.43A). Analysis of cells with lymphoid potential 
showed 14.65% (±10.67) cells positive for VENUS expression within the common 
lymphoid progenitor populations (CLP, Figure 5.43A).  
 
 
Figure 5.43: Bone marrow analysis of Pumilio2-IRES-
VENUSnucmem x Tie2-CRE transgenic mouse. Percentage of VENUS+ 
cells within myeloid progenitor populations (A). Percentage of VENUS+ cells 
within HSC populations and CLP (B). Data shows average of two transgenic 
mice analyzed. Error bars show standard deviation.
 
 
 
 
 
When we compared percentages of cells within bone marrow populations of 
this transgenic mouse to C57/Bl6 we did not find a significant difference in any 
population. However, since percentages of VENUS+ cells are rather low we did not 
expect them to have a marked influence on total bone marrow cells. 
The low percentage of VENUS+ cells in the bone marrow, reflecting the 
efficiency of CRE recombination in this mouse can be explained by the known low 
efficiency of Tie2-CRE on a C57/Bl6 background (personal communication with Dr. 
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Lothar Henninghausen). However, the Pumilio2-IRES-VENUSnucmem mouse line is 
nevertheless useful and will now be crossed to an Mx1-CRE expressing mouse line 
where high recombination efficiency in C57/Bl6 has been shown (personal 
communication with Dr. Lothar Henninghausen). 
In summary we found that indeed the Pumilio2-IRES-VENUSnucmem 
transgenic mouse line was functional, expressing VENUS (and presumably Pumilio2) 
upon recombination in the bone marrow. This was especially advantageous since 
Pumilio2 proved to be a gene difficult to work with when overexpressing it in 
lentiviral constructs. Overexpression of Pumilio2 in transgenic mice allowed survival 
of HSC, CLP and early myeloid lineages. The lack of surviving GMP could reflect the 
recombination efficiency of Tie2 CRE in Bl6, but could also point towards a 
detrimental effect of Pumilio2 on this cell type. 
 
 
5.3. Conclusion 
In conclusion we identified and quantified asymmetric fates of individual HSC 
daughter cells but we could not elucidate the molecular mechanism that influences 
these fate decisions. We found that HSC compared to MPP show an intrinsically 
controlled delay in cell cycle entry time. A specific difference in sister generation 
times of HSC daughters can be attributed only to the influence of a certain 
environment but is not intrinsically controlled. In contrast, the asymmetric onset of 
the loss of stemness marker CD48 specifically in HSC daughters reflects an intrinsic 
control of self renewal versus differentiation divisions in HSC.  
We could not verify the hypothesis that asymmetric protein segregation during 
HSC division generates asymmetric daughter cell fates, since none of our candidates 
could be observed to segregate asymmetrically during division with the methods 
tested. We found however, that all tested candidates have a detrimental effect on 
HSC maintenance as tested by reconstitution experiments with candidate 
overexpressing cells. In addition, some of the candidates also displayed in vitro 
effects on progenitor lineage potential. Pumilio1 inhibited long term survival and 
colony formation of progenitors and the effector protein Quaking1 influenced myeloid 
lineage decisions when overexpressed. 
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6. Discussion 
 
It is currently not known how HSC maintain constant numbers throughout the 
life of an organism and at the same time manage to produce millions of blood cells 
every day. It is assumed but has not been proven yet that the mechanism of 
asymmetric cell division enables HSC to achieve this goal by dividing into another 
HSC and a differentiated daughter cell. This Thesis tries to elucidate the mechanism 
of asymmetric cell division of mouse HSC by assessing their potential to produce 
asymmetric fates in vitro in both stroma and stroma free culture and by examining 
possible mechanisms involved in controlling the generation of asymmetric fates. We 
found that HSC intrinsically control asymmetric fate decisions of self renewal and 
differentiation of daughter cells. Further exploration of the mechanism controlling the 
generation of asymmetric daughter cell fates revealed that selected candidate genes, 
Staufen1, Staufeni and Pumilio1, are not segregated during HSC division and are 
unlikely to contribute to the generation of asymmetric fated HSC daughter cells. 
 
 
6.1. Asymmetric Fate Potential of HSC 
Previous studies have attempted to elucidate if ACD is a mechanism employed 
by HSC. As far back as 1983 have researcher quantified asymmetric fates of 
hematopoietic progenitor cells (Suda, Suda et al. 1983; Ogawa, Suda et al. 1984; 
Suda, Suda et al. 1984). By separation of cells shortly after their division and by 
analysing the fate potential of their daughters by colony formation assays, it could be 
shown that these cells were able to produce asymmetrically fated daughter cells. 
These studies however were flawed, as they used highly heterogeneous starting cell 
populations with an unknown percentage of cells with specific reconstitution 
potential. Later studies used human blood progenitor populations containing 
extremely low percentages of HSC from various tissues to conduct similar 
experiments with separation of daughters by micromanipulation (Leary, Strauss et al. 
1985; Mayani, Dragowska et al. 1993). As a readout in these studies again colony 
formation in methylcellulose as well as prolonged colony formation on stroma was 
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used to assess immaturity and lineage potential (Punzel, Liu et al. 2003; Giebel, 
Zhang et al. 2006). In addition, label retaining experiments in single cell cultures 
revealed asymmetric proliferation potential of daughter cells (Huang, Law et al. 
1999; Punzel, Zhang et al. 2002). The low percentage of true HSC, that are able to 
reconstitute the bone marrow of a recipient in vivo for life, within the populations 
used in these studies, prevent any conclusions as to HSC specific properties.  
In contrast, a more recent study examined asymmetric fates using clearly 
defined bone marrow populations from mouse containing high (41%) numbers of 
cells with reconstitution potential (Ema, Takano et al. 2000). Daughter and 
granddaughter cell fates of HSC were analyzed by colony formation and lineage 
potential as well as reconstitution potential. It was found that HSC produce varying 
percentages of daughter pairs with asymmetric fates regarding maintenance of HSC 
potential and multipotency depending on the culture conditions (Ema, Takano et al. 
2000; Takano, Ema et al. 2004). However, this study, like previous studies 
mentioned above, used micromanipulation to transfer daughter cells after their 
division. It is not clear how this change in microenvironment that is created by the 
blood cells themselves as well as the mechanical manipulation affects HSC in their 
lineage choice. In addition, cells were cultured in well defined stroma free media that 
allows deduction of the influence of single factors on the cells, but does not assess 
behaviour of HSC in an environment that contains cellular components and 
resembles closer the niche present in the in vivo situation. 
Both problems were attempted to be overcome by Wu et al. (Wu, Kwon et al. 
2007), who used time lapse microscopy and highly purified HSC cultured on stromal 
cells to answer questions regarding ACD. Using a notch activity reporter mouse as 
readout for immaturity of HSC daughters, they observe asymmetric fates of dividing 
HSC on 7F2 and OP9 stroma. In our hands however, when we analyzed GFP 
expression in bone marrow population of this GFP Notch activity reporter mouse line, 
we found no enrichment of GFP expressing cells in highly HSC enriched populations 
(personal communication Dr. Masaki Shigeta). Also, the time intervals that Wu et al. 
used for their time lapse movies are rather long (every 15 min) and we know from 
our own experiments that identities of cells can easily be mixed when observed in 
low temporal resolution. For these reasons, no conclusion can be drawn from their 
results regarding asymmetric fate potential of HSC. 
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To overcome all the mentioned flaws of previous studies, the present study 
used CD34-KSL mouse bone marrow cells, which contain a high percentage of cells 
with reconstitution potential. We further observed cells continuously with a high 
temporal (every 2 min) and spatial resolution using time lapse microscopy and 
recorded their divisional kinetics as well as fate potential by single cell tracking for at 
least 4 days. We cultured cells on stroma as well as in stroma free suspension culture 
and used self renewal as well as differentiation promoting culture conditions to be 
able to compare the effects of different environments on HSC behaviour and to 
distinguish extrinsically from intrinsically controlled HSC behaviour. In order to assess 
asymmetric fate potential of individual HSC we used two different readouts, 
generation time of daughter cells as well as loss of reconstitution potential as 
assessed by a live marker. And we compared the asymmetric fate potential of HSC as 
well as their divisional kinetics to MPP, which are closely related cells that have lost 
reconstitution potential. This enabled us to distinguish characteristics that are unique 
to true HSC from behaviour common to all immature hematopoietic progenitor cells. 
Therefore, the identification of HSC specific properties, especially regarding their 
divisional behaviour and fate choice, is a first step required to be able to expand HSC 
for the use in clinical transplantations.  
 
 
6.2. Choice of Culture Conditions 
In order to study asymmetric fate decisions of HSC it is important to choose 
culture conditions that promote HSC homeostasis where asymmetric divisions of HSC 
yielding a self renewed and a differentiated daughter could take place. That means 
that HSC potential has to be maintained for several days by the environment, but 
without expanding HSC which can only be achieved by symmetric self renewal 
divisions. Our chosen stromal environment, PA6, has been proven to support HSC 
maintenance and does not expand HSC. Another stromal cell line, OP9, is widely 
used to support hematopoiesis, however it was not sufficiently studied if and how 
much HSC potential they maintain (Ueno, Sakita-Ishikawa et al. 2003). Sys-1 Stromal 
cell line in conjunction with LIF slightly expands HSC and therefore is not useful 
either to study asymmetric divisions.  
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Stroma free conditions that claim to expand stem cell numbers have been 
published as well. Cultures containing IL-11 in addition to SCF can expand HSC 
numbers slightly (Miller and Eaves 1997; Audet, Miller et al. 2002) and expansion of 
HSC can be also observed in the presence of SCF, thrombopoietin (TPO), insulin-like 
growth factor 2 (IGF-2) and fibroblast growth factor 1 (FGF-1) (Zhang and Lodish 
2005; Noda, Horiguchi et al. 2008). These culture conditions are not appropriate to 
study ACD as they likely promote symmetric self renewal divisions. However, it might 
be interesting to compare expansion with maintenance cultures to elucidate cellular 
pathways that differ in the response to either signal. 
Ema et al. have described two stroma free suspension conditions that allow 
maintenance of various percentages of initial HSC potential as well as one cytokine 
combination that leads to rapid differentiation (Ema, Takano et al. 2000). Using the 
maintenance conditions allowed us the analysis of asymmetric fates as well as to 
study the mechanism behind asymmetric fate choices.  
 
 
6.3. Divisional Kinetics of HSC and MPP 
The use of generation time length of HSC daughters as readout for 
asymmetric fates was prompted by previous studies showing that cultured HSC 
compared to MPP showed longer generation time in the first and also in subsequent 
divisions as measured by label retaining experiments (Nygren, Bryder et al. 2006). 
This proliferation difference between HSC and MPP that can be observed in vitro is 
also true for freshly isolated cells. The percentage of cells in G0 was highest in 
freshly isolated HSC, indicating a long generation time, and decreased upon 
differentiation of these cells into MPP and further differentiated populations 
(Passegue, Wagers et al. 2005; Wilson, Laurenti et al. 2008).  
When we compared divisional kinetics of HSC and MPP on stroma containing 
as well as stroma free environments, we found in our experiments, like expected 
from previous studies, that HSC enter the cell cycle later than MPP and that HSC also 
within the first three divisions show a longer GT than MPP. Similar proliferative 
behaviour in all culture conditions tested indicates intrinsic control of divisional 
kinetics of HSC and MPP. 
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Not only seems there to be a difference in divisional kinetics of HSC and MPP 
but also does generation time length seem to serve as an indicator to distinguish true 
HSC from other cells in populations that are highly enriched for HSC potential. 
Dykstra et al., who like the present study used video monitoring of cells, showed that 
HSC potential was preferentially found in clones of cultured HSC that displayed 
longer cell cycle times than clones derived from cells with HSC surface phenotype 
that failed to reconstitute mice (Dykstra, Ramunas et al. 2006). Again the in vitro 
behaviour reflects in vivo properties of HSC. Label retaining in vivo experiments 
showed  that phenotypic HSC that are slowly dividing within the organism have a 
clear advantage in competitive repopulation experiments compared to faster dividing 
cells with the same phenotype (Nygren, Bryder et al. 2006; Wilson, Laurenti et al. 
2008). Therefore, a change in proliferate capacity was assumed to precede a change 
in surface phenotype that marks the loss of reconstitution potential.  
 
 
6.4. Asymmetries in Generation Time Length of Daughter Cells 
As generation time length clearly distinguishes HSC from MPP but also seems 
to identify reconstitution potential in phenotypically identical cells, we concluded that 
daughter cells of single HSC that showed longer generation time would be more 
immature than daughters with short generation time. Therefore, HSC daughters that 
are asymmetric in their generation time length could indicate an asymmetric fate 
decision in the mother cell. In accordance with this Dykstra et al. saw a greater 
difference in generation time length of daughter cells in clones containing HSC 
potential than in clones without reconstitution potential when cultured in stroma free 
conditions. Our results showed in support of this theory more trees with asymmetric 
generation time of HSC daughters than of MPP daughters when cells were cultured 
on PA6 stroma.  
However, culture of HSC and MPP in stroma free environment showed no 
difference in the number of cells with asymmetric generation time of daughter cells 
and thus revealed environmental rather than intrinsic control of asymmetric 
generation time of daughter cells. It is widely assumed that asymmetric cell division, 
yielding a self renewed and a differentiated daughter would be an intrinsic property 
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of HSC. As we showed that asymmetric generation time is not intrinsically controlled, 
it could, rather than indicating asymmetric fate decisions, indicate the effect of non 
uniform stromal cells on identical HSC daughter cells to yield different cell fates that 
are accompanied by asymmetric generation time. In absence of these signals from 
stromal cells different fates of initially equal daughter cells could not be produced. 
 
 
6.5. Intrinsic Control of Asymmetric Fate Decisions 
The recent establishment of the SLAM code enables isolation of highly purified 
bone marrow populations containing a high percentage of HSC (Kiel, Yilmaz et al. 
2005). Freshly isolated HSC are negative for the expression of CD48 and also 
recently it was shown that cultured HSC remain negative for CD48 expression (Noda, 
Horiguchi et al. 2008). Therefore, we have used live CD48 staining in time lapse 
movies to assess loss of HSC potential of daughter cells. By comparing the time of 
onset of CD48 expression in sister cells we were able to quantify asymmetric and 
symmetric fate decisions in HSC progeny. This revealed that more HSC compared to 
MPP have progeny with asymmetric CD48 onset and this could be observed on 
stroma as well as in stroma free environments and is therefore an intrinsic property 
of HSC. 
Asymmetric fates of human hematopoietic progenitors (HPC), which are ill 
defined and contain only low percentages of true HSC, have been previously 
described.  Giebel et al (Giebel, Zhang et al. 2006) found that a high percentage of 
the most immature cells produced daughter cells of which only one daughter 
received the immature fate of the mother cell. Also Punzel et al. (Punzel, Liu et al. 
2003) found a constant percentage of progenitors with asymmetric daughter cell 
fates within dividing cells when cells were cultured on AFT024 stroma and in stroma 
free culture containing different cytokine combinations (Punzel, Zhang et al. 2002; 
Punzel, Liu et al. 2003). As these studies did not utilize purified HSC as described in 
this thesis, no conclusion about asymmetric fates of HSC daughters can be made 
from their data.  
In the present study we used unmanipulated, highly purified HSC and found 
similar percentages of asymmetric fates, read out by asymmetric CD48 onset in HSC 
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progeny cells, when HSC were cultured in stroma free self renewal and 
differentiation conditions. In contrast, Takano et al. when using micromanipulated 
HSC, found varying percentages of asymmetric fates of HSC daughters depending on 
the culture conditions (Takano, Ema et al. 2004). In addition, this study used colony 
potential to distinguish differently fated daughter cells. Only in a separate study, 
when culturing HSC in self renewal conditions, was the HSC potential of HSC 
daughters tested by long term in vivo bone marrow reconstitution (Ema, Takano et 
al. 2000). Culture condition dependent percentages of HSC with asymmetric 
daughters described by Takano et al. (Takano, Ema et al. 2004) do not contradict 
our data, as we assessed the amount of HSC with asymmetrically fated daughters as 
a percentage of all trees that switched on CD48 in there progeny. Thus, trees which 
were committed to differentiation in the mother cell or did not differentiate at all 
were not included in this analysis. As the percentage of trees with progeny CD48 
onset differed between environments, also the absolute percentage of HSC with 
asymmetrically fated daughters differed between culture conditions.  
As CD48 not only enables us to read out asymmetric fate choices but also to 
assess indirectly the reconstitution potential of cultured cells, we compared our data 
to data obtained by Ema, who compared the reconstitution potential of HSC cultured 
under self renewal and differentiation conditions (Ema, Takano et al. 2000). Ema 
showed that HSC cultured in serum free medium containing SCF and TPO retain a 
large proportion of reconstitution potential for at least 6 days (66.7% of initial 
potential after 3d, and 26.5% after 6d). Our data from HSC cultured in SCF and TPO 
confirms this high reconstitution potential. The percentage of CD48 expressing trees 
remained low and almost half of the trees did not express CD48 in any of their 
progeny for the course of 4 days. Similar trends could be observed for culture of HSC 
on PA6, which are able to maintain HSC potential for at least 2 weeks. Our data of 
HSC cultured in SCF and IL3 still fits data concerning reconstitution potential of 
cultured HSC from Ema who found 27.5% of initial HSC potential retained in HSC 
cultured in SCF and IL3. When analyzing CD48 expression in pedigrees at 3 days 
after start of movie we found that about 30% of trees had not switched on CD48. 
After 4d however, only a small percentage of trees (5%) remained CD48 negative 
and thus had not lost HSC potential. Also the overall percentage of CD48+ trees 
increased rapidly over time resulting in many trees with progeny onset of CD48. 
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From previous data of HSC cultured in IL6 it was expected that trees from HSC 
cultured in IL6 would switch on CD48 even earlier than when cultured in IL3, 
because HSC cultured in SCF and IL6 for 3 days had lost all their reconstitution 
potential (Ema, Takano et al. 2000). However in our experiments, more trees 
remained CD48 negative throughout 4 days of culture when cultured in SCF and IL6 
compared to SCF and TPO and also less cells showed early commitment to 
differentiation of the mother cell.  
The explanation for the discrepancy in results can only be explained by the 
differential readout of HSC potential in the two studies. Ema et al. used 
reconstitution of single cells after culture in different environments however, we 
utilized a molecular marker to avoid manipulation of cultured cells (Ema, Takano et 
al. 2000). It is known that CD48 does not start to be expressed immediately after the 
loss of reconstitution potential, but rather slightly later. This was shown in Wilson et 
al and also in this Thesis by analysing the expression of CD48 on freshly isolated 
CD34+KSL cells (Wilson, Laurenti et al. 2008). It is known that murine bone marrow 
cells that express CD34 have lost their reconstitution potential (Yang, Bryder et al. 
2005). However, not all of these cells do express CD48. We also do not know what 
effect various cytokines have on the expression of CD48. It is possible that IL6 either 
actively suppresses expression of CD48 in cells that have already lost HSC potential 
or that IL6 leads to a loss of HSC potential but keeps cells in a pre CD48 expressing 
state. To clarify these questions it will be necessary to repeat reconstitution 
experiments of cells cultured in SCF and IL6 in addition to monitoring their CD48 
expression status.  
 
 
6.6. Exploring the Mechanism Controlling Asymmetric Fate Choice 
As we show here that individual mouse HSC generate asymmetric fates that 
are probably intrinsically controlled, the mechanism controlling these asymmetric fate 
decisions was addressed as well. From invertebrates it is known that asymmetric cell 
fates are often controlled by the asymmetric segregation of determinants during 
division (Knoblich, Jan et al. 1995; Broadus, Fuerstenberg et al. 1998). It is widely 
assumed that protein segregation during division is conserved also in fate decisions 
Discussion 133
of mammalian stem cells of adult tissues. Evidence for this has been brought 
forward: For example in the developing mouse cortex the mouse homolog of 
drosophila Numb, an inhibitor of Notch signalling, was found to segregate 
asymmetrically during division and is crucial for the formation of two differently fated 
daughter cells (Zhong, Jiang et al. 2000; Shen, Zhong et al. 2002).  
In addition to segregating molecular determinants, it has been postulated that 
stem cells would also retain one set of chromosomes in the self renewed HSC 
daughter after division to avoid accumulation of mutations in the stem cell 
compartment. This “immortal strand hypothesis” could be validated in satellite 
muscle cells (Shinin, Gayraud-Morel et al. 2006), Nestin+ neural stem cells 
(Karpowicz, Morshead et al. 2005) and mammary epithelial label retaining cells 
(Smith 2005) but was not found true for mouse HSC (Kiel, He et al. 2007).  
Furthermore in human HPC, it was shown that several endosomal 
determinants are segregated during division, however, no conclusion concerning 
their role in fate specification could be drawn from this data since protein distribution 
was analyzed in fixed cells (Fargeas, Fonseca et al. 2006; Beckmann, Scheitza et al. 
2007). No proof for protein segregation as a measure to specify asymmetric fates in 
HSC daughters has been brought forward. The only evidence that hematopoietic cells 
specify fates by segregating determinants asymmetrically during division was found 
in T-lymphocytes (Chang, Palanivel et al. 2007). T-cells when they recognize an 
antigen presented by a dendritic cells form an immunological synapse which leads to 
asymmetric distribution of proteins in the T-cell and subsequent asymmetric 
segregation of proteins into daughter cells during mitosis. The protein segregation 
causes asymmetric cell specification into an effector and a memory T-cell. 
 
 
6.7. Candidate Segregation in HSC Divisions 
Observing protein segregation in HSC divisions and following fate decisions of 
HSC daughters can only be accomplished by using time lapse microscopy and single 
cell tracking, which allow assessment evaluation if a segregated protein is the cause 
of the specification of a certain cell lineage. We first quantified fluorescence intensity 
during divisions of HSC that overexpressed fusions of candidate proteins with 
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fluorescent reporters. We chose candidates whose asymmetric segregation in 
invertebrate developing cells is crucial to cell specification and embryonic patterning 
(Li, Yang et al. 1997; Lin and Spradling 1997). In addition, we found them to be 
expressed in mouse HSC. We found however, that none of our candidates, Staufen1, 
its splice isoform Staufeni, and Pumilio1 segregated asymmetrically during division of 
HSC. It is possible that these factors fulfil to date unknown functions in HSC and 
other blood cell lineages. They might not control asymmetric fate decisions or these 
fate decisions might not be controlled intrinsically despite our data supporting this 
notion.  
Other reasons why we did not see any asymmetrically segregated candidates 
might lie in the method that was applied. It is possible, that the fusion to a 
fluorescent protein changes the function of the candidate so that asymmetric 
segregation is not possible anymore. For Staufen1 and its splice isoform previous 
publications showed normal function of similar fusion genes (Wickham, Duchaine et 
al. 1999; Duchaine, Wang et al. 2000). In agreement with this we also did not see 
differences in the effect of lineage potential between fusion genes and Staufen1 IRES 
constructs (data not shown), indicating that the fusion did not alter Staufen1 and 
Staufeni function. In contrast, Pumilio1 has not been expressed as a fusion 
previously. In this Thesis we could not compare effects of fusion and IRES construct, 
as the latter when overexpressed by lentivirus did not yield a significant number of 
infected cells. Although this might suggest that Pumilio1 in its wildtype form is toxic 
to cells and therefore, the Pumilio1 fusion could alter the protein as we saw colony 
formation of Pumilio1 fusion infected cells.  
Another reason for the lack of observed asymmetric protein segregation could 
be that the overexpressed protein is present in much higher levels than endogenous 
protein and therefore overloads the segregation machinery. It is possible that not all 
protein is segregated, but is masked by non segregated protein. This was shown in 
the Drosophila egg, where an increase of Staufen protein did not lead to more 
localized Staufen in the presence of constant levels of target mRNA (Ferrandon, 
Elphick et al. 1994). 
Our camera and fluorescence quantification tools are sensitive enough to 
detect 2 fold differences in protein concentration between the two sister cells. It can 
not be excluded that even lower differences between sister cells could lead to 
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asymmetric cell fates. However, this is unlikely since asymmetric segregated proteins 
observed in fixed cells showed often that differences in protein concentrations are 
easily detectable by eye from still images (Beckmann, Scheitza et al. 2007).  
We observed in cells that overexpressed high amounts of Staufeni fusion as 
measured by VENUS expression the formation of fluorescent clumps. These clumps 
were described previously by Duchaine et al. as overexpression artefacts arise only 
from overexpression of Staufeni alone but are not apparent in Staufeni and Staufen1 
coexpressing cells (Duchaine, Wang et al. 2000). We did not observe any toxic 
effects of these clumps but did see slight differences in sister cell fluorescent 
intensities of Staufeni expressing cells of some monitored divisions, however, we do 
not think this reflects a biological function of the endogenous protein, but rather is 
an overexpression artefact. 
We did not examine the segregation of a fourth candidate, Prominin1, because 
unlike the other candidate genes we did not find Prominin1 to be expressed in mouse 
HSC, but only in GMP. The expression of Prominin1 has been widely studied in 
human, where it is referred to as CD133 and has been implicated as a stem cell 
marker in various tissues. CD133 is used for example in the blood (Giesert, Almeida-
Porada et al. 2001), the neuronal system (Uchida, Buck et al. 2000), and the 
intestine (Zhu, Gibson et al. 2009) to identify stem and progenitor cells and is also a 
marker of cancer stem cells (Vercauteren and Sutherland 2001). The expression of 
mouse Prominin1 however, has not been studied in the blood and HSC and 
therefore, our finding that Prominin1 is expressed not in HSC but only in myeloid 
progenitors is rather interesting. 
 
 
6.8. Candidate Influence on Fate Decisions 
6.8.1. Effect of Staufen1 on Fate Decisions 
Although we did not detect asymmetric segregation of our candidate genes, 
indicating no role in asymmetric fate decisions of HSC, it is still interesting if they 
influence fate choices of HSC and progenitors in another manner. We found no effect 
of either Staufen1 or Staufeni on in vitro colony potential and lineage choice, 
however, HSC maintenance was inhibited in HSC overexpressing either Staufen 
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isoform as measured by reconstitution of bone marrow. This suggests an HSC 
specific role for Staufen1. It has recently been described that Staufen1 when 
overexpressed inhibits the formation of oxidative stress induced granules that 
promote silencing of translation (Thomas, Tosar et al. 2009). As it is especially 
important for HSC to be protected from oxidative stress, inhibition of stress granule 
formation by Staufen1 could lead to the observed loss of HSC maintenance. 
However, further studies are necessary to elucidate the role of stress granules in 
HSC.  
There is no information about Staufen function in blood cells, but Staufen2 
was found to be expressed in various leukemias (Faubert, Lessard et al. 2004). We 
had chosen Staufen1 and not Staufen2 as a candidate gene, because in contrast to 
Staufen2, Staufen1 ORF was readily available and also expressed in HSC. We also 
tested in colony replating experiments of Staufen1 expressing progenitors show any 
leukemic behaviour, but they behaved like the vector control infected cells.  
 
 
6.8.2. Effect of Pumilio on Fate Decisions 
When we overexpressed Pumilio1 in HSC we found that HSC could not be 
maintained as measured by bone marrow reconstitution. Also in vitro, in a colony 
assay we found reduced colony formation potential but Pumilio1 overexpression in 
progenitors allowed formation of all myeloid lineages. However, we saw an increase 
in GM colonies at the expense of G colonies, indicating that Pumilio1 influences 
bipotent GM progenitors. This result might be not relevant, because upon reanalysis 
of mature cells by FACS at the end of the colony assay, we found that only 3% of 
cells still expressed Pumilio1 in contrast to 64% of cells still expressing the vector 
control. We had seeded only VENUS+ cells into the colony formation assay and 
therefore, it is unlikely that so many colonies were produced by uninfected cells. It is 
also unlikely that Pumilio1 when expressed as VENUS fusion is completely toxic to 
bone marrow cells as we could detect up to 35% of Pumilio1 positive cells 3 days 
after virus infection by FACS analysis. It is possible however, that Pumilo1 expression 
is silenced in many cells as cells expressing Pumilio1 could have a disadvantage 
compared to cells without it. In time lapse movies of vector and candidate gene 
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infected cells we sometimes saw sister cells, that first displayed equal intensity of 
fluorescence immediately after division. Subsequently however, we saw loss or 
decrease of VENUS signal in only one daughter cell while the other daughter retained 
its fluorescence signal with the same intensity (data not shown), indicating probably 
the formation of two different fated cells by extrinsic signals. As VENUS mean 
fluorescence intensity was much higher in vector control infected cells compared to 
cells infected with any of the candidates, a decrease in VENUS signal in a candidate 
infected cell would result more readily in a loss of detectable signal than in vector 
control infected cells. Therefore, one would expect less VENUS expressing cells in 
mature cells from candidate infected cells than from vector control infected cells. 
However, when we measured the percentage of VENUS+ cells in Staufen1 and 
Staufeni infected cells at the end of the colony assay, we found still up to 40% of 
VENUS expressing cells (data not shown). As the mean fluorescence of Staufen1 
IRES expressing cells is lower than mean fluorescence of Pumilio1 fusion positive 
cells, we would expect even more VENUS+ cells in Pumilio1 fusion infected cells. 
Therefore, it is likely that Pumilio1, when expressed as a fusion, affected on the one 
hand colony formation by various means: Pumilio1 expression could lead to cell 
death of progenitors at a certain differentiation stage, it could interfere with 
proliferation of progenitors so that they could not produce visible colonies, or it could 
cause fast differentiation of progenitors into mature cells that do not have colony 
potential. On the other hand since we detected only few VENUS positive cells at the 
end of this assay, it is for sure that a large number of cells must have silenced 
Pumilio1 expression to levels that are not detectable by FACS anymore. Gerber et al., 
looking for mRNA targets of Pumilio in adult Drosophila ovary, found Pumilio mRNA 
as a target of Pumilio protein, although they did not find a consensus binding motif 
in the Pumilio RNA sequence (Gerber, Luschnig et al. 2006). Also in C.elegans it was 
found that two Pumilio homologues autoregulate each other by translational 
repression of the mRNAs (Lamont, Crittenden et al. 2004). A Pumilio homolog in 
C.elegans is also inhibited by Notch signalling (Lamont, Crittenden et al. 2004) a 
target of GLD-3, a subunit of an atypical Poly-A polymerase and the STAR protein 
GLD-1, which both are themselves also targets of Pumilio (Eckmann, Kraemer et al. 
2002; Kimble and Crittenden 2007). Therefore, it is conceivable that also mouse 
Pumilio controls its own translation either by direct interaction with its mRNA or via a 
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feedback loop that involves other regulators and thus could explain the observed 
silencing. 
 We did not see any or very few VENUS+ cells in Pumilio1 IRES as well as in 
Pumilio2 fusion and Pumilio2 IRES infected HSC. There are several explanations for 
this result. As viral titers were low, either because the constructs were too large or 
wildtype Pumilio1 and or 2 were interfering with virus production and assembly, this 
could explain low infection efficiency of HSC. However, we used the same MOIs as 
for other viral vectors. In addition, infection of PA6 stromal cells, that can be infected 
easily also with low-titer viruses, yielded barely any infected cells with only weak 
fluorescence signal. Therefore, the IRES behind the fairly long Pumilio reading 
frames resulted in insufficient translation of VENUS and therefore too low 
fluorescence signals. For these proteins it might be of advantage to use 2A 
sequences instead of IRES to separate the candidate gene from the fluorescent 
reporter (de Felipe, Martin et al. 1999). Cloning a 2A sequence between the 
candidate and the reporter leads to translation of one long polypeptide that is 
subsequently cleaved by cellular proteinases resulting in equal amounts of candidate 
and reporter.  
The other explanation for the low infection efficiencies of these viruses could 
be that these proteins when overexpressed in wildtype form are toxic to cells and 
therefore, cells could die even before a VENUS signal becomes apparent. Against a 
toxicity of Pumilio2 speaks that we saw VENUS positive cells within the HSC 
compartment as well as other progenitor compartments when Pumilio2 was 
specifically expressed in the bone marrow by crossing inducible Pumilio2 transgenic 
mice with Tie2CRE mice. From this result we conclude that at least some cells with 
HSC phenotype are produced and maintained when Pumilio2 is expressed. This result 
also speaks against low VENUS signals as a reason for low infection efficiencies since 
transgenic mice were produced from a Pumilio2 IRES construct and we did not have 
difficulty detecting VENUS signal in these mice. Further experiments will have to 
examine Pumilio2 expressing HSC and progenitors from these mice for their 
reconstitution and fate decision properties.  
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6.8.3. Effect of Quaking1 on Fate Decisions 
The overexpression of Quaking1 in HSC and progenitors allowed colony 
formation and generation of all myeloid lineages in vitro. In vivo reconstitution 
experiments however showed that Quaking1-6B expression did not allow HSC 
maintenance as measured by bone marrow reconstitution. Quaking1-5A expression 
allowed maintenance of very few phenotypical HSC that we found in the bone 
marrow of reconstituted mice, however, the low number of events positive for 
VENUS expression within the HSC population leaves doubts as to the relevance of 
those few percent. The loss of HSC potential in Quaking1 overexpressing cells is not 
astonishing, when comparing Quaking1 to its C.elegans homolog Gld1. Gld1 in the 
C.elegans germline promotes oocyte differentiation from germline stem cells. In null 
mutants of Gld1, germcell tumors are formed and oocyte differentiation is inhibited 
(Francis, Barton et al. 1995). If this is transferred to HSC, abolishment of Quaking1 
would result in leukemic HSC expansion but gain of Quaking1 in increased 
differentiation. Indeed only very few progenitor cells as well as more mature cells of 
the GM and erythroid lineage could be detected in the bone marrow of mice 
transplanted with Quaking1 expressing HSC. Also PB levels in transplanted mice 
showed a rapid decrease in Quaking1 expressing cells. Therefore, it is likely that 
Quaking1 expression led to a fast differentiation in vivo. The in vitro data of 
Quaking1 expressing cells indicates however, that differentiation could not have 
progressed too far down the hierarchy of blood development, as these cells could still 
form normal colonies of all lineages. The reduced G colonies in both Quaking1-5A 
and -6B as well as more GM and more M colonies in Quaking1-5A and -6B 
respectively, indicates that G colony formation was somehow inhibited in Quaking1 
expressing progenitors. The role of Quaking1 in GM lineage decisions is interesting 
and should be further explored in time lapse movies. We selected Quaking1 as a 
candidate partly because its homolog Gld1 is regulated by C. elegans Pumilio 
(reviewed in Kimble and Crittenden 2007).  The fact that both Pumilio1 as well as the 
Quaking1 isoforms seem to have an effect on GM lineage decisions in vitro could hint 
towards a connection of Pumilio and Quaking1 in mammals, although studies as to 
their interaction have to be undertaken to confirm this notion. 
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In summary, Staufen1, Staufeni, Pumilio1, Quaking1-5A and -6B interfere with 
HSC maintenance in expansion condition of reconstituted mice. The Pumilio2 effect 
on HSC maintenance was not examined under these same conditions, but resulted in 
at least some HSC maintenance in homeostasis conditions in a transgenic mouse 
model. It would be interesting to see if Staufen1 as well as Quaking1 isoforms and 
Pumilio1 would allow HSC maintenance under homeostasis conditions as well. 
Unfortunately no functional transgenic mice were available expressing these 
candidates. It will be also interesting to transplant HSC expressing Pumilio2 from 
transgenic Pumilio2 mice into recipients and evaluate the effect of Pumilio2 on HSC 
behaviour in expansion situation.  
In addition, if the loss of HSC potential caused by candidate overexpression 
results in rapid loss of HSC potential before the first division of HSC, it is possible 
that protein segregation of candidates cannot take place anymore if this is an HSC 
specific mechanism that is not active in non-HSC anymore. 
 
 
6.9. Conclusion 
We could show at the single cell level and with a high temporal resolution that 
HSC differ in their division kinetics as well as in their fate decision properties from 
MPP. We show that HSC produce asymmetric fated daughter cells independently of 
their environment and intrinsically control the decision between self renewal and 
differentiation as measured by a live marker. The mechanism how this is achieved 
remains unknown, but we show here a method how a large number of candidate 
genes can be screened fast and efficiently for their potential role in protein 
segregation and fate decisions. Although they were not segregated in HSC divisions, 
the here examined candidate genes, Staufen1, Staufeni, Pumilio1, and Quaking1-5A 
and -6B, do influence HSC maintenance and fate decisions and therefore must play a 
critical role in HSC function.  
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7. Experimental Procedure 
 
 
7.1. Isolation of Stem and Progenitor Populations 
For isolation of HSC, MPP populations and CLP, femurs, tibias and hipbones 
were removed from 12 week old male C57Bl/6J mice, cleaned of muscle tissue and 
crushed with a mortar and pestle. The obtained cell suspension was passed through 
a cell strainer (cat no 8240816, BD Biosciences). Cells were resuspended in FACS 
buffer containing 2% FCS (cat no P30-3302, PAN Biotech GmbH, Aidenbach, 
Germany), 1mM EDTA (cat no 8043.2, Roth, Karlsruhe, Germany), 0.1% Sodium-
Azide (cat no S2002-25G, Sigma, Taufkirchen, Germany) and PBS. PBS was prepared 
from 8 g NaCl (cat no S/3160/65, Fisher Scientific, Schwerte, Germany), 0.2 g KCl 
(cat no 4936.1000, Merck, Darmstadt, Germany), 0.2 g KH2PO4 (cat no 
1.04873.1000, Merck, Darmstadt, Germany) and 1.18 g Na2HPO4 (cat no T876.2, 
Roth, Karlsruhe, Germany) dissolved in 1l bidistilled water and sterilized. For isolation 
of myeloid progenitors, as well as for analysis of bone marrow progenitors of 
transplanted mice, bone marrow was flushed from tibias and femurs and 
mononucleated cells were isolated using a Histopaque 1083 gradient (Sigma Aldrich). 
Cells were then resuspended in FACS buffer for staining.  
Cells from bone marrow - PA6 cocultures were dissociated using Hank’s 
enzyme free dissociation buffer (cat no 13150-016, Gibco/Invitrogen, Karlsruhe, 
Germany) for 40 min at 37°C, resuspended in FACS buffer containing propidium 
iodide (PI, P4170, Sigma, Taufkirchen, Germany) and filtered through a cell strainer 
(cat no 352235, BD Falcon, Franklin Lakes, USA) before analysis.  
Colonies in semisolid medium were resuspended after counting in 10ml PBS 
per 35mm cell culture dish, pelleted and resuspended in FACS buffer containing PI. 
 
 
7.2. Antibody Staining 
All stainings were performed in 50µl volume of FACS buffer.  
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For isolation and analysis of HSC, MPP and CLP, cells were stained with 50ng 
each per 106 cells of the following biotinylated lineage antibodies: Ter-119 (Ter119, 
cat no 13-5921), CD11b (M1/70, cat no 13-0112), Gr-1 (RB6-8C5, cat no 13-5931), 
CD41 (MWReg30, cat no 130411), CD3ε (145-2C11, cat no 13-0033), B220 (CD45R, 
RA3-6B2, cat no 13-0452), and CD19 (1D3, cat no 130193, all eBioscience, San 
Diego, USA). Cells were lineage depleted according to manufacturer’s instruction 
using 20% of reagents from Easy Sep Biotin Selection kit (cat no 18556, Stem Cells 
Technology, Vancouver, Canada). Lineage depleted cells were stained with the 
following antibodies for HSC and MPP stains per 106 cells each: 40ng Streptavidin 
Alexa750 (cat no 47-4317, eBioscience), 60ng c-kit PECy7 (2B8, cat no 25-1171, 
eBioscience), 40ng sca-1 Pacific Blue (D7, cat no 108120, Biolegend, San Diego, 
USA), 100ng CD34 Alexa647 (RAM34, cat no 51-0341, eBioscience), and 40ng CD48 
PECy5 (HM48-1, cat no 103420, Biolegend). For experiments analyzing asymmetric 
fates, 106 cells were additionally stained with 60ng Flt3 PE (A2F10, cat no 12-1351, 
eBioscience). For protein segregation experiments and viral infections, 106 cells were 
stained instead with 40ng CD150 PE (TC15-12F12.2, cat no 115904, Biolegend) in 
addition to HSC antibodies. For isolation of CLP, lineage depleted cells were stained 
with 40ng Streptavidin Alexa750, 60ng c-kit PECy7, 40ng sca-1 Pacific Blue, and 
40ng IL7Rα-PE (A7R34, cat no 12-1271, eBioscience). 
For isolation of myeloid progenitor populations 106 isolated mononucleated 
bone marrow cells were stained with 50ng each of the following biotinylated 
antibodies: Ter-119, Gr-1, CD41, CD3ε, B220, CD19, IL7Rα (A7R34, cat no 13-1271, 
eBioscience), with the addition of 50ng biotinylated Flt3 (A2F10, cat no 13-1351, 
eBioscience) for CMP isolation and 50ng biotinylated CD71 (R17217, cat no 13-0711, 
eBioscience) for MEP isolation. For the isolation or analysis of CMP, GMP and MEP, 
cells were additionally stained with 60ng c-kit PECy7, 40ng sca-1 Pacific Blue, 100ng 
CD34 Alexa647, 40ng FcγR FITC (2.4G2, cat no 553144, Pharmingen/BD Biosciences, 
Heidelberg, Germany) and 40ng Streptavidin APC-Cy7.  
For analysis of bone marrow progenitors of transplanted mice, 106 
mononucleated cells were stained with 40ng CD45.2 PECy5.5 (104, cat no 35-0454, 
eBioscience). For analysis of myeloid lineage cells, 106 isolated cells were stained 
with 40ng Ter119 APC Alexa780, 50ng biotinylated Mac-1, and 40ng Ly6G PE (1A8, 
551461, Pharmingen/BD Biosciences). For analysis of erythroid lineage cells, 106 cells 
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were stained with 40ng the following lineage antibodies, all in APC: Mac-1 (M1/70, 
cat no 170112, eBioscience), Gr-1 (RB68C5, ) cat no 17-5931, eBioscience), B220 
(RA3-6B2, cat no ,17-0452,  eBioscience), as well as 50ng biotinylated CD71 (R17-
217, cat no 130711, eBioscience), 50ng Ter119 PE (Ter119, cat no 556673, 
Pharmingen/BD Bioscience) and 40ng Streptavidin Pacific Blue.  
 
 
7.2.1. Labelling of CD48 Antibody 
CD48 (HM48-1, cat no 103408, Biolegend) was labelled with Alexa647 (cat no 
A20186, Bioprobes/Invitrogen, Karlsruhe, Germany) according to the manufacturer’s 
instructions. 
 
 
7.2.2. Titration of CD48 Antibody 
The CD48 antibody was titrated using 0.2, 0.5, 1, and 2 µg labelled antibody 
per 106 lineage+ bone marrow cells, which were a by-product of the lineage 
depletion. Lineage+ cells were suspended in 50µl of FACS buffer, stained with 
antibody for 30 minutes at 4°C, and analyzed with the FACS Aria. 
For in culture titration, KSL cells were cultured in SFEM (SFEM, no 09650, 
Stem Cell Technologies) containing 100 ng/ml SCF (cat no 250-03, PeproTech, 
Hamburg, Germany), 10ng/ml IL3 (cat no 213-13, PeproTech), and 10ng/ml IL6 (cat 
no 216-16, PeproTech) for 4 d in the presence of CD48 Alexa647 at the following 
final concentrations: 0, 2, 1, 0.2, and 0.1µg/ml. After 4 d of culture, cells were 
pelleted, washed, resuspended in FACS buffer and stained with CD48 FITC (cat no 
11-0481, eBioscience) for 30 minutes on ice before FACS analysis. 
 
 
7.3. Flow Cytometry 
Cells were analyzed by flow cytometry using a FACS Calibur System (Becton 
Dickinson, San Jose, USA) equipped with 488 nm and 635 nm lasers. FITC and 
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VENUS signals were detected using the filter 530/30, PE and tdTOMATO signals were 
analyzed with the 585/42 filter, PI was detected with the filter 630 LP and APC and 
Alexa647 signals were detected with the filter 661/16. 
A FACSAria cell sorter (Becton Dickinson, San Jose, USA) was employed to 
isolate individual populations by cell sorting. VENUS and FITC signals were analyzed 
using the 488 nm laser and 530/30 emission filter. PE and tdTOMATO were excited 
with the 488 nm laser and detected using the emission filter 575/26. PE-Cy7 signals 
were recorded using the 488 nm laser and the 780/60 emission filter. APC and 
Alexa647 were illuminated with the 633 nm laser and detected in the 660/20 
emission filter. PI was excited using the 407 nm laser and detected using the 610/20 
emission filter. Sorting was performed with a maximal flow rate of 3 using high 
precision mode (0/32/0). Sorting purity was ensured either by reanalysis of sorted 
cells for progenitor populations or by conducting a resort analysis before the actual 
sorts for HSC. Data were analyzed with FACS DiVa (Becton Dickinson), CELLQuest 
Pro (Becton Dickinson) and WinMDI 2.8 (www.facs.scribbs.edu) softwares. 
 
 
7.4. Cell Culture Conditions 
All cells were cultured at 37°C, 5% CO2 and 95% relative air humidity in a 
standard tissue culture incubator (Microbiological Incubator CD210; Binder; 
Tuttlingen, Germany). 
All centrifugation steps were carried out with 240 x g for 5 min if not indicated 
differently. Cells were washed using sterile PBS. To ensure good quality of the 
media, cell culture media were not stored for longer than 4 weeks after preparation. 
 
 
7.4.1. Colony Formation Assay 
For colony assays of virus infected cells, cells were infected in 96 well plates 
for 3 d in 100ng/ml SCF and 100ng/ml TPO in 100µl SFEM. VENUS positive cells were 
sorted into IMDM with 2% FCS. Cells were counted in Terasaki plates by adding 5µl 
of cell suspension per Terasaki well and centrifugation at 400xg for 5 min. 400 cells 
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were added in 100µl IMDM with FCS to 1.1ml semi solid media allowing formation of 
all myeloid lineages (Methocult, cat no 03434, Stem cell Technologies) and 1% 
Pencillin/Streptomycin (cat no 15070063, Invitrogen). The suspension was vortexed 
for 10 s and pipetted carefully, to avoid transferring of bubbles, into one 35mm 
plate. After 7 d (progenitors) or 10 d (stem cells) at 37°C, cell clusters containing a 
minimum of 30 cells were counted as colonies.  
Colony types were identified as follows: Erythroid colonies contain at least 30 
erythroid cells that are tiny and irregular in shape and appear as if they are fused 
together. Mature erythroid colonies turn red-brown at the center, as they produce 
hemoglobin. Megakaryocyte colonies contain at least 2 megakaryocytes. 
Megakaryocytes can be identified by their large size and their orange-skin appearing 
plasma membrane. They also have a segmented nucleus that can be easily identified 
when observing nuclear membrane localized fluorescent protein infected cells. 
Granulocyte colonies contain at least 30 small cells that are slightly bigger than 
erythrocytes. Granulocyte colonies can be small and dispersed or when they are 
larger become tightly packed and contain several clusters. Macrophage colonies 
contain at least 30 cells. Macrophages can be easily identified by their small nucleus 
and long spindle-like shape, which becomes especially apparent when they are able 
to attach to the bottom of the dish due to limited amount of methylcellulose. GM 
colonies are characterized by the presence of both granulocytes and macrophages. 
They can be identified by tightly packed centers and are more spread out around the 
edges. ME colonies contain megakaryocytes and erythrocytes and it is important to 
try to identify erythroid clusters among the large megakaryocytes. Large 
megakaryocyte only colonies also contain smaller cells which are megakaryocyte 
committed cells and not erythrocytes. GEMM colonies contain all four myeloid cell 
types and are consistent of 500 or more cells. To distinguish them from large GM 
colonies, it is easiest to identify the large megakaryocytes among them. Also 
erythrocyte clusters should be present on the colonies edges.  
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7.4.2. Cell Lines 
7.4.2.1. PA6 Cell Culture 
PA6 (MC3T3-G2/PA6) stroma cells were cultured as described previously 
(Kodama, Amagai et al. 1982). PA6 cells were kept in medium containing 10% of 
FCS (cat no P30-3302, PAN Biotech GmbH) in α-minimal essential medium (α-MEM). 
α-MEM was prepared from powder (cat no 25080, Gibco/Invitrogen, Karlsruhe, 
Germany) which was solved in a sodium bicarbonate solution (cat no 11900-016, 
Gibco/Invitrogen) and sterile injection water (cat no 7202A161, Braun, Melsungen, 
Germany) according to manufacturer’s instructions. PA6 cells were only kept for a 
maximum of 25 passages and only dissociated and diluted when 100% confluent as 
otherwise cells lost their supportive properties. In general, PA6 stroma was diluted 
every 4 days 1:4 by washing with PBS, trypsinizing with 0.05% Trypsin/EDTA (cat no 
25300-054, Gibco/Invitrogen) for 2 min at 37°C. Dissociated PA6 cells were 
resuspended in culture medium and mixed gently to obtain a homogenous cell 
solution which was diluted with medium, seeded onto fresh tissue culture dishes and 
moved carefully to ensure equal distribution of cells on the culture plate. 
 
 
7.4.2.2. Freezing and Thawing of Cells 
To store PA6, cells were first trypsinized, resuspended in normal culture 
medium and centrifuged. The cell pellet was then resuspended in culture medium 
containing 10% dimethylsulfoxide (DMSO, cat no D2438, Sigma) and transferred to 
cryotubes and frozen in Cryo Freezing containers (cat no 5100-0001, Nalgene, 
Rochester, USA) at -80 °C. After one day, cells were transferred into the nitrogen 
tank. For thawing, PA6 cells were removed from the nitrogen tank and the lid of the 
cryotube was slightly opened to permit gas pressure release upon warming up. Cells 
were kept in a 37°C water bath for the time the cells needed to defrost completely. 
Cells were washed with 10ml of culture medium to remove DMSO and were 
transferred into a well of a 6-well cell culture dish. The medium was changed again 
on the next day.  
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7.4.2.3. Transient transfections 
All transient transfections were carried out using Lipofectamin2000 (cat no 
11668-019, Gibco/Invitrogen, Karlsruhe, Germany) and Opti-MEM (cat no 51985, 
Gibco/Invitrogen). To check the fluorescence signal produced from ubiquitously 
expressed plasmid DNA, HEK cells were transfected. Cells were prepared in a 10cm2 
dish to be approximately 30% confluent at the day of transfection. For transfection 
10μl Lipofectamin2000 were mixed with 90μl Opti-MEM and incubated 15 min at RT. 
2μg of DNA was added and vortexed. After incubating another 15 min at RT the 
culture medium was removed and replaced with the Lipofectamin2000-DNA 
suspension. Cells were allowed to take up DNA and grow for at least 24 h before 
analysis.  
To check specific localization of ubiquitously expressed tagged fluorescent 
proteins, PA6 cells were transiently transfected. 30% confluent PA6 grown in a 6-well 
dish were transfected as follows: 15μl Lipofectamin2000 were mixed with 85μl opti-
MEM. Separately, 2μg DNA were mixed with Opti-MEM to a final volume of 100μl. 
Both were incubated for 20 min at RT, mixed and incubated for another 20 min at 
RT. Afterwards, the medium of PA6 cells was removed, replaced with the 
lipofectamin-DNA mixture and incubated for 2 d before analysis. 
 
 
7.4.3. Primary Cells 
7.4.3.1. HSC Cocultures on PA6 
Confluent PA6 layers were utilized for cocultures with bone marrow stem and 
progenitor cells. Isolated bone marrow cells were cultured on PA6 layers in IMDM 
(Osmolarity: 315, cat no P04-20451S1, PAN Biotech GmbH) with 20% horse serum 
(HS, cat no 16050-122, Gibco/Invitrogen), 10-7M hydrocortisone (cat no H0888, 
Sigma) and 100ng/ml SCF (cat no 250-03, PeproTech, Hamburg, Germany). For in 
culture staining, CD48 Alexa647 was added to the media at 0.2µg/ml. 
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7.4.3.2. Stroma Free Suspension Culture 
For stroma free cultures of isolated hematopoietic stem and progenitor cells, 
cells were cultivated in serum free media (SFEM, no 09650, Stem Cell Technologies) 
with 100ng/ml SCF (cat no 250-03)), SCF and 100ng/ml TPO (cat no 315-14), SCF 
and 10ng/ml IL3 (cat no 213-13), or SCF and 100ng/ml IL6 (cat no 216-16, all 
PeproTech). As in PA6 cocultures, CD48 Alexa647 was added to the culture media at 
a dilution of 0.2µg/ml. 
 
 
7.4.3.3. Fibroblast Isolation from Mouse Tail Clips 
Fibroblasts were isolated out of 5mm long tailclips from transgenic mice. The 
outer skin containing hair was removed and the remaining tissue chopped into small 
pieces with scissors. Tissue was suspended in 100µl of PBS containing 7mg/ml 
collagenase1 and 7mg/ml collagenase2 and transferred to a 96 well plate. The plate 
was incubated for 30 min in a 37°C shaker. Subsequently, enzymatic reaction was 
stopped by adding 150µl of DMEM with 10% FCS. After 7 days, cells were growing 
out of tissue and can then be infected by adding 105 virus particles per well of CRE 
virus (546 pRRL.PPT.SF.CRE-IRES-mito-tdTomato-pre) or control virus (544 
pRRL.PPT.SF.IRES-mito tdTomato pre). Cells were checked daily for fluorescence 
expressing cells. Cells were trypsinized and resuspended in FACS buffer and analyzed 
on the FACS Calibur. 
 
 
7.5. Virus Production 
HEK 293T cells were kept in DMEM (cat no 41966, Gibco/Invitrogen) 
containing 10% FCS and split every 2 d at a ratio of 1:8. For virus production cells 
were seeded at a density of 5x106 cells per 60cm2. For each 60cm2 dish the following 
plasmids were added to 450µl of water and 50µl of CaCl2 solution (cat no CAPHOS-
1KT, Sigma) 16 h after cell seeding: 5ng of transfer vector containing the candidate 
gene (derived from plasmid 390 pRRL.PPT.SF.GFPpre), 2ng envelop vector 
containing either ecotropic (plasmid 391 K73  pEcoEnv-IRES-puro) or VSVG 
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pseudotyped envelop protein (plasmid 495 pMD2.VSVG), 10ng plasmid containing 
RRE (Rev responsive element, plasmid 393 pMDLg_pRRE), and 5ng plasmid 
containing Rev (regulator of expression of virion proteins, plasmid 392 pRSV_Rev), 
390 pRRL.PPT.SF.GFPpre, 391 K73  pEcoEnv-IRES-puro, 392 pRSV_Rev, 393 
pMDLg_pRRE , and 495 pMD2.VSVG  were all obtained from Dr. Christopher Baum 
and previously published in Schambach et al. 2006 (Schambach, Galla et al. 2006). 
The latter two elements are needed for an increased expression efficiency of 
the viral RNA. The plasmid mix was then added to 500µl of Hepes buffered saline 
(HBS, from CAPHOS-1KT, Sigma) using air bubbling and subsequently the mixture 
was vortexed for 10s and incubated for 20min. This allowed formation of CaPO4 
crystals which enabled transfer of DNA into cells. Growth media was removed from 
HEK 293T cells and replaced by 10ml of transfer media (TF) containing DMEM, 10% 
FCS, 1% sodium pyruvate (cat no S8636, Sigma), 20nM HEPES (cat no 15630-856, 
Gibco/Invitrogen) and 15µM chloroquine (cat no C6628, Sigma). After incubation, the 
DNA-HBS mix was added slowly to HEK 293T cells in fresh TF medium and incubated 
for 8 h in a cell culture incubator allowing DNA uptake by the cells. After incubation, 
medium was replaced by fresh TF medium without chloroquine. Cells were allowed to 
produce virus for 36 h, after which the supernatant was removed, pooled and kept 
on ice. The virus containing media was then centrifuged at 240 x g for 5 min at 4°C 
and the supernatant filtered through a 0.2 µm filter (cat no Minisart 17597, 
Sartorius-Stedim, Göttingen, Germany) to remove cell debris. Cell culture dishes 
containing HEK 293T cells from the virus production were checked under the 
microscope for fluorescent signal produced by transfected expression plasmids. Viral 
supernatant was then transferred to polyallomer centrifugation tubes (cat no 326823, 
Beckman, Krehfeld, Germany) and centrifuged at 10000 x g for 16 h at 4°C for 
ecotropic virus and at 50000 x g for 1 h at 4°C for VSVG pseudotyped virus. After 
centrifugation, the supernatant was removed from the ultra centrifugation tubes, the 
pellet resuspended in 200µl of SFEM and the virus aliquoted and frozen at -80°C. 
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7.5.1. Virus Titration 
3T3 NIH cells were kept in DMEM with 10% FCS and seeded every 3d at 105 
cells per 25cm2. For virus titration, 5x104 cells per well were seeded into a 24 well 
plate. 16 h after cell plating, cells were counted and medium was changed and virus 
was thawed and added in triplicates at dilutions from 10-1 to 10-4. After 48 h cells 
were checked for the presence of fluorescence signal in the microscope. Cells were 
then trypsinized, suspended in 300µl of fresh media per well and subsequently 
analyzed by FACS. The virus titer was calculated considering obtained percentages of 
VENUS+ cells and dilution factors. Briefly, the number of counted cells from one well 
times the percentage of VENUS+ cells and divided by 100 equals the amount of virus 
particles per well.  
The virus titer equals the amount of virus per well times the dilution factor per 
1ml media that the cells are contained in. The virus titers from 3 wells are averaged. 
The final titer is the average of all virus dilutions that yield percentages of VENUS+ 
cells between 3% and 30%. 
 
 
7.5.2. Virus Infection 
Cells isolated by FACS sorting were added in 5µl volume in a Terasaki well and 
centrifuged. Cells that were at the bottom of the well were counted. For virus 
infection, cells were centrifuged in an eppendorf tube for 400xg for 10 min at 4°C 
and left in 100µl of SFEM containing 100ng/ml SCF and 100ng/ml TPO for each viral 
vector.  
For infection of HSC by spin infection wells of a 96 well plate were coated with 
retronectin (cat no TAK T100, Takara, Madison, USA). Per well 50µl of retronectin in 
PBS at a concentration of 20µg/ml were added, incubated for 2 h, blocked with 2% 
BSA for 30 min and washed with PBS. Cells in SFEM were added to the well together 
with 10µg/ml protamine sulfate (cat no P4380, Sigma) and virus at a MOI of 600. 
The plate was spun at 37°C (or as indicated) for 1 h at 400 x g. 
For standard infection procedure, the cell suspension was transferred to a 96 
well plate and virus was added at MOI of 100. Not more than 1000 cells should be 
infected per one well to avoid accumulation of precipitate of virus as this can 
Experimental Procedure 151
interfere with infection efficiency. Adding of virus was done in the S2 lab and cells 
were incubated over night at 37°C in the S2 lab incubator to allow for infection. After 
infection, supernatant still contains active virus so it is important to handle it with 
care. Cells were resuspended in 1ml SFEM containing cytokines pertinent to the 
experiment and washed twice in 1ml in an 1.5ml eppendorf tube by centrifugation. 
 
 
7.6. Transplantation Experiments 
For all transplantation experiments, non irradiated W41/W41 mice, generous 
gift from Dr. Norman Iscove, were used as recipient mice. Bl6 were utilized as donor 
mice. Differential expression of CD45 alleles distinguished donor (CD45.2) from 
recipient (CD45.1) blood cells in peripheral blood (PB).  
For experiments analyzing reconstitution potential of cultured HSC, HSC were 
cultured on PA6 for 90 h, dissociated and stained with antibodies. Cells were stained 
with 50ng CD45 FITC (30-F11, eBioscience), 50ng self labeled CD48 Alexa647 per 
106 cells as well as KSL antibodies (as in HSC isolation from bone marrow) and 
CD45+CD48- and CD45+CD48+ cells were sorted. CD48- cells equivalent to 82 and 
500 CD48-KSL cells respectively as well as CD48+ cells equivalent to 271 CD48+KSL 
cells were transplanted in triplicates into recipient mice. For experiments analyzing 
the effect of candidate gene expression on HSC potential, 700 HSC per mouse and 
virus were cultured in triplicates in the presence of SCF and virus for 2 d and were 
transplanted into recipients.  
For all transplantations, isolated cells were mixed with 105 mononucleated 
bone marrow cells and resuspended in 300µl of sterile PBS per mouse. The tail of the 
recipient mice was pretreated with a heating lamp to facilitate injection into the tail 
vein. Cell suspension was injected using a 28G needle. 
For both experiments, the percentage of donor cells in the PB was assessed 
every 4 weeks for 16 weeks. Briefly, 5mm of mouse tail was cut and 3 drops of blood 
collected in tubes containing 30µl Sodium Salt (H4784, Sigma) dissolved in PBS. The 
following lysis was performed twice: 500µl PBS were added and the solution pelleted 
for 10 min. After removal of supernatant, 30µl of ACK lysing buffer (cat no 10-548E, 
Lonza, Basel, Switzerland) buffer were added to the pellet and vortexed for 1 min. 
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Cells were subsequently resuspended in FACS buffer and stained as follows. For 
analysis of peripheral blood (PB) from transplanted mice, 106 cells were stained with 
50ng biotinylated CD45.1 (A20, cat no 17-0453), 40ng CD45.2 APC (104, cat no 17-
0454, eBioscience), 40ng Mac-1 PECy7 (M1/70, cat no 552850, Pharmingen/BD 
Biosciences), 40ng Gr-1 PECy7 (RB6-8C5, cat no 552985, Pharmingen/BD 
Bioscience), 40ng B220 PE (RA3-6B2, cat no 12-0452, eBioscience), 40ng Ter119 
APC Alexa780 (Ter119, cat no 475921, eBioscience), and 40ng Streptavidin Pacific 
Blue (cat no S11222, Molecular Probes/Invitrogen, Karlsruhe, Germany). 
Ter119 negative cells were analyzed for the expression of CD45.1 (recipient 
cells) and CD45.2 (donor cells). CD45.2 cells were then analyzed for the presence of 
myeloid (Gr-1 and Mac-1 expressing) cells and lymphoid (B220 expressing) cells. 
In mice transplanted with virus infected cells, VENUS expression of donor cells 
was assessed in addition. Mice transplanted with virus infected cells were sacrificed 
18 weeks after transplant, bone marrow was isolated and separated by a Histopaque 
1083 gradient.  The percentage of VENUS+ cells within the donor cells in HSC 
(CD150+CD48-CD34-KSL), KSL, CMP, GMP, MEP, CLP as well as myeloid and erythroid 
lineage cells was determined. 
 
 
7.7. Plasmid Vector Cloning 
7.7.1. Purification of Plasmid DNA 
High copy plasmids were purified from competent bacteria using the Qiaprep 
Spin Miniprep Kit or the Qiagen Plasmid Maxi Kit (cat no 27104 and 12165, 
respectively, Qiagen, Hilden, Germany). All DNA was solved in sterile bi-distilled 
water. 
 
 
7.7.2. Construction of Plasmid DNA 
DNA was constructed using the Clone Manager software 7, 8 and 9 
Professional Editions. 
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7.7.3. Transformation of Bacteria 
To transform bacteria with plasmids, heat-shock competent Escherichia coli 
(DH5α) were defrosted on ice for about 15 to 30 min. 25ng of plasmid DNA or the 
entire heat inactivated ligation cocktail were added to 50μl bacteria. After incubating 
for 0.5 h on ice, cells were heated to 42°C for 45 sec before cooling them in ice for 2 
min. Cells were mixed with 0.5 ml LB (LB Broth Base, cat no 12780-029; Invitrogen, 
Karlsruhe, Germany) medium without any antibiotics and kept at 37°C while 
constantly shaking. 40 and 400 μl bacteria were plated onto LB agar plates 
containing the required antibiotic, and cultured over night at 37°C. 
 
 
7.7.4. Restriction Digestions and Ligations 
Restriction digestions and ligations were carried out using enzymes and 
suitable buffers from NEB (New England Biolabs, Ipswich, USA) or Fermentas 
(St.Leon-Roth, Germany) according to the manufacturer’s instructions. 
 
 
7.7.5. Agarose Gels 
After digestion DNA fragments were separated on 0.8 to 2% agarose gels 
prepared in TAE (Tris: cat no 5429.2, Roth, Karlsruhe, Germany; Acetate: cat no 
1.00063.2511, Merck, Darmstadt, Germany; EDTA disodium salt dihydrate: cat no 
8043.2, Roth, Karlsruhe, Germany), agarose (cat no 8700500, Biozym, Oldendorf, 
Germany) and Ethidium bromide (cat no 2218.2, Roth, Karlsruhe). DNA fragments 
were separated using voltages between 70 and 200 V in TAE-buffer depending on 
the size of gels. 
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7.7.6. Purification of DNA Fragments 
DNA fragments were cut out from agarose gels using a scalpel and purified 
from the agarose gel using the QIAEX II Gel Extraction Kit or the QIAQUICK Gel 
Extraction Kit (cat no 20021 and 28704, respectively, both Qiagen, Hilden, 
Germany). Purification of PCR products was performed using the QIAquick PCR 
Purification Kit (cat no 28104, Qiagen, Hilden, Germany). 
 
 
7.7.7. Sequencing 
Sequencing was either performed in the GSF sequencing facility using 
BigDye® Terminator v3.1 Cycle Sequencing Kit (cat no 4337456, Applied Biosystems, 
Foster City, USA) and the following PCR conditions: 1 cycle at 96°C for 1 min, 35 
cycles 96°C for 10 s, 50°C for 5 s, and 60°C for 4 min. Alternatively, DNA and 
primers were sent to MWG, Ebersberg, Germany. 
 
 
7.8. Reverse Transcriptase-PCR of Stem and Progenitor Cells 
Reverse transcriptase (RT) polymerase chain reaction (PCR) was performed 
with primers detecting candidate genes (Table 1) in all mentioned bone marrow 
populations. For RT-PCR reactions, all steps were performed using previously 
untouched and autoclaved eppendorf tubes and pipette tips with filters. 500 cells of 
each bone marrow population were sorted into eppendorf tubes containing One Step 
RT-PCR (cat no 210210, Quiagen) master mix made up according to manufacturer’s 
instructions. Sorted cell suspension in mastermix was vortexed and frozen. 50 cell 
equivalents in master mix were employed in individual RT-PCR reactions. After 
addition of enzyme and primers, reverse transcription was performed for 30 min at 
50°C. Subsequently the PCR reaction was initiated by activation of polymerase for 15 
min at 95°C. PCR condition constituted 40 cycles of denaturation for 1 min at 94°C, 
annealing for 1 min at 60°C and extension for 1 min at 72°C. A final extension step 
for 10 min at 72°C ensured complete formation of all PCR products. In each sort and 
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RT-PCR reaction all genes including β-actin and all populations were analyzed in one 
experiment. The complete PCR reaction was analyzed on a 2% agarose gel. 
 
 
7.8.1. Primer design 
Primers were designed using the Clone Manager software 7, 8 and 9 
Professional Editions. Primer sequences and binding locations are listed in Table 1. 
Design of specific primers to Quaking1 isoforms was not possible because most 
exons are shared by all three isoforms and additionally sequences are repeated 
within exons. Therefore primers detecting all three isoforms were designed for 
Quaking1. 
 
 
7.9. Time Lapse Microscopy 
7.9.1. Preparation of Specimen 
Cells in culture need constant CO2 levels of 5%. To allow for maintenance of 
CO2 in the culture vessels during time lapse movies, medium and gas containing 5% 
CO2 was contained without exchange for the duration of movies (up to 7 d). In 
detail, purified cells were plated in medium incubated in the cell culture incubator 
over night to allow for CO2 saturation. After cell plating, cell culture flasks and dishes 
were kept in the incubator for at least another hour to allow for gas exchange. 
Immediately before the start of the movie, caps of cell culture flasks were tightly 
closed and multiwell plates were sealed with scotch tape to prevent gas exchange 
with surrounding air.  
 
 
7.9.2. Acquisition of Time Lapse Images 
Time lapse movies were recorded using a Zeiss inverted fluorescence 
microscope (Axiovert 200 M, Zeiss, Hallbergmoos, Germany), a motorized stage (cat 
no 0431478, Märzhäuser, Wetzlar-Steindorf, Germany) and a PECON heating system 
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to heat a XL incubator (Erbach, Germany) at 37 °C. Images were acquired using 
Aviovision 4.5 software up-graded with a software developed in our laboratory by 
Timm Schroeder (Eilken, Nishikawa et al. 2009). 
Phase contrast images were taken every 2 min with 10x EC-Plan-Neofluar Ph1 
(cat no 440331-9902-000, Zeiss) objective, a 0.63x TV adaptor using a AxioCam 
HRm camera at 1388x1040 or 2776x2080 pixel resolution (Zeiss). Fluorescence 
images were acquired at regular intervals using a mercury (HBO 103 W/2) or a 
xenon (XBO 75 W/2 ORF, both Osram, Augsburg, Germany) lamp. Illumination to 
detect CD48 staining was performed every 50 to 100 minutes (800 ms excitation) 
using filtersets 26 (cat no 488026-0000-000, Zeiss), 50 (cat no 488050-0000-000, 
Zeiss), or Cy5 ET-filterset (cat no F46-006, AHF, Tübingen, Germany). VENUS signals 
from lentivirus overexpression of fusion genes were recorded every 12 to 18 min 
(500 to 1000 ms excitation) using filterset 46HE (cat no 489046-0000-000, Zeiss). 
Acquired images were saved in jpg format compressed to 97% quality for 
phase contrast images and left at 100% quality for fluorescent images. 
 
 
7.10. Data Analysis 
Data were analyzed using TTT (Timm’s Tracking Tool, software developed in 
our laboratory, (Eilken, Nishikawa et al. 2009)) on Siemens Celsius R630 
workstations with 4 to 32 GB of RAM and SUSE Linux operating systems with KDE 
desktop. Movies were analyzed using all recorded phase contrast and fluorescent 
images without further compression. Image contrast was manually enhanced for 
each wavelength channel separately to optimize recognition of relevant cellular 
features. Individual cells were observed and tracked manually evaluating every time 
point. Relevant properties and behaviour (division, death, position, adherence, 
fluorescence, morphology) of cells were stored and displayed in pedigrees. 
Fluorescence intensities were quantified with TTT software as well. All cells with 
questionable identity were excluded from relevant analyses. 
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7.10.1. Image Processing 
Movies were annotated and assembled to Audio Video Interleave (AVI) files 
using Metamorph Offline 6.1r4. Still images were processed on Axiovision 4.5 
software. 
 
 
7.10.2. Statistical Analysis 
The statistical significance of differences was determined using the student’s t-
test for unpaired data. 
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9. Legends to Time Lapse Movies 
 
Supplemental Movie 5.1A: 
Time lapse movie shows second division of corresponding pedigree in Figure 5.2. The 
original time lapse video was recorded and analyzed with the same temporal 
resolution as shown in this movie. All time lapse movies were recorded and analyzed 
with this resolution (2 min intervals). Red dots are tracking marks and indicate the 
cells in the pedigree in Figure 5.2A. 
Time scale: days – hours:minutes:seconds 
 
Supplemental Movie 5.1B:  
Time lapse movie corresponding to Figure 5.2 shows colony formation of a single 
isolated HSC on PA6. The first three divisions of the initially plated cell are shown. 
Red circles are tracking marks and indicate the cells displayed in the pedigree in 
Figure 5.2A. Temporal resolution is compressed for displaying purposes.  
Time scale: days – hours:minutes:seconds 
 
Supplemental Movie 5.2:  
Time lapse movie corresponding to Figure 5.5 shows asymmetric generation times of 
progeny of a single isolated HSC on PA6. The first two divisions are shown. Arrows 
and pauses in the movie correspond to panels B, C, and D in Figure 5.5 and indicate 
asymmetric timing of divisions of HSC daughter cells. Temporal resolution is 
compressed for displaying purposes. 
Time scale: days – hours:minutes:seconds 
 
Supplemental Movie 5.3:  
Time lapse movie corresponding to Figure 5.8 shows generation of Megakaryocytes 
from isolated MPP on PA6. Cell size increases and cells undergo endomitosis as cells 
differentiate into Megakaryocytes. Blue and red arrows correspond to arrows in 
pedigree and panels of Figure 5.8. Pauses in movie correspond to panels 5.8B, C, 
and D. Temporal resolution is compressed for displaying purposes. 
Time scale: days – hours:minutes:seconds 
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Supplemental Movie 5.4:  
Time lapse movie corresponding to Figure 5.14 shows mother cell onset of CD48 
expression in colony derived from an isolated MPP on PA6. Left panel displays phase 
contrast images, while right panel displays CD48 Alexa647 fluorescent signals. All 
cells within the colony show CD48 fluorescence. Red circles indicate track marks that 
highlight cell location. Pause in movie corresponds to Figure 5.14B. Temporal 
resolution is compressed for displaying purposes. 
Time scale: days – hours:minutes:seconds 
 
Supplemental Movie 5.5:  
Time lapse movie corresponding to Figure 5.15 shows symmetric onset of CD48 
expression in HSC progeny cells cultured in stroma free suspension culture 
containing SCF and TPO. Left panel displays phase contrast images, while right panel 
displays CD48 Alexa647 fluorescent images. Red circles indicate track marks that 
highlight cell location. Pause corresponds to panel C in Figure 5.15 and indicates 
weak onset of CD48 expression in marked cells. Temporal resolution is compressed 
for displaying purposes. 
Time scale: days – hours:minutes:seconds 
 
Supplemental Movie 5.6:  
Time lapse movie corresponding to Figure 5.19 shows asymmetric onset of CD48 
expression in HSC progeny cells cultured in stroma free suspension culture 
containing SCF and TPO. Left panel displays phase contrast images, while right panel 
displays CD48 Alexa647 fluorescent images. Red circles indicate track marks that 
highlight cell location. Arrows and pauses in movie correspond to cells in panels B, C, 
and D in Figure 5.19. Blue arrows indicate CD48 positive cells, while white arrows 
indicate CD48 negative cells. Temporal resolution is compressed for displaying 
purposes. 
Time scale: days – hours:minutes:seconds 
 
Supplemental Movie 5.7:  
Time lapse movie corresponding to Figure 5.20 shows asymmetric onset of CD48 
expression in HSC progeny cells cultured in stroma free suspension culture 
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containing SCF and IL3. Left panel displays phase contrast images, while right panel 
displays CD48 Alexa647 fluorescent images. Red circles indicate track marks that 
highlight cell location. Arrows and pauses in movie correspond to cells in panels B, C, 
and D in Figure 5.20. Blue arrows indicated CD48 positive cells, while white and 
black arrows indicate CD48 negative cells. Initial viewing field encompassed the 
whole colony, but is shown here in two viewing fields to show cells in detail. 
Temporal resolution is compressed for displaying purposes. 
Time scale: days – hours:minutes:seconds 
 
Supplemental Movies 5.8A-D:  
Time lapse movies corresponding to data points of sister cell pairs of Staufen1 
expressing cells in Figure 5.26A show protein segregation during division. Left panel 
displays phase contrast images, while right panel displays VENUS expression in 
fluorescent images. Orange arrow indicates mother cell, blue arrows indicate 
daughter cells. Temporal resolution is compressed for displaying purposes. 
Time scale: days – hours:minutes:seconds 
 
Supplemental Movies 5.9A-D:  
Time lapse movies corresponding to data points of sister cell pairs of Staufeni 
expressing cells in Figure 5.26B show protein segregation during division. Left panel 
displays phase contrast images, while right panel displays VENUS expression in 
fluorescent images. Orange arrow indicates mother cell, blue arrows indicate 
daughter cells. Temporal resolution is compressed for displaying purposes. 
Time scale: days – hours:minutes:seconds 
 
Supplemental Movies 5.10A-D:  
Time lapse movies corresponding to data points of sister cell pairs of Pumilio1 
expressing cells in Figure 5.27 show protein segregation during division. Left panel 
displays phase contrast images, while right panel displays VENUS expression in 
fluorescent images. Orange arrow indicates mother cell, blue arrows indicate 
daughter cells. Temporal resolution is compressed for displaying purposes. 
Time scale: days – hours:minutes:seconds 
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10. Abbreviations 
 
°C 
μ               
ACD 
AML 
Amp 
APC 
bp  
BSA 
CAG 
cat no 
CLP 
CMP 
CRU 
d  
D 
DMSO 
DNA 
dsRBD 
EDTA  
Ery 
FACS  
FCS  
FITC  
Flt3  
FCS 
FSC  
FOB 
g  
G 
GB 
Degree Celsius 
Micro 
Asymmetric cell division 
Acute myeloid leukaemia 
Ampicillin 
Allophycocyanine 
Base pair 
Bovine serum albumin 
Chicken beta actin 
Catalogue number 
Common lymphoid progenitor 
Common myeloid progenitor 
Competitive repopulation unit 
Day 
Diffusion coefficient 
Dimethyl-sulfoxide 
Desoxiribonucleic acid 
dsRNA binding domain 
Ethylene-diamin-tetraacetic acid 
Erythrocyte colony 
Fluorescence activated cell sorting 
Fetal calf serum 
Fluorescein-isothiocyanate 
Fms-related tyrosine kinase 3 
Fetal calf serum 
Forward scatter 
Fluorescence over background 
Gram 
Granulocyte colonies 
Giga byte 
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GEMM 
GFP 
GM 
GMP 
GT 
h  
HBSS 
HS 
HSC  
IL  
IRES 
L 
LB 
M 
ME 
Mega 
MEM 
MEP 
min  
ml 
MPP 
MOI 
nucmem  
nm 
ng 
PB 
PBS 
PE 
PI  
RCF 
RT  
RT-PCR 
Granulocyte erythrocyte macrophage megakaryocyte colony 
Green fluorescent protein 
Granulocyte macrophage colony 
Granulocyte monocyte progenitor 
Generation time 
Hour 
Hank's buffered saline solution 
Horse serum 
Hematopoietic stem cell(s) 
Interleukin 
Internal ribosomal entry site 
Liter 
LB broth base 
Macrophage colony 
Megakaryocyte erythroid colony 
Megakaryocyte colony 
Minimal essential medium 
Megakaryocyte erythrocyte progenitor 
Minutes 
Milliliter 
Multipotent progenitor 
Moiety of infection 
Nuclear membrane 
Nanometer 
Nanogram 
Peripheral blood 
Phosphate buffered saline 
Phycoerythrine 
Propidium iodide 
Radial central force 
Room temperature 
Reverse transcriptase polymerase chain reachtion 
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Sca-1 
SCF 
SCID 
SDS 
s  
SSC  
STAR 
TAE  
TCR 
TPO 
TTT  
V  
VSVG 
wt 
Stem cell antigen 1 
Stem cell factor 
Severe combined immune deficiency 
Sodium dodecyl sulfate 
Seconds 
Side scatter 
Signal transducer and activator of RNA 
Tris acetate EDTA 
T-cell receptor 
Thrombopoietin 
Timm's Tracking Tool 
Volt 
Vesicular stomatitis virus G protein 
Wildtype 
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